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Acronyms and Glossary 
Act Primary legislation produced by Parliament 
ALBs Arm’s Length Bodies: independent organisations, sponsored by the DH to undertake its executive functions 
Audit 
Commission 
An independent public body responsible for ensuring that public money is spent economically, efficiently, 
and effectively 
Clinical 
Governance 
A system through which NHS organisations are accountable for continuously improving the quality of their 
services and safeguarding high standards of care, by creating an environment to encourage clinical 
excellence 
CPMP Committee for Proprietary Medicinal Products, part of EMEA 
CSD Committee on Safety of Drugs (now known as the Committee on Safety of Medicines, CSM) 
Department of 
Health (DH) 
The government headquarters of the NHS, led by the Secretary of State for Health and responsible for a 
strategic direction, securing resources and setting national standards 
DES Direct Enhanced Services, part of the 2004 GMS contract 
EMEA European Medicines Agency, decentralised body of the European Union 
FCE Finished Consultant Episode, the denominator for Reference Costs 
Foundation 
Trust 
Established in 2003, Foundation Trusts are independent public benefit corporations, a type of NHS hospital 
run by local managers, staff and members of the public. 
GDS General dental services 
GMC General Medical Council 
GMS General medical services 
GOS General ophthalmic services 
GP General (medical) practitioner; primary care physician 
GPS General pharmaceutical services 
Health Authority Established in 1995, the 100 Health Authorities in England were dissolved in 2002 (see SHA)  
Healthcare 
Commission 
The independent inspection body for NHS, private and voluntary healthcare organisations, an ALB 
HRG Health care Resource Group 
HSC Health Service Circular (a type of Department of Health guidance) 
ICHA International Classification for Health Accounts 
IVF In vitro fertilisation 
LAC Local Authority Circular 
MHRA Medicines and Health care products Regulatory Agency, an ALB 
NHS National Health Service 
NHS Direct A 24-hour telephone service staffed by nurses 
NHS Plan Published in 2000, the Plan outlines the government’s intentions for investment in and reform of the NHS 
NHS Trust A group of NHS hospitals that operates as a single legal entity 
NICE National Institute for Clinical Execellence,  a Special Health Authority (renamed in April 2005 the ‘National 
Institute for Health and Clinical Excellence’) (type of ALB) 
NSF National Service Framework: a document that set national standards for disease management 
Optometrist Ophthalmic optician 
PCT Primary Care Trusts are local health authorities that manage around 75% of the NHS budget.  The 303 
PCTs in England are accountable to their local SHA for planning, securing and improving primary and 
community health care services for their local populations. 
PMS Personal Medical Services are a local alternative to the national GMS contract, aiming to provide greater 
freedom for primary care professionals to address the needs of patients 
PPA Prescription Pricing Authority, an ALB 
PPRS Pharmaceutical Price Regulation Scheme 
QOF Quality and Outcomes Framework, part of the 2004 GMS contract 
RNCC Registered Nursing Contribution to Care 
SDR Statement of Dental Remuneration 
Statutory 
Instrument 
Secondary legislation, made by UK government departments and other Public Authorities which have 
powers to make such instruments (e.g. Department of Health) 
SHA Strategic Health Authority: created in 2002 to manage the local NHS on behalf of the Secretary of State.  
There are 28 SHAs responsible for improving local health services (quality and capacity) and ensuring that 
national priorities are integrated into local health service plans.1 
Special Health 
Authority 
Health authorities which provide a health service to the whole of England; they are independent, but can be 
subject to ministerial direction 
White paper A paper presented to Parliament by a government minister, providing a statement of government policy 
                                                     
1 http://www.nhs.uk/England/AuthoritiesTrusts/Sha/Default.aspx, accessed 08/03/05 
Description of the Benefit Catalogue England 4 
CHE Research Paper 2 
 
   
5
1. Overview of benefit basket in England 
 
The legal framework, within which the National Health Service (NHS) operates, impacts on all six 
categories of the International Classification for Health Accounts (ICHA).  However, duties and 
powers given by the law are not absolute, but tempered by powers of discretion and by the right to 
take resource availability into account.  For example, the duty to provide services is subject to the 
Secretary of State’s judgement of what is necessary to meet ‘all reasonable requirements’ (Secretary 
of State for Health, 1977);(s. 3).  Strictly speaking, this means that patients have no entitlement to 
specific services.   
 
Case law has established that NHS organisations may not operate a ‘blanket ban’ on the provision of 
services (such as particular health technologies or interventions), with the possible exception of 
treatments where the clinical evidence of its inefficacy is overwhelming (Newdick, 2005b);(pp 105-
107).  R v NW Lancashire Health Authority, ex p A, D and G made it illegal for health authorities to 
impose a blanket ban on services they consider to be ‘low priorities’.  Instead, they must adopt a fair 
and consistent policy for decision-making that adequately assesses exceptional cases by considering 
each request for treatment on its individual merits (Newdick, 2005b);(page 101).  This means that 
there are few services that are explicitly excluded from all NHS patients; where exclusions exist, they 
are principally in the domains of medicines and screening.   
 
The NHS therefore produces a situation where patients have no specific entitlements to services, but 
also where little is explicitly excluded.  This means that the internal quality control mechanisms of the 
NHS are important to ensure that citizens’ rights to health care under international law are honoured 
(Montgomery, 2003).  National guidelines, decisions by the National Institute for Clinical Excellence 
and standards employed by regulators in their assessments of NHS performance all contribute to 
what may be considered as ‘reasonable requirements’ for health care provision.  They also help to 
specify the conditions under which patients may be eligible. 
 
Another way in which patient ‘entitlement’ to services might be inferred is by the existence of charges 
or payments.  For example, most patients receiving NHS dental services make co-payments in line 
with a Schedule of Dental Remuneration, with the government paying the remainder of the dental fee.  
This suggests that these services are those that the government endorses as those that, in some 
sense, should be provided.  Equally, the new tariff system of payments for hospital services, whilst in 
no way guaranteeing provision, highlights services that should be accessible on the NHS.   
 
The NHS embodies the statutory package of health care services and is subject to a considerable 
quantity of legislation, regulation and guidance.  We provide an overview of the benefit basket in 
England, clarifying the actors and decision making framework involved by describing the principles 
underpinning the NHS, legislation on and the regulatory framework for health care, the regulation of 
clinicians and the key health care policies that impact upon patient ‘entitlement’ to services.  We also 
describe services excluded from the basket.  A table summarising the findings is presented in the 
Appendix (Table 9). 
 
1.1 Principles underpinning the National Health Service (NHS) 
 
The core principles outlined in the NHS Plan (Department of Health, 2000b) define the desired 
characteristics of the National Health Service to which the government, health care professional 
bodies and trade unions aspire and include the provisions of a ‘comprehensive range of services’ 
(Box 1). 
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Box 1: Core principles of the NHS 
 
1. The NHS will provide a universal service for all based on clinical need, not ability to 
pay. 
2. The NHS will provide a comprehensive range of services 
3. The NHS will shape its services around the needs and preferences of individual 
patients, their families and their carers 
4. The NHS will respond to different needs of different populations 
5. The NHS will work continuously to improve quality services and to minimise errors 
6. The NHS will support and value its staff 
7. Public funds for health care will be devoted solely to NHS patients. 
8. The NHS will work together with others to ensure a seamless service for patients. 
9. The NHS will help keep people healthy and work to reduce health inequalities 
10. The NHS will respect the confidentiality of individual patients and provide open 
access to information about services, treatment and performance 
 
 
Source: Department of Health (2000). The NHS Plan: a plan for investment, a plan for reform. HMSO, London.  
 
The NHS Plan clarifies the meaning of the second principle: 
 
The NHS will provide access to a comprehensive range of services throughout primary 
and community health care, intermediate care and hospital based care. The NHS will 
also provide information services and support to individuals in relation to health 
promotion, disease prevention, self-care, rehabilitation and after care.  The NHS will 
continue to provide clinically appropriate cost-effective services (Department of Health, 
2000b). 
 
Firstly, it should be noted that ‘comprehensive’ describes the range of services and these are listed.  
The NHS Plan does not therefore promise that the NHS will provide all possible health care services.  
Furthermore, there is a commitment to provide those services that are ‘clinically appropriate’ and 
‘cost-effective’, implying that there is no guarantee that those services that do not meet these criteria 
will be provided.  Lastly, there is an emphasis on the provision of preventative services, aiming to 
reduce the demand for curative services.   
 
The fundamental principles stated in the NHS Plan are important because they guarantee to British 
citizens that their right to health care will be honoured (Montgomery, 2003);(page 52).  Legislation 
directs that Primary Care Trusts and Strategic Health Authorities must ‘have regard’ to the NHS Plan 
when exercising their functions (Secretary of State for Health, 2002);(reg. 3(4)).  However, citizens’ 
rights are not generally enforceable through the legal system, but are recognised through the 
managerial structure of the NHS.  Nevertheless, health care law plays an important role in signalling 
the broad categories of service provided by the NHS, as well as conferring particular duties on the 
Secretary of State for Health and on the local health care organisations that implement the law and 
deliver the services. 
 
An overview of the legal and quasi-legal framework defining benefits for England is given in Table 1.  
For details of benefit-defining documents listed by ICHA category, see Appendix (Table 9). 
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Table 1: Documents defining Benefit Basket, England April 2005 
Catalogue: type of document, actors and contents 
Type of 
Document 
Acts of 
Parliament 
 
Statutory 
Instruments 
(SI) 
 
Directions 
 
National Service 
Frameworks 
 
NICE 
technology 
appraisals 
NICE clinical 
guidelines 
 
NICE 
interventional 
procedures 
 
Contracts 
 
Waiting time 
guarantees2 
 
HRG tariffs 
 
Devices tariff 
 
Fee schedules 
 
Legally Binding Y Y Y N Y3 N N Y N N N N 
Decision makers Parliament Parliament Secretary of 
State for 
Health 
SHAs 
Monitor 
Department of 
Health 
External 
reference group 
(multidisciplinary) 
Department 
of Health 
Appraisal 
Committee 
National 
Collaborating 
Centres 
Guideline 
Development 
Group 
Stakeholders 
Interventional 
procedures 
Advisory 
Committee 
Department of 
Health 
Professional 
bodies / 
associations 
Department 
of Health 
Department of 
Health 
Secretary of 
State for Health 
PPA 
Department of 
Health 
Professional 
bodies / 
associations 
 
(Original) 
purpose, e.g. 
entitlements, 
reimbursement, 
target-setting 
Establishes 
duties and 
powers for 
broad 
categories of 
care 
Clarify / 
amend 
primary 
legislation 
Direct NHS 
organisations 
to undertake 
action 
Improve quality / 
decrease 
variations in 
service 
Improve 
quality / 
decrease 
variations in 
service 
Improve 
quality / 
decrease 
variations in 
service 
Quality 
/safety 
assurance 
Reimbursement Improve 
quality / 
decrease 
variations in 
service 
Reimbursement Reimbursement Reimbursement 
Positive/ 
negative 
definition of 
benefits 
P P/N P P P/N P P/N P P P P P 
Degree of 
explicitness4 
1 1 to 3 2 2 or 3 3 2 or 3 3 1 to 3 2 2 or 3 3 3 
If itemised: 
goods/ 
procedures only; 
linked to 
indications 
 Goods 
Procedures 
 Goods 
Procedures 
Goods 
Procedures 
Goods 
Procedures 
Procedures Procedures Procedures Procedures Goods Procedures 
Updating Irregular 
Amended by 
further Acts of 
Parliament or 
by Statutory 
Instrument 
Irregular 
Amended / 
revoked by 
further  
Statutory 
Instrument 
and/or 
directions 
No Unclear Every 4 
years 
Every 4 to 6 
years 
Unclear Infrequent – 
although small 
amendments 
more frequent 
Irregular Still evolving Monthly Annually (at 
least) 
                                                     
2 The dominant instrument for securing these are performance ratings prepared by the Healthcare Commission 
3 The statutory duty is upon PCTs to ensure funding is available to facilitate implementation, not upon doctors to adopt the approved technology. 
4 ‘Explicit’ is subdivided as 1 : all necessary; 2: areas of care; 3: items 
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Catalogue: type of document, actors and contents 
Type of 
Document 
Acts of 
Parliament 
 
Statutory 
Instruments 
(SI) 
 
Directions 
 
National Service 
Frameworks 
 
NICE 
technology 
appraisals 
NICE clinical 
guidelines 
 
NICE 
interventional 
procedures 
 
Contracts 
 
Waiting time 
guarantees2 
 
HRG tariffs 
 
Devices tariff 
 
Fee schedules 
 
Criteria used for defining benefits 
Need √ √ √ √    √ √   √ 
Costs     √ √    √ √  
Effectiveness  √ √ √ √ √ √  √    
Cost-
effectiveness 
 √   √ √     √  
Budget  √ √     √  √ √ √ 
Other As the 
Secretary of 
State judges 
‘necessary to 
meet all 
reasonable 
requirements’ 
Safety     Safety    Safety, quality, 
appropriateness 
 
Sources: (Montgomery, 2003, Department of Health, 2000b, Newdick, 2005b); DH website (http://www.dh.gov.uk/Home/fs/en); HMSO website (http://www.hmso.gov.uk/); expert advice (see Acknowledgements )  
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1.2 Legislation on health care 
 
Within the NHS, legal and quasi-legal rights ‘mainly take the form of general statutory duties rather 
than individual entitlements’ (Montgomery, 2003);(page 80).  The NHS was created under the 
National Health Service Act 1946 (chapter 81): 
 
 ‘to provide for the establishment of a comprehensive health service for England and 
Wales and ... to provide or secure the effective provision of services in accordance with 
[the provisions of the Act].’  
 
Section 3 of the 1946 Act specifies the provision of hospital accommodation; medical, nursing or other 
service required at or for the purposes of the hospitals and service of specialists.  Section 19 of the 
1946 Act describes the health services to be provided by local health authorities (in 2005, local health 
authorities are known as Primary Care Trusts, or PCTs).  Local health authorities must provide ‘health 
centres’ (s. 21(1)) to facilitate the provision of the services they must or may secure through 
arrangements with local practitioners.  These services include general medical and dental services, 
pharmaceutical services, ophthalmic services and any other specialist outpatient services (ss. 31-48).  
There are also duties on local health authorities to provide care for mothers and children (ss. 22-24), 
home nursing (s. 25), vaccinations and immunisations (s. 26) and ambulance services (s. 27).   
 
The 1977 NHS Act (c. 49) consolidated health care legislation published since 1946.  Under the 1977 
Act, the Secretary of State for Health (the politician in charge of health care) has a duty (Secretary of 
State for Health, 1977);(s.1(1)): 
 
..to continue the promotion in England and Wales of a comprehensive health service 
designed to secure improvement –  
(a) in the physical and mental health of the people of those countries, and  
(b) in the prevention, diagnosis and treatment of illness, and for that purpose to provide 
or secure the effective provision of services in accordance with this Act.’ 
 
The 1977 NHS Act lists broad categories of service, such as hospital accommodation, including high 
security psychiatric services (s. 3(1)(a)), medical, dental, nursing and ambulance services (s. 3(1)(c)), 
‘such other services as are required for the diagnosis & treatment of illness’ (s. 3(1)(f)) and family 
planning services (s. 5(1)(b)) (Secretary of State for Health, 1977).  However, the Secretary of State is 
obliged to provide these ‘...to such extent as he considers necessary to meet all reasonable 
requirements’ (Secretary of State for Health, 1977);(s. 3).  Importantly, the 1977 NHS Act does not 
impose an absolute duty on the Secretary of State to provide specified services; the courts have 
established that he may also take economic factors into account (Newdick, 2005a): 
 
 ‘ a comprehensive service may never, for human, financial and other resource reasons, 
be achievable…. …The [1977 NHS] Act does not impose an absolute duty to provide the 
specified services.  The Secretary of State is entitled to have regard to the resources 
made available to him under current government economic policy (R v. North & East 
Devon Health Authority, ex p. Coughlan 16th July 1999).   
 
The exercise of discretion is therefore at the heart of the statutory duties (Montgomery, 2003);(page 
64).  Strictly speaking, this means that patients have no entitlement to specific services.  Moreover, 
the Secretary of State’s duties are delegated to Strategic Health Authorities (who now carry the duty 
to promote a comprehensive health service) and to Primary Care Trusts (PCTs) (Newdick, 2005a).5  
The burden of prioritising service provision falls to PCTs, and these organisations are also subject to 
an obligation to keep within their financial allocation (Secretary of State for Health, 1977);(s. 97(c)). 
 
There are two ways in which patients may attempt to use the law to enforce duties.  Firstly, patients 
may claim that the NHS has failed to perform its statutory duties.  This process uses judicial review 
and is a public law matter (see Box 2).   The court may overturn the decision by an NHS body to 
refuse treatment, but it is unlikely that judges will order treatment to be offered.  However, such 
actions are seldom successful, although they may improve services as a result of bringing adverse 
                                                     
5 The relevant statutory instruments are: S.I. 1989/51; S.I. 1996/654; S.I. 1996/708;S.I. 2000/89; S.I. 2000/695; S.I. 2001/747; S.I. 
2002/2375 
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publicity to current provision (Montgomery, 2003);(page 68).  Secondly, patients may appeal to the 
civil law obligations of the NHS to perform its functions properly.  This may result in the patient 
receiving compensation for his or her loss and that future service provision will be different in order to 
avoid further claims.   
 
Attempts to use the law to enforce legal duties have generally proved frustrating for litigants 
(Montgomery, 2003);(page 67).  This means that the internal quality control mechanisms of the NHS – 
a constitutional structure for planning, purchasing and providing care – are important to ensure that 
citizens’ rights to health care under international law are honoured.  However, there are also rules that 
govern practice, principles that people are bound to follow, even if they are unenforceable. 
 
Legal rules in a strict sense, as developed by Parliament and the courts, are not the only 
type of binding norm that is relevant to health care law (Montgomery, 2003);(page 4). 
 
Apart from legislation that operates within the UK (Box 2), there are also Human Rights established 
by European Law.  The European Convention for the Protection of Human Rights and Fundamental 
Freedoms (1950) assigns citizens political rights.  The European Social Charter (1996) grants social 
and economic rights, including disease prevention and health promotion.  Nevertheless, the 
Convention does cover public health (Articles 8 to 11) and the right to access to health services.  
There is also a right to found a family (Article 12) (Montgomery, 2003);(page 13).  The United Nations’ 
International Covenant on Economic, Social and Cultural Rights recognises in Article 12 ‘the right of 
everyone to the enjoyment of the highest attainable standard of physical and mental health’.6 
 
The UK Human Rights Act (1998) ruled that courts must interpret the law to comply with the 
Convention (Secretary of State for Health, 1998).  If an existing law incompatible with Convention, 
then there must be a ‘declaration of incompatibility’ (s. 4).  An example of this relates to the part of the 
Mental Health Act 1983 that put the onus patients to demonstrate that there was no longer justification 
for their detention.  The Act was found to be incompatible with the Convention (Articles 4 and 5), and 
a Statutory Instrument was written to amend sections 72(1) and 73(1) of the Mental Health Act 1983 
thereby removing the incompatibility of those provisions with a Convention right (Newdick, 2005a, 
Montgomery, 2003).  As it is unlawful for public authority – this includes NHS bodies – to act in a way 
that is incompatible with a Convention right (Secretary of State for Health, 1998);(s. 6), victims may 
sue (s. 7).  EC Treaties and regulations are binding on Member States (Montgomery, 2003);(page 
13). 
 
The law also makes provision for overseas visitors to receive NHS treatment.  Under the 1977 NHS 
Act, ‘persons not ordinarily resident in Great Britain’ may be charged for services received (Secretary 
of State for Health, 1977);(s. 121) and 1989 Regulations place health authorities under a duty to 
recover costs.7  Some services are exempt (e.g. emergency care);(S.I. 1989/306);(reg.3) as are 
certain overseas visitors (reg. 4) and nationals of member states, refugees and stateless persons 
whose need arose during their visit (reg. 5).  Treatment of ‘temporary residents’ is also covered by 
legislation.  A person is a temporary resident if ‘when he arrives … he intends to stay there for more 
than 24 hours but not more than three months’ (Secretary of State for Health, 2004a);(reg. 16(2)).  
Temporary residents are eligible for free primary and emergency NHS care, but may be charged for 
hospital care if they are not ‘ordinarily resident’ in the UK. 8  
                                                     
6 http://www.unhchr.ch/html/menu3/b/a_cescr.htm, accessed 24/02/05 
7 http://www.legislation.hmso.gov.uk/si/si1989/Uksi_19890306_en_1.htm, accessed 18/04/05 
8 http://www.dh.gov.uk/PolicyAndGuidance/International/OverseasVisitors/fs/en, accessed 19/04/05 
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Box 2: Overview of Legislation relating to Health Care 
Type of 
Law 
Derivation Types 
General 
law 
Statute law comes from the legislative work of Parliament and includes: 
Primary legislation (Acts of Parliament).  These establish duties and 
powers to provide broad categories of service provision.  Acts are 
divided into sections (abbreviated as ‘ss’) and subsections. 
Secondary legislation (Statutory Instruments; directions) clarifies, 
amends, updates or enforces existing primary legislation.  Statutory 
Instruments are divided into regulations (abbreviated as ‘reg’.)  SIs may 
negative or positive procedures.  Under negative procedures, the SI is 
laid before Parliament and comes into force unless Parliament prevents 
it.  Under positive procedures, the SI needs a positive decision by 
Parliament in order to come into force.  A Secretary of State may issue 
directions to other bodies (e.g. health authorities) to act on his behalf 
under the NHS Act 1977 (ss. 13-17).  Failure to comply may result in 
use of default powers (s. 85).  Directions, unlike SIs, may be subject to 
judicial review. 
Case law is law that has been established from cases tried in the 
courts.  The outcome of the test case creates a precedent by which 
future cases are judged.  The court cannot take decisions on behalf of 
NHS bodies, but can refer cases back for reconsideration.  It is rare for 
patients to pursue their rights through the courts, but successful court 
cases may be very important in determining patient entitlement. 
Common law is a part of English Law that has not come from 
Parliament.  It consists of rules of law that have developed from 
customs or judgements made in courts over hundreds of years.  
There are three types of general law: 
1. Civil law deals with relationships 
between citizens 
2. Criminal law deals with the 
relationship between wrongdoer 
and society  
3. Public law deals with the 
relationship between citizens and 
the state (e.g. limits of power for 
Department of Health) 
Quasi 
Law 
The term ‘quasi-law’ covers rules that are not usually legally binding, 
although they may have some legal force, but which will in practice 
determine the way in which people act. 
Professional Law  
Entrance to professional register 
Conditions upon continuing registration 
– for example, the General Medical 
Council describes doctors’ duties, 
guidance on good practice and can 
remove doctors’ right to practise 9 
Guidance from the Department of 
Health, such as Health Service 
Circulars10 and National Service 
Frameworks 
Guidance on clinical practice or codes 
of practice from professional bodies, 
such as Royal Colleges 
Sources: (Montgomery, 2003, House of Commons Information Office, 2002, Newdick, 2005b) 
 
1.3 The NHS regulatory framework 
 
Since regulation and policy play such an important role in determining which services are available 
within the NHS, we describe below the key aspects of the English regulatory health care framework.  
Many of these concepts11 were introduced by the Labour government in its White Paper of 1997, ‘The 
New NHS: modern, dependable’ (Department of Health, 1997).  Concerns over issues of fairness and 
consistency within the NHS underpinned the White Paper (§ 7.1) with the availability of services to be 
determined by issues of effectiveness and cost-effectiveness (§7.5).  The practicalities of 
implementation and delivery were provided in the NHS Plan of 2000 (Department of Health, 2000b).  
Important components of the regulation include National Service Frameworks; the work of the 
National Institute for Clinical Excellence (NICE); and guidance from the Department of Health. 
                                                     
9 http://www.gmc-uk.org/standards/default.htm, accessed 24/02/05 
10 Health Service Circulars may sometimes take the form of directions from the Secretary of State for Health and so impose statutory 
obligations upon the organisations they address 
11 Some regulations, such as those relating to nursing home care, predate the 1997 White Paper 
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1.3.1 NHS Plan 
The government’s 1997 White Paper proposed far reaching structural changes across the NHS 
(Department of Health, 1997).  The NHS Plan implemented those changes, outlining a 10-year 
process of reform to transform the manner in which NHS meets its obligations (Department of Health, 
2000b, Montgomery, 2003);(page 61).  Published in 2000, ‘the NHS Plan: a plan for investment, a 
plan for reform’ described a new delivery system for the NHS as well as changes between health and 
social services, and changes for NHS doctors, for nurses, midwives, therapists and other NHS staff 
(Department of Health, 2000b).  The Plan also documented changes for patients and in the 
relationship between the NHS and the private sector. 
 
The central tenet of the NHS Plan is that there is a shortfall between what the NHS is and what 
patients and staff would like it to be.  In order to modernise it for the twenty-first century, the Plan 
specifies three principal goals, derived from a public consultation: 
 
1. More and better paid staff using new ways of working 
2. Reduced waiting times and high quality care centred on patients 
3. Improvements in local hospitals and surgeries 
 
Recognising that chronic underfunding was partly responsible for the failings of the NHS, the 
government pledged to increase NHS funding by one-third in real terms over a five-year period.  New 
hospitals, equipment and more investment in the recruitment and retention of staff, increasing their 
skills and enabling them to extend their roles, were planned.  Reforms would ensure that the extra 
money was translated into better care.  The Plan describes a dynamic and emerging set of changes 
that will have implications for many years.  These changes include the introduction of Patient Choice, 
new contracts for NHS staff, national standards and inspection, diversification of providers through the 
introduction of NHS Foundation Trusts and private providers and the devolution of the main 
responsibility for planning services, and the money to go with it, to Primary Care Trusts (PCTs).  
These changes seek to make the NHS more responsive to local needs and individual patients, while 
treating everyone fairly.  The aim is to make NHS organisations more accountable locally, less reliant 
on central intervention and top-down performance management and more subject to checks and 
balances within the system.  However, this internal regulation is subject to ‘effective external 
regulation’ (Audit Commission, 2004b).  In practice, the balance of power may simply have shifted to 
intermediate regulators, such as Strategic Health Authorities, the Healthcare Commission and Monitor 
(Newdick, 2005b);(page 77).  
 
Until recently, there was no guarantee on quality of care.  Principle 5 of the NHS Plan states that the 
NHS will work continuously to improve quality services and to minimise errors (Department of Health, 
2000b): 
 
The NHS will ensure that services are driven by a cycle of continuous quality 
improvement. Quality will not just be restricted to the clinical aspects of care, but include 
quality of life and the entire patient experience. Healthcare organisations and professions 
will establish ways to identify procedures that should be modified or abandoned and new 
practices that will lead to improved patient care. All those providing care will work to 
make it ever safer, and support a culture where we can learn from and effectively reduce 
mistakes. The NHS will continuously improve its efficiency, productivity and performance.  
 
Under the NHS Plan, waiting lists for hospital appointments and admission were to be abolished and 
replaced with booking systems, aiming to give all patients a choice of a convenient time within a 
guaranteed maximum waiting time (Department of Health, 2000b): 
 
• Access to a primary care professional within 24 hours, and to a general practitioner (GP) 
within 48 hours (§12.6) 
• Maximum wait of no more than four hours in accident and emergency from arrival to 
admission, transfer or discharge (§12.10) 
• Maximum waiting time for a routine outpatient appointment of three months (§16.6) 
• Maximum wait for inpatient treatment of six months (§16.6) 
• Maximum wait for any stage of treatment to three months (long term goal) (§12.21) 
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Some of these targets represent agreements between the Department of Health and the Treasury.  
Further details of the ‘Public Service Agreements’ are given in the section on Patient choice. 
 
National Service Frameworks (NSFs), introduced in the 1997 White Paper, embodied new approach 
to rationing: by specifying national standards, they encourage the selection and adoption of some 
treatments and approaches, whilst rejecting others (Montgomery, 2003);(page 61).  However, waiting 
times remain the main rationing mechanism.  Private health care acts as a valve for releasing 
pressure within the NHS: patients’ use of private health care reflects the disutility of waiting rather 
than dissatisfaction with the quality of care (Yates, 1995);(pp. 20-21).    
 
The treatment of cancer, heart disease and mental health services receives special attention in the 
NHS Plan.  This includes the expansion of cancer screening programmes and broadening the 
availability of cancer drugs; the introduction of rapid access chest pain clinics, intermediate care 
services for the mentally ill and the elderly; and free nursing care for people in nursing homes.  The 
Plan also states the government’s commitment to enable access to NHS dentists for all who want it by 
September 2001, supported by NHS Direct (a 24 hour telephone service staffed by nurses), additional 
funding for more dental access centres and improvements to dental practices and improved rewards 
for NHS dentists (Department of Health, 2000b).  At the time of writing (April 2005), this commitment 
is still to be realised.  
1.3.2 National Service Frameworks (NSFs) 
National Service Frameworks (NSFs)12 form one of a range of measures that seek to raise quality and 
decrease variations in service.  NSFs were introduced in the government’s 1997 White Paper and 
consultation document on quality (Department of Health, 1997, Department of Health, 1998).  They 
set national standards, identify key interventions for a defined service or care group that should be 
available, establish strategies to support implementation and outline ways to ensure progress within 
an agreed time scale (Department of Health, 1997).  Essentially, NSFs provide positive guidance and 
do not explicitly stipulate interventions that should not be undertaken.  They are modelled on an 
existing framework on cancer services (Calman and The Expert Advisory Group On Cancer, 1995), 
and cover a range of disease areas (Table 2). 
 
The rolling programme of NSFs, launched in April 1998, usually produces only one new framework a 
year.  Each NSF is developed with the assistance of an external reference group (ERG), which seeks 
to engage a full range of views by bringing together health professionals, service users and carers, 
health service managers, partner agencies, and other advocates.  However, the economic input into 
NSFs is sometimes weak.  The Department of Health supports the ERGs and manages the overall 
process.  It is unclear how NSFs are to be updated to reflect changes in the evidence base that 
underpins them. 
 
There is no statutory obligation on health care organisations to implement NSF standards.  However, 
the Health And Social Care (Community Health And Standards) Act 2003 gave the Secretary of State 
powers to publish standards for health care (s. 46(1)) that NHS bodies are bound to take into account 
(s. 46(4)); NSFs could inform these standards (Secretary of State for Health, 2003).  Furthermore, in 
April 2004 the Healthcare Commission began reviewing health care organisations’ implementation of 
the NSFs for Coronary Heart Disease and for Older People, reinforcing the quasi-legislative nature of 
NSF guidance (see The Healthcare Commission).  Guidance contained within each NSF covers many 
of the International Classification for Health Accounts (ICHA) categories (Table 3).   
 
                                                     
12http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/HealthAndSocialCareArticle/fs/en?CONTENT_ID=4070951&chk=
W3ar/W, accessed 24/02/05 
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Table 2: Published National Service Frameworks, April 2005 
Topic Date of 
Launch 
Comments 
Paediatric 
intensive 
care 
July 1997 The Paediatric Intensive Care NSF aims to ensure appropriate levels of care for sick children. 
The National Co-ordinating Group on the provision of paediatric intensive care was set up in 
June 1996.  Its report, ‘Paediatric Intensive Care: A Framework for the Future’ put in place a 
policy framework for developing the service and the standards which should be met in all 
hospitals providing paediatric intensive care.  
Mental 
health 
September 
1999 
The NSF for Mental Health is a statement on how mental health services will be planned, 
delivered and monitored until 2009.  The NSF lists seven standards that set targets for the 
mental health care of adults aged up to 65.  These standards span five areas: health promotion 
and stigma, primary care and access to specialist services, needs of those with severe and 
enduring mental illness, carers' needs, and suicide reduction.   
Coronary 
heart 
disease 
March 2000 The NSF for Coronary Heart Disease sets 12 standards for improved prevention, diagnosis and 
treatment, and goals to secure fair access to high quality services. The standards are to be 
implemented over a 10-year period. 
Cancer September 
2000 
The Calman Hine report set out a framework for cancer care provision in 1995 (Calman and 
The Expert Advisory Group On Cancer, 1995). The NHS Cancer Plan provides a statement of 
the government's comprehensive national programme for investment and reform of cancer 
services in England. 
Older 
people 
March 2001 The NSF for Older People seeks to set new national standards and service models of care 
across health and social services for all older people whether they live at home, in residential 
care or are being cared for in hospital. 
Diabetes December 
2001 
1.3 million people in England suffer from diabetes, and the number is increasing.  The diabetes 
NSF aims to ensure these people, wherever they live, receive the same high standard of care. 
Embodied in the NSF is the central value of the NHS Plan—that good service is the outcome of 
genuine partnership between the patient and the provider.  The NSF seeks to substantially 
reduce the suffering caused by diabetes. 
Renal January 
2004 
The Renal Services NSF aims to raise standards, reduce variations in services and improve 
health care for kidney patients.  The National Service Framework sets five standards and 
identifies 30 markers of good practice to try to help the NHS and its partners manage demand, 
increase fairness of access and improve choice and quality in dialysis and kidney transplant 
services. 
Children, 
Young 
People, 
Maternity 
October 
2004 
The Children’s NSF is a 10-year programme intended to stimulate long-term and sustained 
improvement in children’s health. Setting standards for health and social services for children, 
young people and pregnant women, the NSF aims to ensure fair, high quality and integrated 
health and social care from pregnancy, right through to adulthood. 
Long term 
conditions 
March 2005 The National Service Framework for long-term conditions aims to improve the lives of the many 
people who live with neurological and other long-term conditions by providing them with better 
health and social care services.  Key themes are independent living, care planned around the 
needs and choices of the individual, easier, timely access to services and joint working across 
all agencies and disciplines involved. 
Source: Department of Health Website12 
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Table 3: ICHA categories covered by selected NSFs 
ICHA 
Category 
National Service Framework 
 Children CHD Diabetes Mental Health Older People Renal 
HC.1 
Services of 
curative care 
Guidance on hospital-
based services for 
children (standard 7) 
and on community-
based care 
(standard 3)  
Standard 7 
NHS Trusts to 
provide 
appropriate 
investigations and 
treatments for 
patients with 
suspected or 
confirmed CHD 
Standard 7 
NHS to 
provide rapid 
and effective 
treatment for 
diabetic 
emergencies 
Inpatient 
hospital beds 
including 
intensive care 
beds for people 
needing a short 
period of 
intensive 
intervention and 
observation 
Standard 4 
Need for 
appropriate 
specialist care 
Standard 7 
Effective 
diagnosis, 
treatment and 
support for those 
with mental 
health problems 
Quality requirement 2 
Timely, appropriate and 
effective investigation, 
treatment and follow-up 
for those with chronic 
kidney disease 
Standard 5 
All likely to benefit from a 
kidney transplant to 
receive a high quality 
service which supports 
them in managing their 
transplant  
HC.2 
Services of 
rehabilitative 
care 
Standard 7 
Guidance on hospital 
services for children 
includes 
recommendations 
covering rehabilitation 
Standard12 
NHS Trusts to 
offer patients 
cardiac 
rehabilitation 
NA Standard 5 
All users with 
severe mental 
health needing 
rehabilitation 
have timely 
access to an 
appropriate 
‘mental health 
place’  
Standard 3 
Intermediate care 
to include 
effective 
rehabilitation 
services 
NA 
HC.3 
Services of 
long-term 
nursing care 
Standard 8 
Care for disabled 
children, young 
people and those with 
complex health needs 
Standard 6 
Care for children with 
long-term conditions  
NA 
 
NA Standards 4 & 
5 
Care of people 
with severe 
mental illness 
Standard 4 
At discharge from 
hospital, access 
to long term 
nursing care is 
one of three 
options listed in 
the NSF 
Quality requirement 4 
Jointly agreed palliative 
care plan for those with 
renal failure 
HC.4 
Ancillary 
services to 
health care 
Standard 7 
Services to be 
available for children 
in hospital include 
dietetics, 
physiotherapy, 
occupational therapy, 
speech and language 
therapy, and 
psychological support 
services. 
Standard 12 
Patients with CHD 
invited to 
participate in 
multidisciplinary 
programme for 
secondary 
prevention 
 
Standard 12 
All people with 
diabetes 
requiring multi-
agency 
support will 
receive 
integrated 
health and 
social care 
Standard 3 
Access to 
psychological 
therapies is a 
performance 
measure listed 
in the NSF 
 
Standard 4 
Hospital-based 
care should 
include access to 
audiology, 
ophthalmology, 
podiatry and 
orthotics services 
Standard 6 
Stroke patients to 
have access, as 
indicated,  to 
physiotherapy, 
speech therapy 
and occupational 
therapy services 
Standard 1 
Access to a multi-skilled 
renal team whose 
members have the 
appropriate training, 
experience and skills. 
HC.5 Medical 
goods 
dispensed to 
out-patients 
Standard 10 
Children and Young 
People should have 
access to safe and 
effective medicines 
prescribed on the 
basis of the best 
available evidence. 
Standard 11 
Patients with 
heart failure to be 
offered treatments 
most likely to both 
relieve their 
symptoms 
and reduce their 
risk of death 
Standard 4 
All adults with 
diabetes to 
receive high 
quality care 
throughout 
their lifetime 
Standards 2-5 
One of the NSF 
milestones is 
that all service 
users should be  
assessed for 
and receive new 
antipsychotics 
where indicated 
A Medicines 
Management 
booklet 
accompanies the 
NSF 
A Medicines 
Management booklet 
accompanies the NSF 
HC.6 
Prevention 
and public 
health 
services 
Standard 1 
Child Health 
Promotion 
Programme 
Standard 11 
Maternity services 
Standards 1 & 2: 
NHS and partner 
agencies to work 
to reduce heart 
disease in the 
population 
Standard 1 
NHS to reduce 
the risk of 
developing 
Type 2 
diabetes in the 
population  
Standard 7 
To reduce the 
death rate from 
suicide and 
undetermined 
injury by at least 
a fifth13 
Prevention of 
stroke (standard 
5), falls 
(standard 6) and 
promotion of 
active healthy 
living (standard 
8) 
Part 2 of the NSF deals 
with the prevention of 
established renal failure 
Sources: (Department of Health, 2004h, Department of Health, 2004g, Department of Health, 2000a, Department of Health, 2002a, Department of 
Health, 1999, Department of Health, 2001b) 
 
 
                                                     
13 This target was set in the government document ‘Saving lives: Our Healthier Nation’ (1999) 
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Table 4: NICE Clinical Guidelines, April 2005 
CODE  Wave Publication Review 
CG6 Antenatal care  6 Oct 2003  
CG22 Anxiety  6th wave Dec 2004 Dec 2008 
CSG Breast (CSG)  Inherited Aug 2002  
CG13 Caesarean section  2nd programme Apr 2004 Apr 2008 
CG5 Chronic heart failure  2nd Programme Jul 2003 Jul 2007 
CG12 Chronic obstructive pulmonary disease  6th Wave Feb 2004 Feb 2008 
CSG Colorectal (CSG)  Inherited Jun 2004  
CG19 Dental recall  7th wave Oct 2004 Oct 2008 
CG23 Depression  2nd programme Dec 2004 Dec 2008 
CG17 Dyspepsia  1st programme Aug 2004 Aug 2008 
CG9 Eating disorders  2nd programme Jan 2004 Jan 2008 
C Electronic fetal monitoring  Inherited May 2001 May 2005 
CG20 Epilepsy  6th wave Oct 2004 Oct 2008 
CG21 Falls  6th wave Nov 2004 Nov 2008 
CG14 Familial breast cancer  6th wave May 2004 May 2008 
CG11 Fertility  6th wave Feb 2004 Feb 2008 
CSG Haemato-oncology (CSG)  Inherited Oct 2003  
CSG Head and neck (CSG)  Inherited Nov 2004  
CG4 Head injury  2nd programme Jun 2003 Jun 2007 
CG18 Hypertension  1st Programme Aug 2004 Aug 2008 
D Induction of labour  Inherited Jun 2001 Jun 2005 
CG2 Infection control  2nd programme Jun 2003 Jun 2007 
CG24 Lung cancer  6th wave Feb 2005 Feb 2009 
CG8 Multiple sclerosis  1st Programme Nov 2003 Nov 2007 
A Post MI  Inherited Apr 2001 Apr 2003 
CG26 Post-traumatic stress disorder (PTSD) 6th wave Mar 2005 Mar 2009 
CG3 Preoperative tests  1st Programme Jun 2003 Jun 2007 
CG7 Pressure relieving devices  6th wave Oct 2003 Oct 2007 
B Pressure ulcers  Inherited Apr 2001 Apr 2005 
CG1 Schizophrenia  1st programme Dec 2002 Dec 2006 
CG16 Self-harm  6th wave Jul 2004 Jul 2008 
CSG Supportive and palliative care for people with cancer (CSG)  Inherited Mar 2004  
CG15 Type 1 diabetes  2nd programme Jul 2004 Jul 2008 
G Type 2 diabetes - blood glucose  Inherited Sep 2002 Sep 2005 
CG10 Type 2 diabetes - footcare  1st update Jan 2004 Jan 2008 
H Type 2 diabetes - management of blood pressure and blood lipids  Inherited Oct 2002 Oct 2005 
F Type 2 diabetes - renal disease  Inherited Feb 2002 Mar 2005 
E Type 2 diabetes - retinopathy  Inherited Feb 2002 Mar 2005 
CSG Urological (CSG)  Inherited Sep 2002  
CG25 Violence  6th wave Feb 2005 Feb 2009 
1.3.3 NICE guidance 
The National Institute for Clinical Excellence (NICE) was introduced in April 1999 to promote clinical 
excellence within the NHS by reducing the variations in uptake of new technologies (Secretary of 
State for Health, 1999c, Newdick, 2005a).  In August 1999, the law was amended14 to ensure that 
cost effectiveness considerations were included in the Institute’s decisions: 
 
(2) In article 3 (functions of the Institute) after the words ‘promotion of clinical excellence’ 
there are inserted the words ‘and of the effective use of available resources’ (Secretary 
of State for Health, 1999b). 
 
                                                     
14 The National Institute for Clinical Excellence (Establishment and Constitution) Amendment Order 1999 (S.I. 1999/2219) 
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NICE produces three types of guidance, which may ensure the availability of treatment in any 
category in the International Classification for Health Accounts (ICHA).   
 
1. Technology appraisals: guidance on the use of new and existing treatments within the NHS.  
To date (April 2005), 88 technology appraisals have been published.  Technologies may 
include: 
 
a. Medicines 
b. Medical devices (e.g. inhalers) 
c. Diagnostic techniques (e.g. cervical cytology)  
d. Surgical procedures (e.g. use of coronary artery stents)  
e. Health promotion activities (e.g. ways of helping people with diabetes manage their 
condition). 
 
The NICE Appraisal Committee is an independent advisory body constituted of individuals 
drawn from a range of professional backgrounds. The Committee considers the evidence 
from an academic assessment group and from company submissions.  Clinical specialists 
and ‘expert patients’ are also present to give their views, though are asked to leave when the 
Committee discusses the Appraisal Consultation Document.  This Document then goes out to 
consultation.  The Final Appraisal Determination is then developed, approved by the NICE 
Guidance Executive put out again for consultation.  Following an appeal process, the 
guidance is published (National Institute for Clinical Excellence, 2004).  All guidance is 
reviewed at regular intervals and recommendations reconsidered in the light of any new 
evidence.  It should be noted that the overwhelming majority of technologies used in the NHS 
are not the subject of recommendations by the NICE Appraisal Committee.  
 
2. Clinical guidelines: these offer guidance on the appropriate treatment and care of people 
with specific diseases and conditions within the NHS (Table 4).  Clinical guidelines are based 
on the best available evidence and are intended to help health care professionals in their 
work, but do not replace their knowledge and skills.  Topics include the management of 
chronic heart disease, dyspepsia and hypertension.  Settings covered include primary, 
secondary and tertiary care.  There are currently (April 2005) 39 guidelines, of which 14 were 
previously commissioned guidelines ‘inherited’ by NICE.  The clinical guidelines interpret, and 
provide detail about how to implement, the National Service Frameworks.  For example, the 
NICE guideline on the ‘Management of Type 2 Diabetes’ describes the treatment of renal 
disease, for which the broad aims of management are identified in the National Service 
Framework on Diabetes (Table 2).  National Collaborating Centres support NICE by 
managing and publishing the guideline.15  To develop a guideline, the National Collaborating 
Centre establishes a Guideline Development Group, with members capable of appraising 
evidence from systematic reviews of the research evidence, examining clinical - and cost-
effectiveness issues, integrating clinical understanding and considering the views of patients 
and carers.  An extensive consultation with stakeholders also informs the guideline. 
 
3. Interventional procedures: guidance on whether interventional procedures used for 
diagnosis or treatment are safe enough and work well enough for routine use in the NHS.  
These generally cover new procedures, although existing procedures may be reviewed if 
there are safety concerns.  Topics include radiotherapy for age-related macular degeneration 
and dynamic cardiac monitoring.  Settings include primary, secondary and community care 
and the Department of Health has provided guidance on the registration of new procedures in 
a Health Service Circular (HSC 2003/011).  To date (April 2005), guidance on 114 
interventional procedures has been issued, with 10 additional topics completed, but no 
guidance issued.16  The Interventional procedures Advisory Committee, an independent body 
of 24 members with a range of expertise, considers procedures only in terms of safety and 
efficacy; it does not examine clinical or cost effectiveness.17  The Committee produces a 
Consultation Document and published guidance reflects comments received over the 4-week 
consultation period.   
                                                     
15 http://www.nice.org.uk/pdf/GDP_An_Overview_for_Stakeholders_the_Public_and_the_NHS.pdf, accessed 18/03/05 
16 http://www.nice.org.uk/ipsearch.aspx?o=interventionalprocedures.home, accessed 15/04/05 
17 http://www.nice.org.uk/pdf/ip/IPProgrammeManual.pdf, accessed 18/03/05 
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Although health promotion is within the remit of NICE, the Health Development Agency is the body 
with principal responsibility for producing evidence-based guidance on public health issues. 18   The 
rationalisation of Arms Length Bodies saw the two institutions joining forces, with NICE taking over 
the functions of the Health Development Agency from 1st April 2005 (Table 5). 
NICE guidance generally acts like a quasi law, but one aspect of guidance on technology appraisals 
is supported by statute.  If NICE produces guidance on a technology appraisal to say that a new 
medicine should be made available to NHS patients who meet particular criteria, then the NHS bodies 
responsible for providing funding for that treatment are under a statutory obligation to ensure that the 
technology: 
 
...is, from a date not later than three months from the date of that Technology Appraisal 
Guidance, normally available (Secretary of State for Health, 2001b).   
 
The Department of Health sometimes extends this deadline (e.g. Appraisal No. 68 on macular 
degeneration).  However, although funding bodies are obliged by law to ensure there are adequate 
resources to facilitate the implementation of NICE guidance, the guidance is not binding on individual 
clinicians, who must assess whether the technology is appropriate for patients under their care 
(Newdick, 2005a).  
 
Compliance with clinical guidelines remains at the discretion of local planners (Primary Care Trusts, or 
PCTs).  There is, however, evidence of political ‘encouragement’ to adhere to these guidelines.  For 
example, the NICE clinical guideline on fertility treatments (National Collaborating Centre for 
Women’s and Children’s Health, 2004) recommended that the NHS should provide 3 cycles of in vitro 
fertilisation (IVF) treatment for suitable patients in England and Wales.  Commenting on geographical 
variations in the availability of in vitro fertilisation (IVF), the Secretary of State, John Reid, observed in 
February 2004: 
 
I am glad that NICE itself recognises that the NHS cannot reasonably make this 
expansion overnight.  Our immediate priority must be to ensure a national level of 
provision of IVF is available wherever people live.  As a first step, by April next year 
I want all PCTs, including those who at present provide no IVF treatment, to offer at 
least one full cycle of treatment to all those eligible.  In the longer term I would 
expect the NHS to make progress towards full implementation of the NICE 
guidance (Department of Health, 2004c) 
 
.In addition to the priority criteria recommended by NICE, the Health Secretary stated that couples 
with a child/children from the current or previous relationship should not have access to NHS 
treatment.  
 
Although NICE and NSFs play a part in rationing health care, the principal rationing mechanism is the 
waiting list (Montgomery, 2003);(page 62).  The legal mechanisms needed to enforce and challenge 
these new rationing processes are as yet largely untested (Montgomery, 2003).  Private health care 
acts as a safety valve for cases where demand exceeds NHS supply, with patients relying either on 
insurance cover or self-payments (see above, NHS Plan).  
1.3.4 Department of Health guidance  
The NHS is a centrally planned organisation, whose management is facilitated by the ‘constant 
stream of communication’ from the Department of Health to NHS organisations (Montgomery, 
2003);(page 15). Guidance in the form of Health Service Circulars (HSCs) is the main type of 
communication.  HSCs are formal communications, primarily to NHS chief executives.  They usually 
contain a requirement for significant or urgent specific action.  Some HSCs are issued jointly with a 
local authority circular (LAC) where the topic is relevant to a joint health and local authority 
audience.19  Many are quasi-legislative.  This means that they are rules that are not usually legally 
binding, and therefore carry no legal sanctions, but which in practice determine the way that people 
behave (Montgomery, 2003);(page 16).   
 
                                                     
18 http://www.hda-online.org.uk/, accessed 08/03/05 
19 http://www.dh.gov.uk/PublicationsAndStatistics/LettersAndCirculars/HealthServiceCirculars/fs/en, accessed 18/02/05 
CHE Research Paper 2 
 
   
19
Table 5: Department of Health’s Arm’s Length Bodies (ALBs), England 2004 
Function Long Term ALBs ALBs whose functions will be taken on by other ALBs 
or removed from the ALB sector 
Regulation 1 Healthcare Commission Mental Health Act Commission 
 2 Independent Regulator of NHS 
Foundation Trusts (‘Monitor’) 
 
 3 Commission for Social Care 
 Inspection 
 
 4 Regulatory Authority for 
Fertility and  Tissue 
Human Fertilisation and Embryology Authority 
Human Tissue Authority 
 5 Council for Regulation of 
Health Care 
 Professionals 
 
 6 General Social Care Council  
 7 Postgraduate Medical 
Education and  Training 
Board 
Dental Vocational Training Authority 
 8 Medicines and Health care 
products  Regulatory Agency 
 
   
Standards 9 National Institute for Clinical 
 Excellence 
Health Development Agency 
   
Public Welfare 10 National Patient Safety 
Agency 
National Clinical Assessment Authority 
NB: to continue as a division of the NPSA, supporting five-
year re-licensing by the General Medical Council 
(‘revalidation’). 
 11 Health Protection Agency Commission for Patient and Public Involvement in Health 
 12 National Treatment Agency 
for  Substance Misuse 
Public Health Laboratory Service 
  National Radiological Protection Board 
  National Biological Standards Board 
   
Central services 13 Blood and Transplant 
Authority 
National Blood Authority 
UK Transplant 
 14 NHS Litigation Authority Family Health Services Appeal Authority 
 15 NHS Appointments 
Commission 
(Special Health Authority) 
 16 NHS Institute for Learning, 
Skills and Innovation (NILSI) 
NHS Modernisation Agency 
NHS University 
Leadership Centre 
 17 Health and Social Care 
Information Centre 
NHS Information Authority 
DH statistical services 
 18 National Programme for IT  
 19 NHS Business Services 
Authority 
Prescription Pricing Authority 
Dental Practice Board 
NHS Pensions Agency 
NHS Counter Fraud and Security Management Service 
 20 NHS Purchasing and Supply 
Agency 
NHS Logistics Authority 
NHS Estates 
Removed from 
ALB sector  
NHS Direct 
NHS Professionals20 
Transfer to independent status in 2-3 years 
Sources: (Department of Health, 2004m, Department of Health, 2004f) 
 
However, sometimes circulars can take the form of directions from the Secretary of State and are 
therefore legally binding.10  HSCs may address any of the ICHA categories of health care provision.  
An example an HSC addressing curative care (ICHA 1) is the ‘National Guidance on the Safe 
Administration of Intrathecal Chemotherapy’ (HSC 2003/010), which specified action to be taken by 
Chief Executives of Strategic health Authorities and NHS Trusts.  An example of the Health Secretary 
issuing directions in the form of a Health Service Circular is HSC 2003/006, which addresses long-
term nursing care (ICHA 3) (see HC3 Services of long-term nursing care). 
 
Guidance to PCTs and NHS Trusts may also come from Strategic Health Authorities (SHAs).  SHAs 
are regional organisations accountable to the Secretary of State that manage performance of NHS 
                                                     
20 NHS Professionals is the in-house flexible staffing service run by the NHS for the NHS 
22 PCTs are not empowered to issue directions on behalf of the Secretary of State S.I. 2002/2375;reg. 5(2) 
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bodies at the local level (Newdick, 2005b);(page 77).  Specifically, SHAs have a duty to support and 
monitor PCTs and manage their performance in exercising their functions, with a view to improving 
the quality of health care provided to individuals in their area (Secretary of State for Health, 
2002);(reg. 3(2(b))).  SHAs are also charged with the duty to promote a comprehensive health 
service, can give (statutory) directions22 to NHS Trusts about any of their functions and can request 
the fluoridation of water supplies (Secretary of State for Health, 2002);(regs. 3(3), 5).  The 1999 
Health Act legislation places SHAs, NHS Trusts and PCTs under a duty to co-operate with each other 
(Secretary of State for Health, 1999a);(s. 26). 
 
1.4 Key regulatory bodies 
 
Department of Health ‘Arm’s Length Bodies’ and the Healthcare Commission have important 
regulatory roles in the NHS.  Although the Audit Commission pre-existed the 1997 Labour 
government reforms, it continues to be influential in the regulation of health care, particularly in its 
relation to the Healthcare Commission.  ‘Monitor’, the watchdog responsible for overseeing financial 
management in Foundation Trusts, is also described.  Lastly, some of the key actors in the regulation 
of medicines and devices are outlined.   
1.4.1 Arm’s Length Bodies 
The UK government has a range of Arm’s Length Bodies (ALBs) that service the NHS.  With a view to 
rationalising overlapping and duplicated functions and removing ‘unnecessary’ activities, the 
government aims to reduce ALBs from 38 to 20 and see a 25% reduction in staff working in the sector 
by 2008 (Department of Health, 2004).  The implementation framework groups the ALBs into four 
categories that designate their function (Table 5)(Department of Health, 2004f).   
 
Arm’s Length Bodies that have an important impact on patient entitlement to NHS services are 
described in further detail below.   
1.4.2 The Healthcare Commission 
Established under the Health and Social Care (Community Health and Standards) Act 2003, the 
Healthcare Commission is the independent inspection body for healthcare organisations (Secretary of 
State for Health, 2003).  Regulation of both NHS and independent (private and voluntary) health care 
organisations is within the Commission’s remit.  The Healthcare Commission has a wide range of 
functions, of which the main ones are listed below.24 
 
• To independently assess the performance of the health services from patients’ perspectives, 
using standards set out by the Department of Health; this is a statutory duty for the 
Commission 
• To co-ordinate NHS inspections with a range of other health care organisations in order to 
minimise disruption to health care staff  
• To identify how effectively public funds are used within health care – particularly whether tax 
payers are getting good value for money  
• To develop an independent second stage for complaints about the NHS which can not be 
resolved locally  
• To investigate serious failures in health care services  
• To publish regular ratings of NHS hospitals and trusts, and an annual report on health care 
 
Regulation by the Healthcare Commission includes assessments of compliance with standards.  
Currently, every NHS organisation is assessed annually and awarded a ‘star rating’, ranging from 
zero (lowest level of performance) to three stars (highest).  There are four elements to the star rating.  
Firstly, key targets are set, which vary by type of organisation – so Ambulance Trusts have different 
targets to those set for hospital Trusts25 – and performance against these targets contributes to the 
                                                     
24  http://www.healthcarecommission.org.uk/Homepage/fs/en , accessed 01/11/04 
25 ‘Hospital trusts’, or ‘NHS Trusts’, are groups of hospitals that operate as a single legal entity 
CHE Research Paper 2 
 
   
21
organisation’s star rating.  For example, key targets for hospital Trusts comprise of various waiting 
time indicators, hospital cleanliness, cancelled operations, the financial state of the Trust and a 
demonstrated commitment to improve working conditions.  For most Trusts, there are also three sets 
of subsidiary indicators, comprising of those with a clinical focus (such as emergency re-admission 
rates); a patient focus (such as the resolution of written complaints); and those with a staff focus (such 
as junior doctors’ hours).  Trusts with a ‘balanced scorecard’ – good or high performance in all four 
areas – are then awarded two or three stars respectively (Kaplan and Norton, 1992).   
 
The Healthcare Commission is currently developing a new approach to assessing the performance of 
organisations that provide healthcare in the NHS and independent (private and voluntary) sectors.  
Regulation will take place through licensing, annual ratings and annual inspections.  Aiming to make 
regulation more helpful to patients and users and less burdensome to providers,26 the Commission 
seeks to shift the focus of the assessment towards the quality of care provided to patients and 
towards the capacity of the organisations to deliver services of high quality.  Major revisions to the 
assessment system planned for 2005/06.  Covering seven quality domains,27 the government’s report 
‘National Standards, Local Action’ outlines a set of 24 ‘core’ standards, supported by 13 
‘developmental’ standards.  The core standards seek to integrate existing standards that ‘service 
users have a right to expect’, whilst the developmental standards aim to facilitate continuous 
improvement (Department of Health, 2004i).  The intention is that all health care organisations will be 
judged by the same standards: 
 
The standards apply with immediate effect to services provided under the NHS, whether 
within NHS bodies or within the independent or voluntary sector.  As foreshadowed in the 
consultation document, there will be an appropriate phasing in of the applications of 
these standards to cover other services provided entirely by the independent sector 
(Department of Health, 2004q);(§31). 
 
The Commission is concerned with both treatment and prevention, such as the quality of services that 
help people to stop smoking.  Organisations’ performance will be judged not just by national targets, 
but also by whether high quality care is delivered across a range of areas.  These include NSFs (core 
standard C23; developmental standard D2) and NICE appraisal guidance (core standard C5a) and 
NICE guidance more generally, including NICE clinical guidelines (developmental standard D2).28 The 
expectation is that ‘inspection will be a powerful lever for ensuring that the changes outlined in [the 
NFSs] happen’ (Department of Health, 2004g);(Standard for Hospital Services).  In addition, 
organisations will be able to set their own targets to tackle local priorities.  Although summary 
assessments for health care organisations will continue, the Commission proposes to disband star 
ratings  (Healthcare Commission, 2004).  Instead the performance ratings for the ‘annual health 
check’ will include two four-point scales: firstly, core standards and existing standards will be 
assessed on a scale ranging from ‘fully met’ to ‘not met’; and secondly, a scale ranging from 
‘excellent’ to ‘weak’ will be used for all other components and also serve as an overall rating 
(Healthcare Commission, 2005).   
 
Health care organisations need to ensure that clinicians participate in regular clinical audit and 
reviews of clinical services in order to meet the core standards.  Clinical audit is defined as: 
 
A quality improvement process that seeks to improve patient care and outcomes through 
systematic review of care against explicit criteria and the implementation of change.  
Aspects of the structure, processes, and outcomes of care are selected and 
systematically evaluated against specific criteria.  Where indicated, changes are 
implemented at an individual, team, or service level and further monitoring is used to 
confirm improvement in health care delivery (Department of Health, 2004i). 
 
A range of disease areas and procedures are currently covered by clinical audits, some of which are 
specified by National Service Frameworks (e.g. the NSF for Coronary Heart Disease).  However, 
questions over how the national strategy will develop remain: in particular, it is unclear whether 
participation will be mandatory; how large and comprehensive the programme will be and how 
                                                     
26 http://www.healthcarecommission.org.uk/assetRoot/04/00/00/20/04000020.pdf, accessed 08/11/04 
27 The seven quality domains are: safety; clinical and cost effectiveness; governance; patient focus; accessible and responsive care; care 
environment and amenities; and public health. 
28 http://www.parliament.the-stationery-office.co.uk/pa/cm200405/cmhansrd/cm050110/text/50110w26.htm, accessed 07/03/05  
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necessary action will be enforced; and how the programme will be managed.  Currently, the National 
Clinical Audit Support Programme manages some clinical audits on behalf of the Healthcare 
Commission.29   
1.4.3 The Audit Commission 
Although the Audit Commission pre-existed the 1997 Labour government reforms, it continues to play 
an important role in the regulation of health care, particularly in its relation to the Healthcare 
Commission.  Formally known as the Audit Commission for Local Authorities and the National Health 
Service in England and Wales, the Audit Commission is an independent public body ‘responsible for 
ensuring that public money is spent economically, efficiently, and effectively in the areas of local 
government, housing, health, criminal justice and fire and rescue services’.30   Whilst the Audit 
Commission assesses financial management and value for money at the local level, the Healthcare 
Commission assesses value for money at the national level.  The Health and Social Care (Community 
Health and Standards) Act 2003 places a duty on the two organisations to co-operate with each other 
(Secretary of State for Health, 2003);(s. 65). 
 
Aiming to promote the delivery of high-quality public services, and underpinned by a robust evidence 
base, the Audit Commission works with the Department of Health, the National Assembly of Wales 
and the Healthcare Commission.  The Audit Commission inspects and reports on the performance of 
local authorities, which includes public health issues such as the provision of leisure and sports 
facilities. Primarily, the Audit Commission is concerned with the quality of financial management in the 
NHS.  It produces national reports on topics such as the implications of the new NHS funding system 
(Audit Commission, 2004b), drug misuse (Audit Commission, 2004a), services for older people (Audit 
Commission, 2004c), acute (Audit Commission, 2003) and primary care (Audit Commission, 2004d). 
1.4.4 Monitor 
Monitor is an independent public body established under the Health and Social Care Act 2003 
(Secretary of State for Health, 2003).  Its formal name is the ‘Independent Regulator for NHS 
Foundation Trusts’.  Monitor takes over duties from the Secretary of State, such as the duty to 
promote a comprehensive health service and to provide clinical facilities to universities with medical or 
dental schools (Secretary of State for Health, 2003)(s. 3).  Foundation Trusts are subject to the 
direction of Monitor, not to the Secretary of State. 
 
Monitor is responsible for ensuring the financial sustainability of NHS Foundation Trusts, through 
authorisation, monitoring and regulation.  The Healthcare Commission undertakes performance 
management of these organisations.  Foundation Trusts, also established by the 2003 Health and 
Social Care Act, differ from ordinary NHS Trusts in three ways:31 
 
• Freedom to decide locally how to meet their obligations 
• Accountable to local people, who can become members and Governors  
• Authorised and monitored by Monitor, rather than by the Healthcare Commission 
 
In authorising Foundation Trusts, Monitor specifies the goods and services that may be provided and 
the information required to facilitate monitoring.  In addition, the Healthcare Commission inspects the 
performance of a Foundation Trust against healthcare standards and Monitor receives a copy of the 
inspection report.  Like the Healthcare Commission for NHS Trusts, Monitor has powers to intervene 
in the running of a Foundation Trust if it fails in its healthcare standards or other aspects of its 
activities, when this amount to a significant breach in the terms of its authorisation.  Since Foundation 
Trusts are not subject to directions by the Secretary of State for Health, the contracts they enter with 
Primary Care Trusts are not NHS contracts – the type that operates between ‘ordinary’ NHS Trusts 
and PCTs – but legal contracts which are enforceable through the courts (Newdick, 2005b);(page 86) 
 
                                                     
29 http://www.nhsia.nhs.uk/ncasp/pages/default.asp, accessed 07/03/05 
30 http://www.audit-commission.gov.uk/aboutus/index.asp, accessed 12/02/05 
31 http://www.monitor-nhsft.gov.uk/register_nhsft.php, accessed 18/02/05 
CHE Research Paper 2 
 
   
23
1.4.5 Medicines and Health Care Products Regulatory Agency 
The Medicines and Health care products Regulatory Agency (MHRA) replaced the Medical Devices 
Agency (MDA) and the Medicines Control Agency (MCA) on 1 April 2003.  As an executive agency of 
the Department of Health, the MHRA seeks to protect and promote public health and patient safety by 
ensuring that medicines, health care products and medical equipment meet appropriate standards of 
safety, quality, performance and effectiveness, and are used safely.32 
 
MHRA activities include:33 
 
• Assessing the safety, quality and efficacy of medicines sold or supplied in the UK for human use 
• Authorising medicines 
• Overseeing the organisations that audit device manufacturers 
• Operating post-marketing surveillance and other systems for reporting, investigating and 
monitoring adverse reactions to medicines and adverse incidents involving medical devices and 
taking any necessary action to safeguard public health, for example through safety warnings, 
removing or restricting the availability of products or improving designs 
• Operating a quality surveillance system to sample and test medicines and to address quality 
defects, monitoring the safety and quality of imported unlicensed medicines and investigating 
Internet sales and potential counterfeiting of medicines 
• Regulating clinical trials of medicines and medical devices 
• Monitoring and ensuring compliance with statutory obligations relating to medicines and devices 
through inspection, taking enforcement action where necessary 
• Promoting good practice in the safe use of medicines and devices 
• Managing the General Practice Research Database, the British Pharmacopoeia and the Device 
Evaluation Service, and helping to develop performance standards for medical devices 
1.4.6 Pharmaceutical Price Regulation Scheme 
Whilst the MHRA authorises the medicines and devices that are available within the UK, the 
Pharmaceutical Price Regulation Scheme (PPRS) deals with the pricing of pharmaceuticals.  
Although not strictly a regulatory body, the PPRS has an important, albeit unintentional, impact: by 
influencing the price of pharmaceuticals, the PPRS affects NICE technology appraisals, which 
consider the costs and benefits of pharmaceuticals in order to make recommendations for their use 
within the NHS (see NICE guidance).   
 
Jointly agreed between the UK Health Departments and the Association of the British Pharmaceutical 
Industry, the PPRS seeks to ensure that the NHS has access to good quality branded medicines at 
reasonable prices, and aims to promote a healthy, competitive pharmaceutical industry.   
 
The 2005 Pharmaceutical Price Regulation Scheme is an agreement for the purposes of Section 33 
of the Health Act 1999, which gives the Secretary of State for Health powers to manage the scheme 
(Secretary of State for Health, 1999a).  The stated objectives of the scheme are that it should 
continue to: 
 
(a) Secure the provision of safe and effective medicines for the NHS at reasonable prices 
(b) Promote a strong and profitable pharmaceutical industry capable of such sustained research 
and development expenditure as should lead to the future availability of new and improved 
medicines 
(c) Encourage the efficient and competitive development and supply of medicines to 
pharmaceutical markets in the UK and other countries.  
 
The PPRS restricts the rate of return that pharmaceutical companies are allowed to earn from their 
sales of branded medicines to the NHS; permits freedom of pricing for new active substances on 
                                                     
32 http://www.mhra.gov.uk/, accessed 18/10/04 
33 http://www.mhra.gov.uk/aboutmhra/aboutmhra.htm, accessed 22/01/05 
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market entry but prevents subsequent price increases unless the producing company’s rate of return 
falls below a specified (low) threshold level.  It also covers notification of product discontinuations and 
describes some other informational requirements (Department of Health, 2004a).  In addition, under 
the 2005 Scheme, the prices of medicines covered by the PPRS were reduced by 7% from 1 January 
2005, with no price increases permissible until 31st December 2005.  As an alternative to an across 
the board price reduction, scheme members may modulate the list price of their PPRS products by 
reductions that equate to an overall level of 7% (known as cost-neutral modulation) (Department of 
Health, 2004a). 
1.4.7 Prescribing Prescription Authority 
The Prescription Pricing Authority (PPA) is concerned with the payment and budget management of 
health care professionals.  The PPA prescribing information services seek to improve patient care 
through facilitating performance management of the primary care sector. The PPA processes over 
600 million prescription items annually, mange payments to more than 10,000 pharmacy contractors 
and also calculate the payments due to approximately 4,400 dispensing doctors in England.   
 
The main functions of the PPA are: 34 
 
• to calculate and make payments for amounts due to pharmacists and appliance contractors, 
and calculate amounts due to general practitioners, for supplying drugs and appliances 
prescribed under the NHS  
 
• to produce information for General Practitioners (GPs), Nurses, Primary Care Trusts (PCTs) 
and other NHS stakeholders about prescribing volumes, trends and costs 
 
• to manage a range of health benefits including the NHS Low Income Scheme, Medical and 
Maternity Exemption Certificates, Prescription Pre-payment Certificates and Tax Credit 
exemptions 
 
• to produce the Drug Tariff containing the reimbursement prices of a range of prescribable 
items and remuneration rules 
 
Each month, the Pharmaceutical Directorate of the PPA produces the Drug Tariff for the Secretary of 
State under regulation 18(1) of the National Health Service (Pharmaceutical Services) Regulations 
1992 (Secretary of State for Health, 1992b).35  The Drug Tariff for England and Wales is supplied 
primarily to pharmacists, doctors’ surgeries and (twice yearly) to nurse prescribers (Prescription 
Pricing Authority, 2005).  It provides guidance on dispensing, the schedule of fees and allowances 
and prices of drugs and appliances.  The Drug Tariff also contains lists for dental and nurse 
prescribing and for drugs that may not be prescribed on the NHS under any circumstances (black list 
drugs) or that may be prescribed under special circumstances (grey list drugs).  Although Part IX of 
the Drug Tariff provides a positive list of appliances that may be prescribed on the NHS, there is no 
equivalent ‘positive list’ for drugs.  Instead, Part VIII exists to facilitate the generic prescribing of drugs 
and also to help control the NHS Drugs Bill.36 
 
1.5 Regulation of health care professionals 
 
There is a wide range of self-regulators within the health care profession.  The Council for the 
Regulation of Health Care Professionals, an independent body that seeks to make the framework of 
professional self-regulation more transparent and accountable to Parliament, now oversees these 
bodies.  Of the regulators overseen by the Council, the General Medical Council (GMC) is perhaps 
the most prominent in setting standards for health care.The contracts that physicians sign when 
undertaking work for the NHS may specify – or encourage – particular services.  The new General 
Medical Services (GMS) and consultants’ (secondary care physicians’) contracts are described and 
the services they promote are outlined.  Guidance from Royal Colleges may also affect the availability 
of services and these are considered below.  General dental services and general ophthalmic 
                                                     
34 http://www.ppa.org.uk/ppa/ppa_main.htm, accessed 21/03/05 
35 Now in regulation 56 of the 2005 Regulations (S.I. 2005/641) 
36 http://www.ppa.org.uk/ppa/drug_tariff_guidance_notes.htm, accessed 21/03/05 
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services for which patients may be charged a fee provide an indication of services to which patients 
may assume an entitlement.  
1.5.1 Council for the Regulation of Health Care Professionals 
Established in 2003, the Council for the Regulation of Health Care Professionals is an independent 
body that oversees the work of bodies that regulate health care professionals, and seeks to integrate 
approaches for standard setting, performance monitoring, inspection and validation.  The NHS Plan 
highlighted the need for formal co-ordination of regulators (Department of Health, 2000b);(§10.15), 
and was echoed by recommendation 39 in the Kennedy Report on the Bristol tragedy (Kennedy et al., 
2001).   
 
Existing regulators that the Council oversees include (Department of Health, 2003a): 
 
• General Medical Council  
• General Dental Council  
• General Optical Council  
• Royal Pharmaceutical Society  
• Health Professions Council  
• Nursing and Midwifery Council  
• General Osteopathic Council  
• General Chiropractic Council  
• Pharmaceutical Society of Northern Ireland 
1.5.2 The General Medical Council 
The General Medical Council (GMC) was established under the Medical Act of 1858.37  It has legal 
powers designed to maintain the standards the public have a right to expect of doctors: 
 
The main objective of the General Council in exercising their functions is to protect, 
promote and maintain the health and safety of the public (Medical Act 1983; part 1(1)(a)) 
 
Public confidence in the medical profession’s ability to protect the interest of patients was undermined 
by a series of cases, of which the serial murders by Harold Shipman and the misconduct charges 
brought at the Bristol Royal Infirmary were the most serious.  The Bristol tragedy revealed systemic 
failures of existing forms of self-regulation and audit processes, placing the GMC under heavy 
criticism and eroding public trust in the medical profession more generally (Davies and Shields, 1999).  
The Shipman Inquiry precipitated a review of the GMC’s system by which medical competence is 
monitored and regulated.  Plans to introduce a new licensing and revalidation system for doctors have 
been postponed, following the latest report from the Shipman Inquiry and the recommendations 
contained in the report will be help to inform the proposed system.  
1.5.3 Royal Colleges and Societies 
Medical Royal Colleges have direct responsibility for postgraduate medical education and continuing 
medical education.  They also set standards of medical practice.  The word ‘College’ is slightly 
misleading because Colleges have no students, and give no lectures in the normal sense of the word.  
Medical Colleges are networks of doctors who are committed to improving patient care, developing 
their own skills and developing their ‘specialty’.  The Colleges have no role in disciplinary actions or 
processing complaints from patients – these are the responsibility of the General Medical Council.  
 
The Medical Colleges seek to promote high standards of care through provision of continuing 
education, establishment of training standards, setting and running of examinations and supporting of 
research, giving them considerable influence over service provision.  As well as managing the 
development of national government guidelines, many Colleges produce their own clinical guidelines.  
For example, the Royal College of Physicians has produced a guideline on ‘Stroke in Childhood’, 
covering diagnosis, management and rehabilitation.38  In addition, Colleges seek to support their 
members, educate the public and advise the Department of Health, NHS organisations and other 
professional bodies.  
                                                     
37 http://www.gmc-uk.org/about/default.htm, accessed 18/02/05 
38 http://www.rcplondon.ac.uk/pubs/books/childstroke/, accessed 09/03/05 
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There are also Royal Colleges for other clinicians or paramedical professionals, such as the Royal 
College of Nursing, the Royal College of Midwives and the Royal College of Speech and Language 
Therapists.  Other physician organisations include the British Societies, such as the British Society of 
Haematology and Royal Societies, such as the Royal Pharmaceutical Society of Great Britain for 
pharmacists.  These organisations may also produce guidelines to promote high standards of care.  
Where these guidelines are national, the Healthcare Commission may enforce compliance with their 
recommendations for service provision as part of their core standard assessments (Department of 
Health, 2004i).  Otherwise, the impact of the guidance is unclear, but may be expected to vary. 
1.5.4 Agenda for Change 
Agenda for Change claims to be the most radical shake up of the NHS pay system since the NHS 
began in 1948.  It applies to over a million NHS staff with the exception of doctors, dentists and senior 
managers.39  The new pay scales are based on the findings of job evaluation, so that salaries reflect 
skills, responsibilities, knowledge, effort and working conditions.  However, unlike the new General 
Medical Services (GMS) contract, there are no incentives linked to the provision of specific services.   
1.5.5 The General Medical Services (GMS) Contract 
The General Medical Services (GMS) contract was introduced on 1st April 2004, following negotiations 
between the NHS Confederation and the General Practitioners Committee of the British Medical 
Association.  Primary Care Trusts now have a new duty to secure the provision of primary medical 
services (Department of Health, 2003c).  Under this contract, there are three levels of service that 
general (medical) practitioners (GPs) must or may provide to their patients (Box 3). 
 
Box 3: Service categories in the 2004 GMS contract 
Category of 
service 
Status for General Practitioner provision Services included 
Essential 
services 
Mandatory 
Core hours: weekdays, from 8:00 to 18:30 
Immediate and necessary emergency treatment 
Management of registered patients and temporary 
residents with terminal illness, chronic disease or 
conditions from which recovery is generally expected 
Home visits where GP considers this to be medically 
necessary 
Annual health checks offered to patients aged over 75 
Health checks offered to patients not seen within three 
years 
Health checks offered to newly registered patients 
Additional 
services 
Practices will have a preferential right to 
provide additional services and will 
normally do so but they will have an ability 
to opt out within set rules 
Right to opt out of out-of-hours care from 
01/01/05 
Cervical screening 
Contraceptive services 
Vaccinations and immunisations 
Childhood vaccinations and immunisations  
Child health surveillance (under 5s) 
Maternity services 
Minor surgery 
Direct 
Enhanced 
services (DES) 
Optional PCTs must commission (plan for and buy) 6 DESs 
1. Preparing patient information ready for 
computerisation 
2. Improved access 
3. The childhood immunisation programme 
4. Minor surgery 
5. Protection of GPs, their staff and other patients 
from violent patients 
6. Influenza protection for the over-65s and at-
risk patients 
Other services are commissioned at PCT discretion 
Source: (Department of Health, 2003c) 
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PCTs can now also contract with non-NHS bodies such as voluntary or commercial sector providers 
to supply primary medical services.40   Out-of-hours care is optional for GPs, but PCTs are expected 
to negotiate suitable alternative arrangements so that all patients can continue to access these 
services (Department of Health, 2004d); there is a statutory requirement on PCTs to do this 
(Secretary of State for Health, 2004a),(sch. 6, §70).  Practices receive payments from the ‘global sum’ 
that funds the provision of essential, additional and out-of-hours services and is based on patient 
need and practice costs.41  Practices can earn additional income by contracting with the PCT to 
provide enhanced services. There is also the opportunity for practices to substantially increase 
practice income by participating in the Quality and Outcomes Framework (QOF) (Box 4) (Department 
of Health, 2004l).  This framework lists evidence-based best practices in health care provision, 
including the treatment of patients with chronic conditions.  Some (but not all) of the areas covered by 
the quality framework overlap with Direct Enhanced Services.  For example, influenza immunisation 
for at-risk patients is a DES and is included in the QOF for patients with diabetes, chronic obstructive 
pulmonary disorder, asthma, coronary heart disease and stroke.  However, the DES does not cover 
medicines management, which is part of the quality framework, and the QOF does not address minor 
surgery. 
 
Box 4: Quality and Outcomes Framework (QOF) 
  Total points % 
 Secondary Prevention in Coronary Heart Disease 121 11.5% 
 Stroke or transient ischaemic attacks 31 3.0% 
 Hypertension 105 10.0% 
 Diabetes Mellitus (Diabetes) 99 9.4% 
 Chronic Obstructive Pulmonary Disease (COPD) 45 4.3% 
 Epilepsy 16 1.5% 
 Hypothyroidism 8 0.8% 
 Cancer 12 1.1% 
 Mental Health 41 3.9% 
 Asthma 72 6.9% 
 A. Records and information about patients 85 8.1% 
 B. Patient communication 8 0.8% 
 C. Education and training 29 2.8% 
 D. Practice Management 20 1.9% 
 E. Medicines Management 42 4.0% 
 Patient experience 100 9.5% 
 Additional Services42 36 3.4% 
 Holistic Care 100 9.5% 
 Quality Practice 30 2.9% 
 Access Bonus 50 4.8% 
 TOTAL 1050 100% 
 Source: (Department of Health, 2004l) 
 
Before the beginning of each financial year, practices agree with PCTs the level of quality points that 
they aspire to achieve by the end of that financial year and receive aspiration payments.  During the 
financial year practices and PCTs will review the level of achievement under the quality framework.  
After the end of the financial year, practices will receive their achievement payment, reflecting their full 
achievement, minus the aspiration payment that they have already received.  In the first year, 
practices will receive an average of £75 (€108)43 per quality point, however this will be adjusted for list 
size to reflect workload.  There will be a further workload adjustment to take account of disease 
prevalence (Department of Health, 2004j).   
 
                                                     
40 http://www.natpact.nhs.uk/primarycarecontracting/68.php, accessed 08/03/05 
41 This represents a departure from the previous contract, in which payment was made to doctors (rather than to practices), based on 
unadjusted list size.  This meant that payment levels took no account of the needs of registered patients. 
42 i.e. cervical screening, child health surveillance, maternity services and contraceptive services 
43 Currency conversions performed on 18/03/05 using rate of 1 GBP = 1.43978 EUR 
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The Personal Medical Services (PMS) contract is the local alternative to the new national General 
Medical Services (GMS) contract.44  Whereas the GMS contract is national, but has local flexibilities, 
the PMS contract is a locally agreed contract between Primary Care Trusts and PMS providers, such 
as a GP practice, a salaried GP, nurses or other primary care professionals.  PMS offers GPs a 
salaried contract and facilitates an enhanced role for nurses and when the new GMS contract was 
introduced in April 2004, over 40% of GPs in England were working under PMS contracts 
(Department of Health, 2004r).  The services to be provided under PMS must be specified in the 
contract (S.I. 2004/627);(reg. 11(1)(a)) and these may include essential services (reg. 12(1)).  Since 
PMS is a more flexible contract than GMS, PMS providers may elect to offer a less comprehensive 
service.  In this case, the PCTs bear responsibility for arranging supplementary services from other 
providers (Newdick, 2005b);(page 90).   
 
There are two other forms of primary care service provision.  Firstly, Primary Care Trusts may provide 
services themselves, by employing their own staff or by independently contracting practitioners 
(Newdick, 2005b);(pp. 90 - 91).  This is known as Primary Care Trust Medical Services, a form of 
service provision designed to enable PCTs to ‘plug the gaps’ in areas that do not attract GMS or PMS 
providers.  Under these arrangements, it is the PCT – rather than the prescriber – given the duty to 
ensure that prescribing is in accordance with clinical need.  Under Alternative Provider Medical 
Services, private companies, not-for-profit organisations, NHS Trusts and Foundation Trusts may 
provide primary care services (Newdick, 2005b);(page 91).  The rationale behind this arrangement is 
to facilitate provision of services in areas of historic underprovision.  Importantly, the contract must 
exclude the possibility of financial advantage for the provider.  The duty to prescribe according to 
clinical need is preserved.  
1.5.6 The consultant 45 contract 
Concern over the ‘issue of consultant’s private practice’ underpinned the government’s promise to 
‘fundamentally overhaul’ the national consultant contract of 1948 (Department of Health, 2000b);(§§ 
8.19, 8.20).  The new consultant contract was implemented in April 2004 (Maynard and Bloor, 2004).  
It applies to all new practitioners, but is optional for existing consultants.  Under the new contract, 
consultants agree a ‘Job Plan’ with their clinical manager, setting out the main responsibilities and 
duties.  ‘Programmed Activities’ are agreed; these normally describe a four-hour period and include a 
number of duties.  Each consultant will undertake up to ten Programmed Activities each week, 
although there is scope for flexibility (Department of Health, 2003b).  On average, 7½ Programmed 
Activities will be devoted to direct clinical care: for example, clinical diagnostic work, predictable 
emergency duties, specialty ward rounds, outpatient clinics and clinically related administration.46  
This leave 2½ Programmed Activities for ‘Supporting Professional Activities’, such as training and 
research.  Consultants are paid according to the number of Programmed Activities performed.  
Clearly, individual contracts will specify particular services that must be provided and these will vary.  
However, paragraph 6.1 of the contract specifies that Job Plans must contribute to ‘the efficient and 
effective use of NHS resources’.  
 
The NHS Plan had proposed that newly qualified consultants would have to work exclusively for 
seven years before undertaking any private work (Department of Health, 2000b);(§8.24).  Even then, 
it was envisaged that the right to undertake private practice would depend on fulfilling job plan and 
NHS service requirements (ibid).  However, these conditions form no part of the new contract.  
Instead, the contract specifies that privately paid work or fee-for-service work may not generally be 
undertaken during the time scheduled for Programmed Activities (Department of Health, 2003b);(§§ 
11.2, 11.3).  The code of conduct for private practice, which provides guidance on the contract, states 
that ‘NHS consultants and NHS employing organisations should work on a partnership basis to 
prevent any conflict of interest between private practice and NHS work’ and that ‘the provision of 
services for private patients should not prejudice the interest of NHS patients or disrupt NHS 
services.’47  Therefore, service provision agreed in the contract should not be jeopardised by 
consultants’ private work.   
                                                     
44 http://www.natpact.nhs.uk/primarycarecontracting/4.php, accessed 08/03/05 
45 Consultants are medical or surgical specialists 
46 http://www.modern.nhs.uk/consultants/briefing2003.ppt, accessed 01/04/05 
47 http://www.modern.nhs.uk/consultants/14680/Code.pdf, accessed 08/03/05 
CHE Research Paper 2 
 
   
29
1.5.7 Dental, ophthalmic and pharmacist contracts  
Unlike the regulations governing general medical practitioners, there is no statutory duty upon dental 
medical practitioners, or ophthalmic opticians to provide general dental or general ophthalmic services 
respectively.  Instead, Primary Care Trusts are charged with the duty of ensuring that these services 
are provided (Secretary of State for Health, 2002);(reg. 3(1)).  However, the 1977 NHS Act introduced 
the facility for payments to be made for the provision of dental and ophthalmic services, acting as an 
incentive to encourage potential providers and signal that these services are those patients should be 
able to access on the NHS.   
 
For dental practitioners, the National Health Service (General Dental Services) Regulations 1992 (S.I. 
1992/661) make provision for the Secretary of State for Health to determine dentists’ remuneration, 
including a ‘scale of fees’ for providing particular services (reg. 19(1)).  The Statement of Dental 
Remuneration48 describes the services covered by these fees, including clinical examinations and 
treatment planning, diagnostic procedures, such as radiographic examinations, preventative, 
periodontal, conservation and surgical treatments and the supply of prostheses.  Patients treated 
under general dental services make a co-payment for treatment, with the government reimbursing the 
balance.  For example, the current fee for a clinical examination is £7.30 (€10.51),43 for which the 
patient is charged £5.84 (€8.41).  School and college students and women who are pregnant or who 
have a child under 12 months of age are exempt from co-payment (Secretary of State for Health, 
2005c, Secretary of State for Health, 2004b).  Patients pay 80% of the charge, up to a maximum of 
£384 (€553). 
 
Similarly, the National Health Service (General Ophthalmic Services) Regulations 1986 (S.I. 
1986/975) make provision for opticians and ophthalmic medical practitioners and opticians to make 
charges for sight tests and for optical appliances (Secretary of State for Health, 1986);(reg. 10).  
Currently (April 2005), the charge for a sight test is £18.39 (€26.48).49  For certain patients, vouchers 
are available that reduce or remove the charge incurred by patients.  Eligibility for general ophthalmic 
services, outlined in the Health and Medicines Act 1988 (s. 13), is determined by age, disease (or risk 
of disease) or income (S.I. 2004/642).   
 
The Optician Act of 1958 imposes a duty on opticians (and on general and ophthalmic medical 
practitioners) who test the sight of patients to examine the patient’s eyes for any sign of abnormality, 
disease or injury (section 20B).50  Findings must be reported to the patient and appropriate referrals 
made with patient consent (S.I. 1986/975; schedule 1, reg. 10(2)).  For patients with diabetes or 
glaucoma, sight test results must be reported to the physician, irrespective of patient consent (reg. 
10(3)). 
 
The new pharmacist contract came into effect on 1st April 2005 (Secretary of State for Health, 2005b).  
Like the GMS contract for primary care doctors, the pharmacist regulations define ‘essential services’ 
(S.I. 2005/641);(regs. 3 to 21).  These cover the dispensing services (including dispensing of 
electronic prescriptions), disposal services, the promotion of healthy lifestyles and support for self 
care.  Other services include ‘prescription linked intervention’ (reg. 16), public health campaigns (reg. 
17) and signposting (reg. 18).  Under ‘prescription linked intervention’ services, the pharmacist has a 
duty to provide appropriate advice to patients who want to have their prescription dispensed and who 
appear to the pharmacist to be suffering from diabetes, to be at risk of coronary heart disease or who 
appear overweight or who appear to be smokers.  The pharmacist must record any advice given in a 
way that will facilitate audit and follow up care.  Where pharmacists are unable to provide advice, they 
must provide the patient with contact details of relevant health or social care services; this is known 
as ‘signposting’.  Pharmacists are also under a duty to co-operate with a request from PCTs to 
participate in up to six public health campaigns annually.  ‘Directed services’, are additional 
pharmaceutical services provided in accordance with a direction under section 41A(a) of the 1977 
NHS Act.  These essentially cover the supply of ‘proper and sufficient drugs and medicines and listed 
appliances’.  Reimbursement for directed services is determined by the Secretary of State for Health 
(Secretary of State for Health, 2005a).   
                                                     
48 
http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/Dental/DentalDocumentsArticle/fs/en?CONTENT_ID=4002195&ch
k=tPT5CG, accessed 28/02/04 
49 http://www.dh.gov.uk/assetRoot/04/10/70/47/04107047.pdf, accessed 25/04/05 
50 Section 20(B) was added to the Opticians Act 1958 by the Health and Medicines Act 1988 (c. 49)(section 14) 
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1.6 Key health care policies 
1.6.1 Patient choice 
Giving patients more choice about how, when and where they receive treatment is one cornerstone of 
the government’s health strategy, as outlined in the NHS Plan.  Another is giving members of the 
public more influence in shaping local care systems.  As such, choice is a characteristic of the ‘basket’ 
of health care services. 
 
Government research highlighted shorter waiting times as a top priority for patients.  In response, the 
Public Service Agreements, which specify national goals within the public sector, outline waiting time 
targets for the NHS (HM Treasury, 2004): 
 
• By the end of 2005, patients will wait a maximum of six months for inpatient admission and no 
more than 13 weeks for an outpatient appointment 
• By the end of 2008 the maximum wait from general practitioner (GP) referral to hospital treatment 
will be 18 weeks 
 
Targets that should already be achieved, and henceforth maintained, include the 4-hour maximum 
wait for emergency care51 and the 24/48 target for accessing primary care.52  From December 2005, 
'choose and book' system should be operational, whereby patients needing elective treatment will be 
offered a choice of four or five hospitals once their GP has decided that a referral is required.  These 
could be NHS Trusts, Foundation Trusts, treatment centres, private hospitals or practitioners with a 
special interest operating within primary care.  As well as choosing where they go, patients should be 
able to choose when, thanks to a national electronic booking programme.  Appointments can be 
made at the practice surgery, by calling a contact centre, online and eventually via digital television.  
1.6.2 Payment by Results 
‘Payment by Results’ is a case payments system, similar to many DRG (Diagnostic Related Group) 
payment mechanisms.  First proposed in 2002, Payment by Results seeks to radically change the 
NHS funding mechanism and requires higher standards of financial management in Primary Care 
Trusts, NHS Trusts and Foundation Trusts (Department of Health, 2002b).  It was introduced 
ostensibly as a means of delivering the NHS Plan, but Payment by Results could also stimulate non-
price competition between the NHS and private sector, as tariffs include HRGs critical to waiting time 
targets (Street and AbdulHussain, 2004).  The system offers major opportunities and incentives, but it 
also carries ‘major risks, which if not well managed will lead to financial instability and service 
difficulties’ (Audit Commission, 2004b).  
 
Previously, funding of services was based mainly on block contracts between purchasers and 
providers, allowing local circumstances and marginal costs to be taken into account.  ‘Payment by 
Results’ aims to facilitate and support NHS modernisation by paying hospitals for the work they do, 
rewarding efficiency and quality.  It does this through a nationally fixed price or tariff for each 
procedure.  Tariffs are classified by Health care Resource Group (HRG), defined by diagnosis and 
complexity, and are based on an average of all hospital costs for that procedure (known as ‘reference 
costs’).  Therefore, a procedure that can be offered as either a day case or inpatient case receives a 
single tariff, based on a weighted average of the day case and inpatient reference costs.  Adjustments 
are made for wage and price inflation, as well as the impact of NICE and NSF guidance.   
 
The Payment by Results system was first piloted in Foundation Trusts in April 2004 and covered all 
types of care.  Tariffs are still evolving and are not yet fully formed.  For the rest of the NHS, tariffs 
currently cover only elective care involving 48 HRGs (Street and AbdulHussain, 2004).  Earlier plans 
to roll out tariffs to include non-elective and outpatient activity from April 2005 have been postponed, 
but the expectation remains that national tariff prices will apply to 90% of specialities by 2008/09.53  
Local price negotiations will not take place for work covered by the tariff, except where service 
changes result in significant efficiency gains.  Unavoidable regional cost differences are to be funded 
                                                     
51 The 4-hour wait target is that patients should spend no more than 4 hours in an Accident and Emergency hospital department from 
arrival to admission, transfer or discharge 
52 The 24/48 target is that patients will be able to see a general practitioner within two working days or another primary care professional 
within one working day. 
53 http://www.dh.gov.uk/assetRoot/04/10/09/34/04100934.pdf, accessed 15/04/05 
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nationally.  All contracts between PCTs and NHS Trusts will be ‘cost and volume’ with payment linked 
directly to the actual work done.  Therefore, if an operation is cancelled and the hospital fails to offer a 
new appointment date, the money allocated for that operation would move to a new provider.54  
Increases or reductions in activity will be charged at full rather than marginal cost. 
 
A recent study of Foundation Trusts’ activity under the Payment by Results system showed that there 
had been an increase in short-stay inpatient admissions through Accident and Emergency, compared 
with non-Foundation NHS Trusts (Rogers et al., 2005).  This raises the concern that providers may 
reclassify patients into more complex (and more expensive) HRGs in order to increase revenue.   
 
The tariff system of payments for hospital services, whilst in no way guaranteeing provision, place an 
NHS price on particular services, thereby ‘suggesting’ a basket of services. 
 
1.7 Services or technologies excluded from NHS provision 
 
Historically, treatments appear to have been excluded on the basis of culture or tradition.  However, 
NHS Trust purchasing contracts made explicit exclusions at the local level, covering various forms of 
cosmetic surgery (tattoo removal, buttock lift, breast augmentation and procedures for pinning back 
ears).  The reversal of sterilisation and of vasectomy also featured frequently in the contracts, as did 
in vitro fertilisation (Klein, 1997).  
 
Case law has established that NHS organisations may not operate a ‘blanket ban’ on service 
provision, with the possible exception of treatments where the clinical evidence of its inefficacy is 
overwhelming (Newdick, 2005b);(pp 105-107).  R v NW Lancashire Health Authority, ex p A, D and G 
made it illegal for health authorities to impose a blanket ban on services they consider to be ‘low 
priorities’.  Instead, they must adopt a fair and consistent policy for decision-making that adequately 
assesses exceptional cases by considering each request for treatment on its individual merits 
(Newdick, 2005b);(page 101).  This means that there are few services that are explicitly excluded 
from all NHS patients; where exclusions exist, they are principally in the domains of medicines and 
screening. 
 
The law imposes certain restrictions on general practitioners’ (GPs) prescribing.  Some drugs must 
not be prescribed at all on the NHS (the so-called ‘black list’), whilst others may be prescribed only for 
‘specified patients and specified purposes’ (the Selected List Scheme, or ‘grey list’).  These 
restrictions are outlined under section 28U of the Health and Social Care (Community Health and 
Standards) Act 2003 and specified under S.I. 2004/629.  The black list includes thousands of items, 
covering a bizarre range of products from 4711 Cologne, Barkoff Cough Syrup, Cow & Gate Premium 
Baby Food, Elizabeth Arden Flawless Finish, Gale's Honey, Heinz Weight Watcher Baked Beans and 
Ribena!  The ‘grey list’ in S.I. 2004/629 is much shorter and contains products that can be prescribed 
on the NHS only under specific circumstances; drugs for the treatment of erectile dysfunction are an 
example of those included on the grey list and two influenza drugs have recently been added (S.I. 
2004/3215).  However, ‘black’ or ‘grey’ listed products may still be prescribed privately (Secretary of 
State for Health, 2004a);(sch. 6, §42(2)). 
 
Of the 88 NICE technology appraisals published to date (April 2005), only a few have received 
‘negative’ decisions regarding NHS provision (Table 6).  Still fewer of these appraisals have been 
entirely negative; for example, guidance No. 8 on hearing aids did not recommend digital aids but did 
encourage the NHS to make full use of the analogue aids available. 
 
There are also some examples of technologies that received negative decisions on their first 
appraisal, but subsequent appraisals that considered additional evidence produced positive decisions.  
Examples of these were NICE appraisals of laparoscopic surgery for hernia (Appraisal Nos. 18 and 
83), zanamivir for influenza55 (Appraisal Nos. 15 and 58) and of liquid-based cytology for cervical 
cancer (Appraisal Nos. 5 and 69).  However, most of the ‘positive’ appraisals include caveats on 
eligibility (i.e. negative decisions for certain patient groups, tantamount to a partial rejection).  For 
instance, Appraisal No. 23 (Guidance on the use of temozolomide for the treatment of recurrent 
malignant glioma (brain cancer)) endorses the use of the drug on the NHS for patients who have 
                                                     
54 http://news.bbc.co.uk/1/hi/uk_politics/4323749.stm, accessed 07/03/05 
55 However, S.I.2004/3215 added zanamivir to the Selected List Scheme (‘grey list’ drugs) 
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failed first-line chemotherapy treatment with other agents, but excludes NHS provision for patients 
who have failed primary therapy (surgery and/or radiotherapy), except in the context of a randomised 
controlled trial against a standard-treatment comparator.56   Equally, Appraisal No. 57 (Guidance on 
the use of continuous subcutaneous insulin infusion for diabetes) recommended the use of insulin 
pumps for patients with type I, but not for type II, diabetes.57  Lastly, NICE has recently proposed – a 
final decision is awaited – that the NHS ceases to fund anti-dementia drugs, although patients already 
receiving treatment will continue to do so.  This has precipitated hostile responses from the press and 
from patient groups (Kmietowicz, 2005). 
 
Table 6: ‘Negative’ decisions from NICE technology appraisals, April 2005 
Topic (Guidance No) Drug/Device Summary of guidance 
Wisdom teeth - removal 
(No. 1) 
Procedure The practice of prophylactic removal of pathology-free impacted 
third molars should be discontinued in the NHS. 
Hearing disability - new 
advances in hearing aid 
technology (No. 8) 
Device Nationwide introduction of digital hearing aids not recommended.  
Guidance withdrawn three years later following successful pilots 
and the subsequent widespread availability of digital aids. 
Colorectal cancer - 
laparoscopic surgery (No. 
17) 
Procedure Open rather than laparoscopic surgery should be used for the 
treatment of colorectal cancer and laparoscopic surgery should be 
restricted to randomised controlled clinical trials. 
Colorectal cancer 
(advanced) - irinotecan, 
oxaliplatin & raltitrexed 
(No. 33) 
Drug  Irinotecan or oxaliplatin in combination with 5-fluorouracil and 
folinic acid not recommended for routine first-line therapy for 
advanced colorectal cancer.  Raltitrexed not recommended for the 
treatment of advanced colorectal cancer. 
Lymphoma (follicular non-
Hodgkin's) - rituximab 
(No. 37) 
Drug Permitted only for last-line treatment, in the context of a 
prospective case series. 
Ultrasound locating 
devices for placing central 
venous catheters (No. 49) 
Device Audio-guided Doppler ultrasound is not recommended for inserting 
central venous catheters. 
Flu - zanamivir (review), 
amantadine and 
oseltamivir (No. 58) 
Flu - (prophylaxis) 
amantadine and 
oseltamivir (No. 67) 
(review) 
Drug Amantadine is not recommended for the treatment (No. 58) or 
prevention (No. 67) of influenza.  
ECT - Electroconvulsive 
therapy (No. 59) 
Procedure ECT is not recommended as a maintenance therapy in depressive 
illness.58 
Rheumatoid arthritis - 
anakinra (No. 72) 
Drug Anakinra not recommended for the treatment of rheumatoid 
arthritis, except in the context of a controlled, long-term clinical 
study. 
 
 
Some dental treatments are not available on the NHS.  For example, the most recent Statement of 
Dental Remuneration implicitly excludes cosmetic treatments such as teeth whitening (Secretary of 
State for Health, 2005c).   
 
The UK National Screening Committee, an advisory body to UK Health Ministers, has recommended 
that certain types of screening be excluded from current public NHS provision.  The Committee uses 
                                                     
56 http://www.nice.org.uk/page.aspx?o=16566, accessed 15/03/05 
57 http://www.nice.org.uk/pdf/57_Insulin_pumps_fullguidance.pdf, accessed 15/03/05 
58 However, short-term ECT is available on the NHS for a narrowly-defined group of patients 
62 
http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/SexualHealth/SexualHealthGeneralInformation/SexualHealthGener
alArticle/fs/en?CONTENT_ID=4084098&chk=CSLxsK, accessed 02/03/05 
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research evidence to identify programmes that do more good than harm, then makes policy 
recommendations about those programmes that will do more good than harm at a reasonable cost 
(UK National Screening Committee, 2004).  Current exclusions include but are not limited to: 
 
• Screening for prostate cancer for any age or gender group 75 
• For pregnant women, routine tests are not recommended for Chlamydia, 62 cystic fibrosis and 
hepatitis C, diabetes  
• For newborn babies, routine tests are not recommended for Duchenne muscular dystrophy, 
neonatal alloimmune thrombocytopenia and neuroblastoma  
• For children, screening is not recommended for autism, hypertension, speech and language 
delay, iron deficiency anaemia, lead poisoning, obesity and vision defects  
• For adults, screening is not recommended for Alzheimer’s disease; anal, bladder, lung, oral, 
ovarian cancers; depression; hepatitis C; and osteoporosis 
 
Other exclusions from NHS provision include single vaccines for measles, mumps and rubella 
(Montgomery, 2003);(page 34) and the smallpox vaccine.63   
                                                     
63 http://www.homeoffice.gov.uk/terrorism/threat/faq/, accessed 17/03/05 
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2. Definitions of entitlements and benefits by sector 
 
Under the OECD classification of personal health care services and goods, there are six categories of 
service known as the International Classification for Health Accounts (ICHA).  NHS provision covers 
all six categories.  A description of the benefits that are provided within the English health care system 
is given below, covering the legislative and regulatory frameworks and the role of central government 
and other actors.  Further details are presented in the Appendix (Table 9). 
 
All services are defined implicitly, in the sense that there are no positive lists of treatments to which 
patients are entitled.  Although PCTs may interpret national policy differently, there is only one payer, 
the government, to whom this applies.   
 
An overview of statutory accountability within the NHS is given in figure 1.  The duty placed on the 
Secretary of State for Health to promote a comprehensive health services has been delegated to 
Strategic Health Authorities, who may issue directions on behalf of the Secretary of State to both NHS 
Trusts and to PCTs.  Foundation Trusts are not accountable to the Secretary of State for Health, but 
to the independent regulator, Monitor, who also carries a duty to promote a comprehensive health 
services. 
 
PCTs are responsible for providing, or arranging the provision of services, stipulated under sections 3, 
4 and 5 of the 1977 NHS Act.  To do this, they must contract with NHS Trusts.  However, these NHS 
contracts are not legally binding.  In contrast, the contracts between Foundation Trusts and PCTs are 
legally binding.  Section 26 of the 1999 Health Act placed duty on NHS organisations to co-operate 
with each other; the Health and Social Care (Community Health and Standards) Act 2003 extended 
this duty to explicitly include Foundation Trusts (Secretary of State for Health, 2003);(s. 29). 
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Figure 1: Statutory Accountability within the NHS, England 2005 
 
2.1 HC2 Services of rehabilitative care 
 
This includes care where the principal medical intent is to relieve symptoms or reduce severity or 
protect against exacerbation or complication of illness or injury.  Care may be delivered in inpatient, 
day case or outpatient settings, including ambulatory care. 
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2.1.1 Summary of legal entitlement 
The National Health Service Act 1946 (c. 81) and the National Health Service Act 1977 (c. 49) 
address the establishment and promotion of ‘a comprehensive health service’ and require the 
Secretary of State for Health (the ‘Minister for Health’ in the 1946 Act) ‘to provide or secure the 
effective provision of services’.  However, discretion is at the heart of these duties and the politician in 
charge of health care is entitled to take into account the resources available to him.   
 
The 1977 NHS Act specifies that the Secretary of State for Health has a duty to provide ‘to such 
extent as he considers necessary to meet all reasonable requirements’ (Secretary of State for Health, 
1977): 
 
• Hospital accommodation (s. 3(1(a))), including high security psychiatric services (s. 4) 
• Other accommodation necessary for the purpose of any other services required by the Act (s. 
3(1(b))) 
• Medical, dental and nursing services (s. 3(1(c))) 
• Such other services as are required for the treatment of illness (s. 3(1(f))) 
 
The 1977 Act defines ‘medical’ as including ‘surgical’ and ‘illness as including a mental disorder and 
any injury or disability requiring medical or dental treatment or nursing (Secretary of State for Health, 
1977);(s. 128(1)). 
 
Facilities and services that the Secretary of State for Health has powers to provide ‘as he considers 
appropriate’ include facilities for the care of persons suffering from illness (s. 3(1(e))).  Following 
secondary legislation,5 the responsibility for providing these services has passed to the local health 
authorities, which in the current organisational structure are known as Primary Care Trusts (PCTs). 
 
The 1977 NHS Act places a duty on Primary Care Trusts (‘Area Health Authorities’, in the original 
terminology) to provide general medical services (s. 29), general dental services (s. 35), 
pharmaceutical services (s. 41) and general ophthalmic services (s. 38). 
 
As well as the primary legislation embodied by the 1946 and 1977 Acts, there is also a considerable 
quantity of relevant secondary legislation.  Most recently, the National Health Service (General 
Medical Services Contracts) Regulations 2004 (S.I. 2004/291) provide details of the terms of service 
for general practitioners (GPs) (Secretary of State for Health, 2004a).  This Statutory Instrument 
legislates for the provision of curative (and other) services by GP practices.  For example, ‘essential 
services’ must be provided, covering emergency treatment and treatment for patients with chronic, 
terminal and self-limiting disease (reg. 15(3)(5)(6)(8)).  However, the provision of other services is 
incentivised under the voluntary Quality and Outcomes Framework (Department of Health, 2004l).  
For example, payments are awarded to practices for ensuring that a given proportion of patients with 
coronary heart disease receive regular blood pressure checks and lipid tests.   
 
In case law, R v NW Lancashire Health Authority, ex p A, D and G examined the case of three 
applicants suffering from ‘gender identity dysphoria’ (Newdick, 2005b);(page 101).  The Health 
Authority had identified this illness as amongst the bottom 10% in terms of need64 and so transsexual 
surgery would be provided only in cases of ‘overriding clinical need’.  The court acknowledged the 
need for priority setting in which issues of effectiveness, the seriousness of the condition and cost 
were taken into account.  However, the court found that the Health Authority had in practice adopted a 
‘blanket ban’ and recommended the authorities introduced a fair and consistent policy for decision-
making that adequately assessed exceptional cases by considering each request for treatment on its 
individual merits.  The case therefore made it illegal for Health Authorities to impose a blanket ban on 
gender reassignment surgery and other ‘low priority’ services.   
2.1.2 Regulatory regimes / quasi law 
The Department of Health issues National Service Frameworks (NSFs) that cover some services of 
curative care.  For example, the NSF for renal diseases aims to increase fairness of access and 
improve choice and quality in dialysis, which comes under the ICHA classification of ‘day cases of 
curative care’ (Department of Health, 2004h).  The ICHA category ‘outpatient curative care’ is 
                                                     
64 Also included in the bottom 10% were cosmetic surgery, reversal of sterilisation, correction of myopia and most ‘alternative’ medicines. 
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addressed by the NSF for Mental Health, which sets the standard that patients should have 24-hour 
access to an approved duty doctor and to an approved social worker (Department of Health, 1999).   
 
Clinical guidelines by the National Institute for Clinical Excellence (NICE) cover the management of 
various conditions and may include recommendations for curative treatment.  For example, the NICE 
guidelines on Dyspepsia (CG18) and Post Myocardial Infarction (an ‘inherited’ guideline that predated 
the establishment of NICE) recommend lifestyle advice and appropriate medication as secondary 
preventative measures.  The guideline on Head Injury (CG4) specifies treatment pathways covering 
emergency, outpatient and inpatient care. 
2.1.3 Role of central government and other actors 
Under current legislation, the two types of NHS body primarily responsible for the provision of curative 
services are Primary Care Trusts (PCTs) and Strategic Health Authorities (SHAs).  The Secretary of 
State for Health can delegate his functions directly to Primary Care Trusts (Secretary of State for 
Health, 2002);(reg. 3(2(a))).  SHAs have to support PCTs and manage their performance in exercising 
these functions (reg. 3(2(b))).  Previous legislation places PCTs and SHAs under a duty to co-operate 
(Secretary of State for Health, 1999a);(s. 26).  Therefore, the provision of curative services, such as 
hospital accommodation and other facilities or treatments for the care of the sick, is now the 
responsibility of PCTs. 
 
Some functions may not be exercised by PCTs, but these do not include any curative services.  
However, the provision of high security psychiatric services by PCTs were conditional upon joint 
provision with an NHS Trust and with the approval of the Secretary of State (Secretary of State for 
Health, 2002);(reg. 8(1)(a))). 
 
The functions of NHS Trusts are outlined in the National Health Service and Community Care Act 
(Secretary of State for Health, 1990) and the Health Act 1999 (Secretary of State for Health, 1999a).  
The 1990 Act describes NHS Trusts’ broad financial functions (duties and powers), which are to be 
carried out ‘effectively, efficiently and economically’ (sch. 2, 6(1)) and makes provision for secondary 
legislation to establish and specify particular functions for individual NHS Trusts (sch. 2, 1-4).  The 
1990 Act confers considerable freedoms on NHS Trusts, summarised in the ‘power to do anything 
which appears to it to be necessary or expedient for the purpose of or in connection with the 
discharge of its functions’.  This includes particular power to acquire and dispose of land and other 
property, to enter into such contracts as seem to the Trust to be appropriate, to accept gifts of money, 
land or other property, including money, land or other property to be held on Trust, either for the 
general or any specific purposes of the NHS Trust or for all or any purposes relating to the health 
service; and to employ staff on such terms as the Trust thinks fit (Secretary of State for Health, 
1990);(sch. 2, 16).  Primary Care Trusts enter contracts (‘NHS contracts, or local service agreements) 
with NHS Trusts to provide services, but NHS Trusts are accountable to the Secretary of State.  This 
creates a tension, because PCTs are bound to arrange the provision of services, but have no 
statutory power over providers. 
 
NHS Foundation Trusts were established by the Health and Social Care (Community Health and 
Standards) Act 2003 (Secretary of State for Health, 2003).  The principal purpose of the trust is the 
provision of goods and services for the purposes of the health service in England (s. 14(2)), and, like 
NHS Trusts, Foundation Trusts must execute their duties ‘effectively, efficiently and economically’ (s. 
39).  However, Foundation Trusts are not subject to the direction of the Secretary of State, but to the 
direction of an independent regulator (s. 3);(see Monitor).  They have greater financial and 
management freedoms than NHS Trusts, including freedoms to retain surpluses and to invest in 
delivery of new services (s. 14(3)).  These ‘new services’ are not specified, but must support the 
principal purpose.  As Foundation Trusts are not subject to direction by the Secretary of State, the 
contracts they enter with PCTs are legal contracts – enforceable by law – rather than NHS contracts. 
 
The 1999 Health Act amends the legislative framework for NHS Trusts, extending the powers of the 
Secretary of State to direct all their functions.  Subject to Secretary of State approval, the 1999 Act 
also gave NHS Trusts powers to provide high security psychiatric services (Secretary of State for 
Health, 1999a);(s. 41).   
 
The National Institute for Clinical Excellence (NICE) produces guidance on the use of some curative 
technologies.  For example, guidance on interventional procedures is given by an independent body 
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asked by NICE to examine the evidence in terms of safety and efficacy; it does not examine clinical or 
cost effectiveness.17  NICE also oversees the production of clinical guidelines that may include 
recommendations about curative care services (e.g. Head Injury, CG4) and undertakes appraisals of 
new and existing technologies, such as the removal of wisdom teeth (Appraisal No. 1).   
 
PCTs are under a statutory duty to provide general medical, ophthalmic and dental services by 
negotiating contracts with doctors, optometrists and dentists (Secretary of State for Health, 2002, 
Secretary of State for Health, 2003);(ss.170,174).  Although general medical practitioners (GPs) are 
bound by the conditions of their contract to provide general (medical) services or personal (medical) 
services, the same is not true of optometrists and dentists.  There is currently a shortage of dentists 
providing general dental services for the NHS.  Private practice has grown rapidly since 1992, 
following a 7% cut in fees that was intended to counteract previous overpayments (Department of 
Health, 2004k, Oliver, 2002).  The lack of access to NHS dentists has triggered an urgent review of 
the regulations governing the dentists’ terms of service and a recent cash injection of over £350 
(€504)43 million, aimed at increasing the number of dentists working for the NHS (Department of 
Health, 2004n).   
 
Perhaps the most important actors in determining whether patients can access curative services are 
the physicians.  Their terms of service grant them considerable freedom to deliver services as they 
perceive appropriate to meet clinical need.  Although specific services are required from general 
practitioners who work under the GMS contract (see The General Medical Services (GMS) Contract), 
the decision of who to treat, when and how are at a GP’s discretion (Newdick, 2005b);(page 22).    
 
2.2 HC2 Services of rehabilitative care 
 
This includes medical and paramedical services delivered to patients during an episode of 
rehabilitative care, where the emphasis is on improving functional levels. 
2.2.1 Summary of legal entitlement 
The 1977 NHS Act specifies that the Secretary of State for Health has a duty to provide ‘to such 
extent as he considers necessary to meet all reasonable requirements’ and ‘as he considers are 
appropriate’ (Secretary of State for Health, 1977): 
 
• facilities for ‘the aftercare of persons who have suffered from illness’ (s. 3(1(e))) 
 
Following secondary legislation,5 the responsibility for providing these services has passed to the 
local health authorities, which in the current organisational structure are known as PCTs.  The 
definition of ‘illness’ includes mental disorder as defined in the 1983 Mental Health Act and any 
disability or injury that requires medical or dental treatment or nursing (Montgomery, 2003);(page 54).  
In the 1977 Act, the word ‘hospital’ specifically includes ‘any institution for the reception and treatment 
of persons during convalescence or persons requiring medical rehabilitation’ (Secretary of State for 
Health, 1977);(s. 128(1)).  Under section 117 of the Mental Health Act 1983, health authorities and 
local social services have a legal duty to provide after-care for patients who have been detained in 
accordance with the Act, but who have left hospital. There is no power to charge for section 117 after-
care. 
2.2.2 Regulatory regimes / quasi law 
Some services of rehabilitation are specified in National Service Frameworks (Table 3).  The NHS 
Plan announced new intermediate care services for older people and those with mental health 
problems (Department of Health, 2000b). The NSF for Older People reflects this in standard 3: 
 
Older people will have access to a new range of intermediate care services at home or in 
designated care settings, to promote their independence by providing enhanced services 
from the NHS and councils to prevent unnecessary hospital admission and effective 
rehabilitation services to enable early discharge from hospital and to prevent premature 
or unnecessary admission to long-term residential care (Department of Health, 2001b).   
 
The NSF for Mental Health includes requirement that all users with severe mental health needing 
rehabilitation have timely access to an appropriate hospital bed or alternative bed or ‘mental health 
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place’ (standard 5)(Department of Health, 1999). The NSF on Coronary Heart Disease specifies 
services that should be available for cardiac rehabilitation, including lifestyle advice, effective 
medicines, exercise sessions and referral to specialist cardiac, behavioural (e.g. exercise, smoking 
cessation) or psychological services as clinically indicated ;(standard 12).  Health care organisations’ 
compliance with NSFs is now monitored by the Healthcare Commission, as part of the new 
assessment framework (see The Healthcare Commission). 
 
Clinical guidelines may also act as quasi law, specifying service patterns and treatment pathways that 
represent best clinical practice.  For example, the Royal College of Physicians has produced a 
guideline on ‘Stroke in Childhood’, covering diagnosis, management and rehabilitation.38  The NICE 
clinical guideline on Supportive and palliative care services for adults with cancer states that those 
responsible for providing care should ‘ensure that patients’ needs for rehabilitation are recognised and 
that comprehensive rehabilitation services and suitable equipment are available to patients in all care 
locations’ (CSG, Recommendation 16).65 
2.2.3 Role of central government and other actors 
See entry under HC2. 
 
2.3 HC3 Services of long-term nursing care 
 
This includes ongoing health and nursing care for patients who need assistance on a continuing basis 
due to chronic impairments and reduced independence and activities of daily living.  The category 
includes respite care, hospice care, palliative care, but excludes social care. 
 
In 1942, the Beveridge Report recommended separating responsibility for provision of health care 
from social care, a distinction reflected in the 1946 NHS Act and the 1948 National Assistance Act.  
Whilst the 1946 Act gave the Secretary of State for Health duties over the provision of (generally free) 
health care services, the 1948 Act gave local social services authorities duties over social care 
provision, for which patients may be charged (Newdick, 2005b);(page 114).  Since then, there has 
been an ongoing debate over the boundaries between social and health care, essentially trying to 
decide the circumstances governing when a ‘patient’ becomes a ‘client’ or ‘resident’.  Services of 
long-term nursing care are one area where this debate is evident.  Legislation has been introduced to 
attempt to clarify the responsibilities of health and social care organisations.  
2.3.1 Summary of legal entitlement 
Under the 1977 NHS Act, the Secretary of State has a duty promote a comprehensive health service 
(1(1)) and to provide nursing care (Secretary of State for Health, 1977);(s. 3(1(c))).  However, the 
courts have determined that this duty is not absolute:  
 
 ‘ a comprehensive service may never, for human, financial and other resource reasons, 
be achievable…. …The [1977 NHS] Act does not impose an absolute duty to provide the 
specified services.  The Secretary of State is entitled to have regard to the resources 
made available to him under current government economic policy (R v. North & East 
Devon Health Authority, ex p. Coughlan 16th July 1999).   
 
The case of Ex parte Coughlan concerned a woman who had been in a serious car accident and was 
severely disabled and living in a care home.  The Health Authority proposed to move the residents of 
a care home into a different home, thereby transferring caring responsibility for the residents from the 
NHS to the local social services authority.  This meant that residents could now be charged for their 
care depending on their income and other forms of wealth (Newdick, 2005b);(pp. 95 ff).  The Court of 
Appeal found this proposal to be illegal: the NHS was entitled, under the 1977 Act, to decide which 
long-term residents were eligible for NHS care, but was not empowered to transfer its duties across to 
local authorities.  However, the Court of Appeal also noted that ‘the Secretary can exclude some 
nursing services from the services provided by the NHS.  Such services can then be provided as a 
social or care service, rather than a health service’ (cited in (Newdick, 2005b); page 117). 
 
The National Health Service Act 1977 gives power to local social services authorities to provide 
residential and nursing accommodation for those in need of care and attention, where these are not 
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CHE Research Paper 2 
 
   
39
otherwise available and need exists by reason of age, illness, or disability (Secretary of State for 
Health, 1977);(s. 21).  A 1993 Local Authority Circular (LAC 93/10) converts this power into a duty for 
some client groups, such as persons who are suffering from, or who have suffered from a mental 
disorder.  However, this duty is upon local social service authorities, rather than upon health 
authorities.  Local authorities can either provide the services themselves or purchase them from other 
providers on behalf of clients (Montgomery, 2003);(page 86).  
 
Whether patients are eligible for institutional nursing care, such as that provided in a nursing home, is 
determined by section 47 of the NHS and Community Care Act 1990 (Secretary of State for Health, 
1990).  The 1990 Act outlines whether individuals have care needs that call for the provision of 
community care services; and if so, whether individuals have need for care and attention that is not 
otherwise available to them under section 21 of the National Assistance Act 1948 (Department of 
Health, 2003d).  Definitions of ‘nursing care’ are given in the Health and Social Care Act 2001 
(Secretary of State for Health, 2001a);(s.49(2)): 
 
…nursing care by a registered nurse means any services provided by a registered nurse 
and involving-  
 
  (a) the provision of care, or  
  (b) the planning, supervision or delegation of the provision of care,  
other than any services which, having regard to their nature and the circumstances in 
which they are provided, do not need to be provided by a registered nurse. 
 
There is a separate system for assessing eligibility for another type of long-term NHS care, known as 
NHS continuing care.  This type of care is for people who do not need care in an acute hospital, but 
who require a high degree of ongoing health care.66  Most people who qualify for NHS continuing care 
are elderly (House of Commons Health Committee, 2005).   
 
On 1 October 2001, the commitment set out in the NHS Plan to bring in free care nursing care from a 
registered nurse for those people paying all the costs of their care – so-called ‘self-funders’ – was 
realised, affecting approximately 42,000 individuals (Secretary of State for Health, 2001a);(s. 49), 
(Department of Health, 2001a).  Further changes were introduced in April 2003 by directions from the 
Secretary of State for Health.  The funding of the nursing care was transferred from local authorities to 
the NHS, affecting around 88,000 residents of care homes who were receiving care from a registered 
nurse (Department of Health, 2003d).  
2.3.2 Regulatory regimes / quasi law 
The report by the Royal Commission on Long Term Care was published in 1999 (Sutherland, 1999).  
One of the main recommendations was that the costs of long-term care should be divided between 
living costs, housing costs and personal care.  Personal care should be available after assessment, 
according to need and paid for from general taxation: the rest should be subject to a co-payment 
according to means. The Commission defined ‘personal care’ as the care needs, often intimate, which 
give rise to the major additional costs of frailty or disability associated with old age. It was to include 
support from skilled professionals. 
 
The government’s response to the Commission’s recommendations was set out in the NHS Plan 
(2000) (Department of Health, 2000b).  Acknowledging that the existing system of funding was 
‘confusing, complicated and anomalous’ (§15.7), the government proposed: 
 
• To change the way in which the value of an individual’s own home was taken into account 
when assessing patient payments for nursing or residential homes 
• To change the law to reduce ‘unacceptable variations in charges for home care’ 
• To make nursing care provided in nursing homes fully funded by the NHS 
• To invest a further £360 million to help people meet the costs of their residential and nursing 
home care. 
                                                     
66 Also known as ‘continuing NHS care’ (see S.I. 2003/2277) 
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The government therefore declined to implement fund personal care, but took steps to ensure the 
NHS would fund all nursing care.  The NHS now aspires to meet the costs of registered nurse time 
spent on providing, delegating or supervising care in all settings, addressing the anomaly of people 
having to pay for care in a nursing home that would be provided free in residential accommodation or 
at home.67   
 
The National Service Frameworks affect the provision of long-term nursing care insofar as they 
recommend particular services.  For example, the NSF for Mental Health addresses the care of 
working aged adults with severe mental illness, and highlights the need for ‘community mental health 
teams’ to include nursing care.  These teams provide care for people in their own homes and work 
across the primary/secondary care interface (Department of Health, 1999).  The NSF states that 
home-based services should be available at weekends and in evenings as well as during office hours 
(Department of Health, 1999);(page 132).  The NSFs for Children also contains recommendations 
about long-term nursing care (Table 3). 
2.3.3 Role of central government and other actors 
The central government has been instrumental in ushering in changes to the way long-term nursing 
care is funded.  Under the 2001 Health and Social Care Act, local authorities were divested of their 
powers to provide or arrange nursing care (Department of Health, 2001a).  Instead, the powers and 
duties to provide nursing care given to the NHS under the 1977 NHS Act were revitalised.  In practice, 
this means that Primary Care Trusts are now responsible for funding long-term nursing care 
(Secretary of State for Health, 2002).  However, many agencies, including the NHS, specialist 
hospices, the voluntary sector and social care and education services (for children), currently provide 
palliative care services that may involve long term nursing care (Department of Health, 2004g).   
 
The Department of Health worked with the Royal College of Nursing and other key stakeholders to 
develop an assessment tool for determining who is eligible for free nursing care provided by a 
registered nurse. 
 
For all adults who were moving into a nursing home, a ‘Registered Nursing Contribution to Care’ 
(RNCC) framework was developed (Department of Health, 2001c).  Informed by a Single Assessment 
Process68 of a person’s needs and the resulting Care Plan, the RNCC framework was intended to 
standardise the assessment process, whilst enabling registered nursing input to be determined on an 
individual basis (Department of Health, 2001c);(page 12): 
 
The tool should not be used in a mechanistic or bureaucratic manner, but should reflect 
the principles that underpin the entire assessment process, i.e. it focuses on the person 
as an individual, looks at their needs in the round, follows a standardised approach, and 
is outcome-centred.  
 
The Single Assessment Process collects information about the person’s self-reported problems and 
expectations, clinical background, disease prevention (e.g. whether they take regular exercise), 
personal care needs, sensory loss and mental health.  In addition, information about the person’s 
social network, personal safety and environment is documented.  The RNCC framework builds on this 
information.  The nurse assessor begins by checking that all opportunities for rehabilitation have been 
taken (i.e. a nursing home is the appropriate setting) and then allocates the person to one of three 
bands: 
 
• High: for people with complex/ unstable / unpredictable needs involving frequent registered 
nursing intervention over 24 hours 
• Medium: for people with stable / predictable needs involving daily intervention by a registered 
nurse, but who may need access to a nurse at any time 
• Low: for people who have chosen to go into a nursing home although care could be provided 
in another setting 
                                                     
67http://www.dh.gov.uk/PolicyAndGuidance/OrganisationPolicy/IntegratedCare/NHSFundedNursingCare/NHSFundedNursingCareArticle/f
s/en?CONTENT_ID=4070915&chk=IK/bDy, accessed 24/01/05 
68 The Single Assessment Process was introduced in 2000 as part of the NSF for Older People 
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The bands correspond to different funding levels (in April 2005 these were £40 (€58), £80 (€115) and 
£129 (€186) 43 per week) (Department of Health, 2004e).  The nurse assessor also provides a 
rationale for the decision and sets a date for review.  Where a person’s needs are significantly greater 
than those covered by the high band, the assessor redirects the person to be assessed for NHS 
continuing care so that they can receive regular and specialist supervision. 
 
Eligibility criteria for NHS continuing care were drawn up in 1995.  These criteria were based on the 
complexity, intensity or unpredictability of a person’s health care needs, where the person required 
regular supervision was by a hospital physician, specialist nurse or other member of the NHS 
multidisciplinary team (House of Commons Health Committee, 2005).  Within this framework, each 
Health Authority was to develop local policies and eligibility criteria (at the time of writing this report 
(April 2005), this responsibility falls to Strategic Health Authorities).  This meant that central guidance 
on the criteria for eligibility for funding was interpreted locally.  Whilst nursing staff carried out the 
initial assessment of a patient's eligibility, in practice, the final decision was often made by a panel.  
This panel met infrequently and had responsibility for a large caseload.   
 
If eligible for NHS continuing health care, a patient's care should be fully funded by the NHS, however 
the lack of uniformity in the eligibility criteria has meant that access to funding is extremely 
fragmented, and has resulted in many patients being wrongly denied funding.  In 2003 the Health 
Service Ombudsman's report into NHS funding for long term care found that many people had been 
wrongly denied funding (Abraham, 2003);(§33): 
 
Given the freedom to decide their own eligibility criteria within the loose national 
framework, health authorities have adopted a range of approaches, both to the criteria 
themselves and to procedures and guidance underlying them. Looking at most of the 
sets of criteria we have seen, it is fairly easy to identify a group of people who would 
definitely not be eligible for funding, and a very small group of people who definitely 
would be eligible (many of whom would not be well enough to leave hospital). But there 
is a large number of people in the group in between.  
 
It recommended that Strategic Health Authorities in England conduct a review of cases and reimburse 
those who had been unfairly treated.  By the end of March 2004 over 6,000 cases had been reviewed 
resulting in more than £180 (€259)43 million in compensation.  Although the problem has been 
highlighted, it has yet to be resolved with many people still not receiving the funding to which they are 
entitled.   
 
Consequently, there was a clear need for centrally supported learning and development materials for 
all staff involved in decisions regarding the provision of funding and subsequent service provision, for 
patients who require NHS continuing health care.  In December 2004, the Department of Health 
announced its intention to introduce national eligibility criteria for continuing health care funding.  In 
2005, the Department of Health is working with Strategic Health Authorities and other stakeholders to 
draft new criteria to assess patients eligible for fully funded NHS continuing care (Department of 
Health, 2004e).  At the time of writing (April 2005), the new criteria have not been published. 
 
2.4 HC4 Ancillary services to health care 
 
This includes a variety of services performed by paramedical or medical technical personnel, such as 
laboratory services, diagnostic imaging and patient transportation. 
2.4.1 Summary of legal entitlement 
The 1946 NHS Act (c. 81) gives the Secretary of State (‘Minister for Health’) powers – but does not 
place a duty on him – to ‘provide a bacteriological service, which may include the provision of 
laboratories, for the control of the spread of infectious diseases’ (s. 17).  The 1977 NHS Act (c. 49) 
the wording is similar, but refers to a ‘microbiological service’ (Secretary of State for Health, 1977);(s. 
2(c)).   
 
Under section 27 of the 1946 Act, local health authorities (PCTs in today’s NHS) are given the duty of 
providing ambulance services ‘for the conveyance of persons suffering from illness or mental 
defectiveness or expectant or nursing mothers from places in their area to places in or outside their 
area.’  In the 1977 Act, the responsibility for ambulance services was transferred to the Secretary of 
Description of the Benefit Catalogue England 42 
State for Health (Secretary of State for Health, 1977);(s. 3(c)), but was subsequently passed back to 
the local health authorities, which in the current organisational structure are known as PCTs.5 
 
In the 1946 Act, there is an implicit duty upon the Secretary of State to provide hospital-based 
diagnostic or other paramedical services, which could be considered to come under the category 
‘other services required at or for the purposes of hospitals’ (s. 3(b)).  The 1977 NHS Act is more 
explicit, stating that the Secretary of State has a duty to provide ‘such other services as are required 
for the diagnosis and treatment of illness’ (s. 3(f)).  Although this is still subject to the proviso ‘to such 
an extent as he considers necessary to meet all reasonable requirements’, these services are no 
longer limited to hospital-based care and the diagnostic services are explicitly mentioned.  As 
medical, dental, nursing services are mentioned separately (s. 3(c)), section 3(f) effectively enables 
the Secretary of State to provide paramedical services.  Once again, these duties are now transferred 
to local health authorities, Primary Care Trusts.5 
2.4.2 Regulatory regimes / quasi law 
There appears to be little quasi-law relating to ancillary services.  The National Service Framework for 
Coronary Heart Disease recommends the use of defibrillators for people with symptoms of a possible 
heart attack: 
 
People with symptoms of a possible heart attack should receive help from an individual 
equipped with and appropriately trained in the use of a defibrillator within 8 minutes of 
calling for help, to maximise the benefits of resuscitation should it be necessary 
(Department of Health, 2000a);(standard 5). 
 
This implies that ambulance staff, appropriately trained to use defibrillators, should be available.  The 
NSF also recommends that complex electrophysiology, including implantable defibrillators should be 
available for the investigation and management of patients with complex arrhythmia (Department of 
Health, 2000a);(§3.32).   
 
NICE technology appraisals have covered some relevant topics (e.g. ultrasound locating devices for 
placing central venous catheters, Appraisal No. 49).   
2.4.3 Role of central government and other actors 
All the duties upon the Secretary of State to provide, or to ensure the provision of, ancillary services 
have been delegated to Primary Care Trusts.  However, NHS Trusts and Foundation Trusts are 
responsible for purchasing decisions on diagnostic equipment.  NHS and Foundation Trusts are 
largely self-governing, but Strategic Health Authorities are responsible for the performance 
management of NHS Trusts and may direct them to provide particular services.  Ambulance Trusts 
are other actors in the provision of ancillary services.  There are 33 Ambulance Trusts in England, 
responsible for the provision of emergency access to health care, although they also provide non-
emergency patient transport.   
 
NICE and the Department of Health, through National Service Frameworks, may also help to 
determine which ancillary services are provided.  The Healthcare Commission reinforces these 
messages through its regulation of NHS bodies (see The Healthcare Commission).  
 
2.5 HC5 Medical goods dispensed to out-patients 
 
This includes services of pharmacies, opticians and chemists, including mail, telephone and web 
shopping.  Prescribed and over-the-counter medicines are included in this category. Therapeutic 
appliances and devices such as prosthetics, wheelchairs, hearing aids and glasses are also included.  
An overview of the regulatory structure for medicines dispensed to outpatients is given in Figure 2 .   
Advisory relationships are denoted by a dotted line. 
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Figure 2: Regulatory structure of outpatient medicines: England, April 2005 
2.5.1 Summary of legal entitlement 
The 1968 Medicines Act regulates the development, manufacturing, distribution and importation of 
medicines (Montgomery, 2003);(page 215).  The 1968 Act established a statutory advisory body 
called the Medicines Commission to give advice on matters specified in the Act relating to medicinal 
products.69 In granting a product licence, the licensing agency (currently the MHRA) must take 
account of safety, quality and efficacy (s. 19), but may not consider relative effectiveness or price (s. 
20 (3)).  Licences cannot be refused without consulting the Committee of Safety of Medicines or the 
Medicines Commission (Montgomery, 2003);(page 217).  The Act classifies medicines as prescription 
only (s. 58);70 ‘pharmacy only’ medicines that can only be supplied by a pharmacist, but can be 
dispensed without a prescription (s. 60); and general sales list medicines (s. 51). 
 
Exemptions are listed in section 12 and include the manufacture and supply of unlicensed relevant 
medicinal products for individual patients (‘specials’); the importation and supply of unlicensed 
relevant medicinal products for individual patients; and the herbal remedies exemption (Montgomery, 
2003);(page 220).  Section 12(1) allows a person to make, sell and supply a herbal remedy during the 
course of their business provided the remedy is manufactured or assembled on the premises and that 
it is supplied as a consequence of a consultation between the person and their patient.  Section 12(2) 
allows the manufacture, sale or supply of herbal remedies, under specific conditions. 
 
European Community (EC) legislation now takes precedence over the Medicines Act, its Instruments 
and Orders, which are amended from time to time to align with new EC requirements.  1995 saw a 
new European system for authorising medicines, enabling a medicine that is marketed in one EC 
country to be made available in other EC countries, subject to the same conditions.  There are two 
procedures: the ‘centralised’ procedure and the mutual recognition (decentralised) procedure.   
The centralised procedure is compulsory for biotechnologies and optional for other innovative new 
medicines.  Applications are submitted to the European Medicines Agency (EMEA) to be evaluated by 
the Committee for Proprietary Medicinal Products (CPMP).  The CPMP contracts out assessments to 
experts in one of the member states (‘rapporteur’), taking the applicant’s preference into account.  
The EMEA then makes a decision (opinion), which it forwards to the European Commission.  The 
                                                     
69  http://www.mca.gov.uk/ accessed 18/10/04 
70 The Prescription Only Medicines (Human Use) Order 1997 (S.I. 1997/1830) brought classification into line with EC marketing 
authorisations.   
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Commission then makes the final decision about marketing authorisation.  An EC authorisation is 
valid throughout the EU and is usually given for five years.71  The mutual recognition procedure is 
based on the existing multi-state procedure: EU Member States recognise each other’s national 
marketing authorisations.   
However, prescribing by general practitioners in England is governed by two factors.  Firstly, doctors 
have a legal duty to prescribe according to perceived medical need (Secretary of State for Health, 
2004a);(sch. 6, §39(1)): 
... a prescriber shall order any drugs, medicines or appliances which are needed for the 
treatment of any patient who is receiving treatment under the contract by issuing to that 
patient a prescription form or a repeatable prescription and such a prescription form or 
repeatable prescription shall not be used in any other circumstances.  
 
These regulations apply to general medical services, but identical regulations exist for personal 
medical services (S.I. 2004/627; sch. 5, §38(1)).  Secondly, the law imposes certain restrictions on 
doctors’ prescribing.  Some drugs must not be prescribed under the contract (the so-called ‘black 
list’), or may be prescribed only for ‘specified patients and specified purposes’ (the Selected List 
Scheme or ‘grey list’).  These restrictions are outlined under section 28U of the Health and Social 
Care (Community Health and Standards) Act 2003 (Secretary of State for Health, 2003).  The right to 
prescribe does not operate on the basis of a specific list of treatments available on the NHS: there is 
no ‘white list’ (Newdick, 2005b);(page 113). However, prescribers may, subject to certain conditions, 
‘prescribe such a drug, medicine or other substance for that patient in the course of that treatment 
under a private arrangement’ (Secretary of State for Health, 2004a);(sch. 6, §42(2)). 
Charges for drugs, medicines or appliances were introduced in the 1977 NHS Act (s. 77) and are 
updated regularly.  Charges for dental and optical appliances (s. 78) and for dental treatment (s. 79) 
were also introduced (Secretary of State for Health, 1977). 
Optometrists and dentists already have limited prescribing rights: optometrists may prescribe, under 
certain circumstances, drugs listed by the General Optical Council (Opticians Act 1989);(s. 31(1(c))), 
whilst dentists may also supply listed drugs under their terms of service (Secretary of State for Health, 
1992a);(sch. 1(22)).  Furthermore, under ‘patient group directions’, nurses or pharmacists may 
‘prescribe’ drugs from a limited formulary; nurses are more likely to have prescribing rights than are 
pharmacists (Cooke et al., 2005).  The Crown Report reviewed the options widening for prescribing 
rights to clinicians other than doctors (Crown, 1999).  Subsequently, the Health and Social Care Act 
2001 amended the 1968 Medicines Act by extending prescribing rights to a range of health care 
practitioners, including osteopaths, chiropractors and pharmacists (Secretary of State for Health, 
2001a);(s. 63).   
2.5.2 Regulatory regimes / quasi law 
The control of medicines by officials in the United Kingdom dates back to the reign of King Henry VIII 
(1491-1547), when the Royal College of Physicians of London had the power to inspect apothecaries' 
products in the London area and destroy defective stock.72  The first ‘London Pharmacopoeia’, was 
published in 1618.  The need for further legislation was under discussion in the early 1960s when the 
thalidomide tragedy occurred.  In June 1963 the Committee on Safety of Drugs (CSD) was set up.  
The CSD consisted of a group of independent experts in the fields of medicine, pharmacy, toxicology, 
pharmacology and statistics.  The pharmaceutical industry agreed to submit data on their products to 
the CSD and abide by its advice.  The CSD advice was concerned with the ‘reasonable safety for its 
intended purpose’.  Evaluation of efficacy alone was not included.  The CSD became the core of the 
Committee for Safety of Medicines (CSM) in 1971, which continues to advise on licensing issues and 
monitors the safety of licensed medicines (pharmacovigilance).72 
 
For new medicines and devices, guidance from the National Institute for Clinical Excellence (NICE) is 
key in determining whether technologies are available on the NHS and, if so, to which patient groups 
and under what circumstances.  Although there is a statutory obligation on PCTs to fund NICE 
appraisal guidance, the implementation of that guidance remains at the discretion of the treating 
clinician (see NICE guidance).  Nevertheless, the so-called ‘negative’ appraisal decisions evoke 
                                                     
71 http://www.mca.gov.uk/ourwork/licensingmeds/european/europelic.htm accessed 18/10/04 
72 http://www.mca.gov.uk/, accessed 18/10/04 
CHE Research Paper 2 
 
   
45
strong feelings amongst the public who perceive their rights to access effective medicines to be 
threatened by NICE decisions (Table 6).  For example, NICE has recently proposed – a final decision 
is awaited – that the NHS ceases to fund anti-dementia drugs, although patients already receiving 
treatment will continue to do so.  This has precipitated hostile responses from the press and from 
patient groups (Kmietowicz, 2005). 
 
Older (post-patent) medicines are not generally subject to NICE scrutiny, except where they are 
compared with newer technologies in the assessment process.  However, NICE makes no 
recommendation on the use of these older technologies and cannot, for example, advise 
disinvestment (Maynard et al., 2004).  The availability of existing drugs is determined by whether they 
are listed in the British National Formulary, although there is no ‘white list’ that specifies drugs to 
which patients are entitled (Newdick, 2005b);(page 113).  
 
The provision of some medicines is incentivised under the Quality and Outcomes Framework, which 
is part of the new contract for general practitioners (Department of Health, 2004l).  For example, 
payments are awarded to practices for ensuring that a given proportion of patients with coronary heart 
disease receive appropriate medication, such as beta-blockers, ACE inhibitors and anti-platelet 
therapy. 
2.5.3 Role of central government and other actors 
Subject to Parliamentary approval, the Secretary of State for Health is responsible for secondary 
legislation that dictates the contents of the black’ and ‘grey’ lists of medicines that are, respectively, 
not available at all on the NHS or that are available only to very narrowly defined patient groups and 
under special circumstances.  The black list dates back to 1985, when the government issued a list of 
preparations not to be prescribed on the NHS, comprising of products that were duplications, or were 
too expensive, not necessary, or that had no medicinal use.73  The grey list contains far fewer 
products than the ‘black list’, comprising chiefly of products for which there are budgetary or clinical 
safety concerns (Newdick, 2005b);(page 113).  The Prescription Pricing Authority produces a monthly 
‘Drug Tariff’ that lists generic drugs, those available for nurse or dentist prescribing and specifies 
which appliances and devices may be prescribed on the NHS (see Prescribing Prescription Authority).   
 
The Medicines and Health care products Regulatory Agency (MHRA) authorises (licenses) medicines 
and devices on behalf of the government (veterinary products are outside its remit).  However, it may 
not take account of relative efficacy or price, but bases its decision upon safety, quality and efficacy 
(Medicines Act 1968; ss. 19, 20).  Licences cannot be refused without consulting the Committee of 
Safety of Medicines (Montgomery, 2003);(page 217).  Appeals can be made to the Medicines 
Commission.   
 
The National Institute for Clinical Excellence also plays an important role in deciding upon which 
(generally) new technologies – drugs and devices – are available for use by the NHS, as part of its 
technology appraisals.  NICE clinical guidelines, though without any mandatory backing, may also 
recommend the use of particular drugs and devices, such as appropriate use of endoscopy and 
proton pump inhibitors for dyspepsia (CG17).  National Service Frameworks may also contain 
recommendations for the use of particular drugs, such as statins for coronary heart disease 
(Department of Health, 2000a).  
 
NHS Trusts also produce their own local formularies and often have committees to assess the impact 
of new medicines on their own budget as well as on primary care (Cooke et al., 2005).  
 
Whilst the MHRA authorises the medicines and devices that are available within the UK, the 
Pharmaceutical Price Regulation Scheme (PPRS) deals with the pricing of pharmaceuticals.  
Although not strictly a regulatory body, the PPRS has an important, albeit unintentional, impact: by 
influencing the price of pharmaceuticals, the PPRS affects NICE technology appraisals, which 
consider the costs and benefits of pharmaceuticals in order to make recommendations for their use 
within the NHS (see NICE guidance). 
 
 
                                                     
73 http://www.ppa.org.uk/ppa/drug_tariff_guidance.htm#link9, accessed 21/03/05 
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2.6 HC6 Prevention and public health services 
 
This includes maternal and child health, family planning services, school health services, the 
prevention of communicable and non-communicable diseases, occupational health care and ‘all other 
miscellaneous public health services’.   
2.6.1 Summary of legal entitlement 
The Ministry of Health Act 1919 gave the Secretary of State responsibility for ‘securing preparation, 
carrying out and co-ordination of measures conducive to public health’.  This duty has now passed to 
Primary Care Trusts (Secretary of State for Health, 2002);(sch. 1). 
 
The 1946 NHS Act gave local health authorities the duty to provide care of mothers and young 
children, including dental care for children under 5 (ss. 22-23).  In the 1977 NHS Act, this 
responsibility was transferred to the Secretary of State, who was no longer bound to provide the 
services, but was instead given powers to provide ‘as he considers appropriate … facilities for the 
care of expectant and nursing mothers and young children’ (s. 3(d)).  However, additional duties given 
to the Secretary of State under the 1977 NHS Act includes:  
 
• Medical and dental inspection at appropriate intervals of pupils in schools maintained by the 
local education authorities (s. 5(1)(a)) 
• Family planning advice (s. 5(1)(b)) 
 
The 1977 NHS Act specifies that the Secretary of State for Health has a duty to provide these ‘to such 
extent as he considers necessary to meet all reasonable requirements’ (Secretary of State for Health, 
1977)(s. 3(1)).  The 1988 Education Reform Act widened the responsibility to include grant 
maintained schools.  Provision of medical and dental inspections in schools is now again the 
responsibility of local health authorities, Primary Care Trusts (Secretary of State for Health, 2002). 
 
The 1946 NHS Act gave local health authorities the duty to provide for the prevention of illness (s. 
28).  The responsibility for providing facilities for preventative services transferred to the Secretary of 
State for Health under the 1977 NHS Act (s. 3(e)), and was tempered by the clause ‘as he considers 
appropriate as part of the health service’.  Therefore, no preventative services are mandated by the 
1977 Act, rather the Secretary of State has a duty to make appropriate provision of facilities to 
accommodate such services. 
 
The Public Health (Control of Diseases) Act 1984 consolidated earlier legislation to give ‘drastic 
powers of entry and investigation’, including compulsory medical examination where notifiable 
disease74 is suspected (Montgomery, 2003);(page 31).  Local authorities are the only bodies with 
powers over public health, but in practice local authorities usually appoint employees of the health 
authority to exercise these powers (page 27).  The 1984 Act may breach of human rights law (page 
34).  
 
Other relevant legislation includes the Food Safety Act 1990; the Environmental Protection Act 1990; 
the Health and Safety at Work Act 1974; the Human Rights Act 1998; the Health & Social Care Act 
2001;and the Health Protection Act 2004.  
 
The Public Health (Infectious Diseases) Regulations 1988 provide for free vaccination and 
immunisation, but only for those who want it (Montgomery, 2003);(page 33).   
 
The recent GMS contract has placed a greater emphasis on preventative care, obliging primary care 
physicians to offer (Secretary of State for Health, 2004a): 
 
• Annual health checks to registered patients aged over 75 
• A health check to newly registered patients  
• A health check to existing patients on the register not seen within three years 
                                                     
74 Notifiable diseases include amongst others AIDS, meningitis, diphtheria, dysentery, typhoid fever, rabies, tuberculosis and malaria 
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Payments are also made for giving smoking cessation advice to patients with diabetes, COPD, 
coronary heart disease, asthma, hypertension and stroke sufferers.  The Quality and Outcomes 
Framework (QOF) also offers payments for primary care physicians to comply with local guidelines on 
antenatal screening and child development (Department of Health, 2004l).  There are also incentives 
in the QOF to offer vaccinations and immunisations to older people and to those ‘at risk’ of influenza 
(Department of Health, 2004l).  
 
The 2005 Pharmacist contract places a duty on pharmacists to participate in up to six public health 
campaigns annually, when requested to do so by their local PCT (Secretary of State for Health, 
2005b);(reg. 17) and to promote healthy lifestyles (reg. 15). 
2.6.2 Regulatory regimes / quasi law 
The NHS Plan included a commitment to improving the prevention of ill health and providing 
screening programmes when they are effective (Department of Health, 2000b). 
 
The Healthcare Commission is concerned with both treatment and prevention, such as the quality of 
services that help people to stop smoking.  Therefore, inspections also look at how well health 
services protect and improve public health.26  
 
Some NICE clinical guidelines include screening advice, such as the guidelines on familial breast 
cancer (CG14), the management of type II diabetes (which addresses screening for diabetic 
retinopathy - a guideline NICE has inherited), or the Routine Antenatal Care guideline (CG6). A 
number of tests may be offered to pregnant women, including tests for HIV, Down’s syndrome, rubella 
immunity and spina bifida (UK National Screening Committee, 2004). 
 
National service frameworks may include advice on screening for particular disease areas, such as 
coronary heart disease (Department of Health, 2000a) or cancer (Calman and The Expert Advisory 
Group On Cancer, 1995).  The recent NSF for Children, Young People And Maternity also deals with 
preventative services over the course of childhood, including immunisations; screening for hearing 
and for diseases such as hepatitis B, sickle cell disease and cystic fibrosis; developmental and needs 
assessments; and health promotion.  Other NSFs also address public health issues (Table 3).  
 
The NHS Plan announced an expansion of cancer screening (Department of Health, 2000b).  The 
NHS Breast Screening Programme provides free breast screening every three years for all women in 
the UK aged 50 to 64, although this is being extended to include women aged up to 70 (Department 
of Health, 2001b).  There is a national programme for cervical cancer screening75 and all women 
between the ages of 25 and 64 are entitled to a test at three or five yearly intervals depending on their 
age and the results of previous tests.  There are plans to introduce a national screening programme 
for colorectal cancer in April 2006 (Department of Health, 2004p).  There are no plans to introduce 
prostate cancer screening unless evidence shows that the benefits outweigh the risks.   
 
Although there is no statutory obligation on PCTs to provide sexual health services, nor a National 
Service Framework on the topic, the Minister for Public Health has recently said that 'there will be 
more fierce forms of monitoring and performance management … there will be a demand that [PCTs] 
deliver on sexual health' (Martin, 2005).  The National Strategy for Sexual Health included the 
recommendation that opportunistic screening for Chlamydia infection is offered to women and men 
under 25 years of age,62 and this is set to become a national programme by 2007 (Department of 
Health, 2004b).  
 
Prior to legislation, the government can introduce statements of its policy in a White Paper.  The 
recent White Paper ‘Choosing Health’ listed some ‘overarching priorities’ (Department of Health, 
2004b): 
 
• Reducing the numbers of people who smoke 
• Reducing obesity and improving diet and nutrition 
• Increasing exercise 
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• Encouraging and supporting sensible drinking 
• Improving sexual health 
• Improving mental health 
 
The 2004 White Paper contained a wide range of proposals to promote public health that recognised 
that co-ordinated multi-sector approaches – by the NHS, industry, communities, schools and 
workplaces – were needed to tackle public health issues.  Proposals included: that all enclosed public 
places and workplaces be smoke free by 2008; access to high-quality NHS Stop Smoking Services in 
all areas; an expansion of school nursing services by 2010; access to an NHS-accredited health 
trainer; and accessible sexual health services delivered in both community and hospital settings 
(Department of Health, 2004b). 
2.6.3 Role of central government and other actors 
The government establishes policy through its White Papers, Health Service Circulars and secondary 
legislation.  Primary legislation requires Parliamentary approval, so other political parties influence 
whether or not legislation is enacted. 
 
Strategic Health Authorities (SHAs) are alone responsible for requesting water fluoridation (Secretary 
of State for Health, 2002);(reg. 5).  Together with PCTs, Strategic Health Authorities are responsible 
for ‘securing preparation, carrying out and co-ordination of measures conducive to public health’, 
including the provisions of care for mothers and young children, family planning advice, the medical 
inspection and treatment of pupils, their dental inspection and treatment and their education in dental 
health (Secretary of State for Health, 2002);(reg. 3(2)). 
 
Primary Care Trusts may prepare and implement population screening programmes, provided that the 
appropriate Strategic Health Authority approves the arrangements for providing or securing the 
provision of such services (Secretary of State for Health, 2002);(reg. 8(4(b))).  The same condition 
applies also to PCT provision of services for sexual transmitted diseases (reg. 8(5)). 
 
The National Institute for Clinical Excellence is an NHS body that commissions (i.e. pays other bodies 
to produce) clinical guidelines.  These may include Royal Colleges, academic institutions and patient 
groups (see above, NICE guidance).   
 
The Department of Health produces National Service Frameworks (NSFs) that address a range of 
public health issues (Table 3).  For example, the NSF for Mental Health includes the target of 
reducing the death rate from suicide and undetermined injury by at least a fifth by 2010 (Department 
of Health, 1999);(standard 7). 
 
The Medicines and Health care products Regulatory Agency (MHRA) oversees the safety of 
medicines and devices and thereby promotes public health.  The Patient Safety Agency, the General 
Medical Council and the Council for the Regulation of Health Care Professionals are all charged with 
the duty of promoting patient safety.   
 
The UK National Screening Committee is an advisory body to UK Health Ministers.  The Committee 
makes recommendations that certain types of screening be included or excluded from current public 
NHS provision.  The Committee is informed by research evidence on effectiveness, risk (or safety) 
and cost (UK National Screening Committee, 2004). 
 
Until April 2005, the Health Development Agency was the national authority for providing evidence-
based guidance on public health issues to improve people’s health and reduce health inequalities.18  
Thus, the Agency evaluated public health interventions, mirroring the appraisals National Institute for 
Clinical Excellence (NICE) conducts of health technologies.  The rationalisation of Arms Length 
Bodies saw the two institutions joining forces, with NICE taking over the functions of the Health 
Development Agency ().  Concerns have been expressed about the appropriateness of applying 
methodologies, designed to appraise to health technologies, to public health interventions (Kelly et al., 
2003).  NICE has launched a public consultation on how public health guidance will be produced; the 
intention is to review both effectiveness and cost-effectiveness evidence, using methods that ‘build 
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upon existing NICE methods, with appropriate modifications to reflect the evidence available in public 
health.’76  
                                                     
76 http://www.nice.org.uk/page.aspx?o=248187, accessed 25/04/05 
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3. Description of benefit catalogues, involved actors and decision criteria 
 
There are few specific and detailed benefit documents relating to the NHS.  These can be grouped 
into professional contracts; NICE technology appraisal guidance; device lists; fee schedules; waiting 
time guarantees; and screening programmes.  
 
3.1 Professional contracts 
An important example of a detailed benefit document is the 2004 contract for general medical 
services (GMS) (Secretary of State for Health, 2004a).  The Statutory Instrument defines ‘essential 
services’ that a general medical practitioner must provide under the GMS contract (Box 3).  Essential 
services are described in S.I. 2004/291);(reg. 15(3)(5)(6)(8) and documented in Table 7. 
Table 7: Eligibility for primary care ‘essential services’ under the 2004 GMS Contract 
Type of Essential Service Eligibility for Treatment  
Immediate and necessary emergency 
treatment 
‘Any person to whom the contractor has been requested to 
provide treatment … at any place in its practice area’ (reg.15(6)) 
Management of terminal illness Registered patients and temporary residents 
Treatment of conditions from which recovery 
is generally expected 
Registered patients and temporary residents 
Treatment of chronic disease  Registered patients and temporary residents 
Advice in connection with the patient's health, 
including relevant health promotion advice; 
Registered patients and temporary residents 
Referral of the patient for other services 
under the [1977] Act 
Registered patients and temporary residents 
Home visits Where contractor considers it inappropriate, because of a 
patient’s medical condition, for the patient to attend the practice 
premises 
Annual health checks Patients aged over 75 
Health checks Patients not seen within three years 
Newly registered patients 
Source: (Department of Health, 2003c) 
 
Essential services must be provided between the ‘core hours’ of 8:00 and 18:30 hours, and this 
includes ‘immediate and necessary emergency treatment’.  However, general medical practitioners 
operating under the Personal Medical Services (PMS) contract are not bound to provide essential 
services.  Therefore, patients registered with these practices employing PMS GPs have no 
entitlement to essential services.   
 
The new contract for pharmacists came into effect on 1st April 2005 (Secretary of State for Health, 
2005b).  Like the GMS contract for primary care doctors, the pharmacist regulations define ‘essential 
services’ (S.I. 2005/641);(regs. 3 to 21).  These cover the dispensing services (including dispensing of 
electronic prescriptions), disposal services, the promotion of healthy lifestyles and support for self 
care.  Other services include ‘prescription linked intervention’ (reg. 16), public health campaigns (reg. 
17) and signposting (reg. 18).  Under ‘prescription linked intervention’ services, the pharmacist has a 
duty to provide appropriate advice to patients who want to have their prescription dispensed and who 
appear to the pharmacist to be suffering from diabetes, to be at risk of coronary heart disease or who 
appear overweight or who appear to be smokers.  The pharmacist must record any advice given in a 
way that will facilitate audit and follow up care.  Where pharmacists are unable to provide advice, they 
must provide the patient with contact details of relevant health or social care services; this is known 
as ‘signposting’.  Pharmacists are also under a duty to co-operate with a request from PCTs to 
participate in up to six public health campaigns annually (Secretary of State for Health, 2005b). 
 
3.2 NICE technology appraisal guidance 
 
Another example of a ‘benefit catalogue’ is the technology appraisal guidance produced by NICE.  
NICE guidance generally acts like a quasi law, but one aspect of guidance on technology appraisals 
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is supported by statute: if NICE produces guidance on a technology appraisal to say that a new 
medicine should be made available to NHS patients who meet particular criteria, then the NHS bodies 
responsible for providing funding for that treatment are under a statutory obligation to ensure that the 
technology: 
 
...is, from a date not later than three months from the date of that Technology Appraisal 
Guidance, normally available (Secretary of State for Health, 2001b).   
 
The Department of Health sometimes extends this deadline (e.g. Appraisal No. 68 on macular 
degeneration).  However, although funding bodies are obliged by law to ensure there are adequate 
resources to facilitate the implementation of NICE guidance, the guidance is not binding on individual 
clinicians, who must assess whether the technology is appropriate for patients under their care 
(Newdick, 2005a).  
 
Technology appraisals include guidance on the use of new and existing treatments within the NHS.  
To date (April 2005), 88 technology appraisals have been published.  Technologies may include: 
 
a. Medicines 
b. Medical devices (e.g. inhalers) 
c. Diagnostic techniques (e.g. cervical cytology)  
d. Surgical procedures (e.g. use of coronary artery stents)  
e. Health promotion activities (e.g. ways of helping people with diabetes manage their 
condition) 
 
The NICE Appraisal Committee is an independent advisory body constituted of individuals drawn from 
a range of professional backgrounds. The Committee considers the evidence from an academic 
assessment group and from company submissions.  Clinical specialists and ‘expert patients’ are also 
present to give their views, though are asked to leave when the Committee discusses the Appraisal 
Consultation Document.  This Document then goes out to consultation.  The Final Appraisal 
Determination is then developed, approved by the NICE Guidance Executive put out again for 
consultation.  Following an appeal process, the guidance is published (National Institute for Clinical 
Excellence, 2004).  All guidance is reviewed at regular intervals and recommendations reconsidered 
in the light of any new evidence.  It should be noted that the overwhelming majority of technologies 
used in the NHS are not the subject of recommendations by the NICE Appraisal Committee.  
 
3.3 Device lists 
 
Although there is no comprehensive ‘positive list’ for pharmaceuticals, there is such a list of 
appliances available in primary care.  The National Health Service (Pharmaceutical Services) 
Regulations 1992 (reg. 18) provides that the Secretary of State shall compile and publish a statement, 
referred to as the Drug Tariff, which shall include, among other things, the list of appliances and 
chemical reagents approved by the Secretary of State for the supply to persons under Section 41 of 
the NHS Act 1977.34  The Secretary of State authorises the Prescription Pricing Authority (PPA) to 
deal with applications on his behalf. This list - Part IX of the Drug Tariff - is of the appliances and 
chemical reagents which general practitioners are able to prescribe on the NHS. The four sections 
covered are dressings, bandages and certain other appliances; incontinence appliances; stoma 
appliances; and chemical reagents.  The Drug Tariff is updated monthly.  To be included in the list, 
appliances must be safe and of good quality; appropriate for primary care prescribing (including nurse 
prescribing, if applicable); and cost effective.77  Safety and quality are determined in accordance with 
EC directives, such that any product bearing a CE mark is deemed to be acceptable.  
Appropriateness for GP or nurse prescribing is determined by factors such as whether community use 
is appropriate, whether the product could be loaned (instead of prescribed) and whether self-
administration is likely.  Depending on whether similar products (or alternative regimens) have been 
listed before, the PPA judges cost effectiveness by absolute (and relative) costs and absolute (and 
relative) effectiveness.  Manufacturers may be asked to submit evidence to support their application – 
particularly if similar products have not been listed before, or if the price requested is higher than that 
of existing alternatives – and may appeal in the event of a negative listing decision. 
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3.4 Fee schedules  
 
Where fee schedules exist for NHS care, patient ‘entitlement’ to services might be inferred.  For 
example, most patients receiving NHS dental services make co-payments in line with a Statement of 
Dental Remuneration; the government pays the remainder of the dental fee.  This suggests that these 
services are those that the government endorses as those that, in some sense, should be provided. 
 
For dental practitioners, the National Health Service (General Dental Services) Regulations 1992 (S.I. 
1992/661) make provision for the Secretary of State for Health to determine dentists’ remuneration, 
including a ‘scale of fees’ for providing particular services (reg. 19(1)).  The Statement of Dental 
Remuneration48 (SDR) is a document that describes over 400 services covered by the fees, including 
clinical examinations and treatment planning, diagnostic procedures, such as radiographic 
examinations, preventative, periodontal, conservation and surgical treatments and the supply of 
prostheses.  The Statement of Dental Remuneration is updated at least annually; the current (April 
2005) SDR is Amendment 93.  Patients treated under general dental services make a co-payment for 
treatment, with the government reimbursing the balance.  For example, the current (April 2005) fee for 
a clinical examination is £7.31 (€10.51),43 for which the patient is charged £5.84 (€8.41).  School and 
college students and women who are pregnant or who have a child under 12 months of age are 
exempt from co-payment (Secretary of State for Health, 2005c).  Patients pay 80% of the charge, up 
to a maximum of £384 (€553).  The Doctors and Dentists Review Body reviews existing fee scales 
and makes recommendations regarding uplift.  The Department of Health then considers these 
recommendations and the Chief Dental Officer for England notifies SHAs, PCTs, NHS Trusts and all 
general dental practitioners of the updated fee scales.78   
 
Similarly, the National Health Service (General Ophthalmic Services) Regulations 1986 (S.I. 
1986/975) make provision for opticians and ophthalmic medical practitioners and opticians to make 
charges for sight tests and for optical appliances (Secretary of State for Health, 1986).  Currently, the 
charge for a sight test is £18.39 (€26.48).43  Charges are determined by the Secretary of State in 
consultation with professional bodies, updated at least annually and amended by Statutory 
Instrument.49  For certain patients, vouchers are available that reduce or remove the charge incurred 
by patients.  Eligibility for general ophthalmic services, outlined in the Health and Medicines Act 1988 
(s. 13), is determined by age, disease (or risk of disease) or income.  Voucher values are updated at 
least annually by secondary legislation (S.I. 2005/483).   
 
Equally, the new national tariff system of payments for hospital services, whilst in no way 
guaranteeing provision, ‘suggests’ services that should be accessible on the NHS.  The national tariff 
system provides a national price schedule for patient services, classified by Health care Resource 
Group (HRG).  A range of clinical procedures, treatments and diagnoses are covered.  Tariffs are 
derived80 from Reference Costs, which contain details of unit cost, length of stay and activity levels for 
a wide range of hospital services, enabling those providing and purchasing services to review and 
examine comparative costs.81  The tariff system is ‘spell-based’, meaning that each tariff covers an 
entire spell of hospital care from admission to discharge for individual patients.  This contrasts with 
Reference Costs, which are based on Finished Consultant Episodes (FCE); there may be multiple 
FCEs in one ‘spell’.  For each provider, the tariff is adjusted by a Market Forces Factor to take 
account of the unavoidable costs faced in different geographic areas.  Table 8 shows the 48 HRGs 
covered by the ‘payment by results’ tariff system for elective inpatient care for 2004/05; these are 
unchanged for 2005/06.  
                                                     
78 http://www.dh.gov.uk/assetRoot/04/10/69/32/04106932.pdf, accessed 25/04/05 
80 An uplift is applied to Reference Costs to take account of changes in the underlying cost of delivering care in each HRG 
81 http://www.dh.gov.uk/assetRoot/04/07/01/09/04070109.pdf, accessed 25/04/05 
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Table 8: Admitted patient care: subset of 48 designated HRGs, England 2004/5 
HRG HRG name Elective spell-
based tariff (£) 
Elective spell-
based tariff 
(€)43 
B02 Phakoemulsification Cataract Extraction with Lens Implant £786 € 1,132 
B03 Other Cataract Extraction with Lens Implant £876 € 1,261 
E03 Cardiac Valve Procedures £10,199 € 14,684 
E04 Coronary Bypass £8,080 € 11,633 
E13 Cardiac Catheterisation with Complications £866 € 1,247 
E14 Cardiac Catheterisation without Complications £895 € 1,289 
E15 Percutaneous Transluminal Coronary Angioplasty (PTCA) £3,326 € 4,789 
E16 Other Percutaneous Cardiac Procedures £2,470 € 3,556 
F71 Abdominal Hernia Procedures >69 or w cc £2,304 € 3,317 
F72 Abdominal Hernia Procedures <70 w/o cc £1,495 € 2,152 
F73 Inguinal Umbilical or Femoral Hernia Repairs >69 or w cc £1,363 € 1,962 
F74 Inguinal Umbilical or Femoral Hernia Repairs <70 w/o cc £1,016 € 1,463 
F75 Herniotomy Procedures £956 € 1,376 
G11 Biliary Tract - Complex Procedures £5,885 € 8,473 
G12 Biliary Tract - Very Major Procedures £2,948 € 4,244 
G13 Biliary Tract - Major Procedures >69 or w cc £2,509 € 3,612 
G14 Biliary Tract - Major Procedures <70 w/o cc £1,857 € 2,674 
H01 Bilateral Px Hip Replacement £7,319 € 10,538 
H02 Primary Hip Replacement £5,568 € 8,017 
H03 Bilateral Px Knee Replacement £7,776 € 11,196 
H04 Primary Knee Replacement £6,182 € 8,901 
H09 Anterior Cruciate Ligament Reconstruct £2,223 € 3,201 
H10 Arthroscopies £1,033 € 1,487 
H11 Foot Procedures - Category 1 £1,025 € 1,476 
H12 Foot Procedures - Category 2 £1,392 € 2,004 
H13 Hand Procedures - Category 1 £752 € 1,083 
H14 Hand Procedures - Category 2 £1,360 € 1,958 
H15 Hand Procedures - Category 3 £1,746 € 2,514 
H16 Soft Tissue or Other Bone Procedures - Category 1 >69 or w cc £1,275 € 1,836 
H17 Soft Tissue or Other Bone Procedures - Category 1 <70 w/o cc £1,159 € 1,669 
H18 Soft Tissue or Other Bone Procedures - Category 2 >69 or w cc £2,830 € 4,075 
H19 Soft Tissue or Other Bone Procedures - Category 2 <70 w/o cc £1,934 € 2,785 
H20 Muscle, Tendon or Ligament Procedures - Category 1 £1,045 € 1,505 
H21 Muscle, Tendon or Ligament Procedures - Category 2 £1,925 € 2,772 
H22 Minor Procedures to the Musculoskeletal System £632 € 910 
J02 Major Breast Surgery including Plastic Procedures >49 or w cc £2,386 € 3,435 
J03 Major Breast Surgery including Plastic Procedures <50 w/o cc £2,308 € 3,323 
J04 Intermediate Breast Surgery >49 or w cc £1,083 € 1,559 
J05 Intermediate Breast Surgery <50 w/o cc £898 € 1,293 
L27 Prostate Transurethral Resection Procedure >69 or w cc £2,088 € 3,006 
L28 Prostate Transurethral Resection Procedure <70 w/o cc £1,819 € 2,619 
L29 Prostate or Bladder Neck Intermediate Endoscopic Procedure 
(Male and Female) £1,243 € 1,790 
L30 Prostate or Bladder Neck Minor Endoscopic Procedure (Male 
and Female) £439 € 632 
M01 Lower Genital Tract Minor Procedures £515 € 741 
M02 Lower Genital Tract Intermediate Procedures £649 € 934 
M03 Lower Genital Tract Major Procedures £2,098 € 3,021 
M04 Lower Genital Tract Complex Major Procedures £5,681 € 8,179 
Q11 Varicose Vein Procedures £1,063 € 1,530 
Source: http://www.dh.gov.uk/assetRoot/04/07/01/21/04070121.xls, accessed 25/04/05 
Note: w cc / w/o cc: with /without comorbidity or complications 
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3.5 Waiting time guarantees 
 
Government research highlighted shorter waiting times as a top priority for patients.  In response, the 
Public Service Agreements, which specify national goals within the public sector, outline waiting time 
targets (or ‘guarantees’) for the NHS (HM Treasury, 2004): 
 
• By the end of 2005, patients will wait a maximum of six months for inpatient admission and no 
more than 13 weeks for an outpatient appointment 
• By the end of 2008 the maximum wait from general practitioner (GP) referral to hospital treatment 
will be 18 weeks 
Targets that should already be achieved, and henceforth maintained, include the 4-hour maximum 
wait for emergency care51 and the 24/48 target for accessing primary care.52  From December 2005, 
the ‘choose and book' system should be operational, whereby patients needing elective treatment will 
be offered a choice of four or five hospitals once their GP has decided that a referral is required.  
These could be NHS Trusts, Foundation Trusts, treatment centres, private hospitals or practitioners 
with a special interest operating within primary care.  As well as choosing where they go, patients 
should be able to choose when, thanks to a national electronic booking programme.  Appointments 
can be made at the practice surgery, by calling a contact centre, online and eventually via digital 
television.  
 
3.6 Screening programmes 
 
There a currently two major screening programmes constituting a type of ‘entitlement’.   The NHS 
Plan announced an expansion of cancer screening (Department of Health, 2000b).  The NHS Breast 
Screening Programme provides free breast screening every three years for all women in the UK aged 
50 to 64, although this is being extended to include women aged up to 70 (Department of Health, 
2001b).  There is a national programme for cervical cancer screening75 and all women between the 
ages of 25 and 64 are entitled to a test at three or five yearly intervals depending on their age and the 
results of previous tests.  PCTs are encouraged to implement the cervical screening programme 
through the 2004/05 Star Ratings system.  In addition, the Ratings support a government target that 
by 2006 a minimum of 80% of people with diabetes to be offered screening for the early detection 
(and treatment if needed) of diabetic retinopathy.  This is to form part of a systematic programme that 
meets national standards, rising to 100% coverage of those at risk of retinopathy by the end of 2007.  
The ‘balanced scorecard’ of the 2004/05 Star Ratings contains an indicator to reflect this target.82  
 
 
 
                                                     
82 http://ratings.healthcarecommission.org.uk/Indicators_2005/Trust/Indicator/indicators.asp?trustType=4, accessed 25/04/05 
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4. Discussion 
 
The NHS is a highly developed, heavily regulated health care system in which the roles of actors are 
in general clearly defined.  However, such clarity of roles does not necessarily lead to clarity about the 
services to which citizens are entitled.  Indeed, the lack of explicitness in the definition of the health 
basket and the lack of a strong legal framework has led to a great deal of uncertainty.   
 
The fact that the provision of a particular service stipulated in statute does not necessarily guarantee 
patient access.  For example, the 1977 NHS Act obliges PCTs to provide, or to arrange for the 
provision of, general dental services (Secretary of State for Health, 1977);(s. 35).  However, a large 
proportion of the population is unable to access general dental services within the NHS because of a 
shortage of dentists willing to provide these services for the NHS.  The problem is due not a shortage 
of dentists, but rather to the rapid growth of private practice since 1992.  This appears to have been 
precipitated by a 7% cut in fees, which was designed to redress the perceived excessive income 
(Department of Health, 2004k, Oliver, 2002).  The problem of access to NHS dentists has triggered an 
urgent review of the regulations governing the dentists’ terms of service and a recent cash injection of 
over £350 (€504)43 million, aimed at increasing the number of dentists working for the NHS 
(Department of Health, 2004n).  The Healthcare Commission’s Star Ratings contain a target to 
encourage PCTs to increase NHS dental activity.  The British Dental Association in is negotiations 
with the Department of Health to develop a new contract which is expected in April 2006.83 
 
The National Service Framework for Coronary Heart Disease (CHD) takes account of the whole 
spectrum of CHD including diagnosis, presentation in primary care, secondary care, emergency 
admissions and transport issues (Department of Health, 2000a).  Within that spectrum, ‘a very small 
number of CHD service elements’ were identified for ‘definite commissioning’ (i.e. ‘purchasing and 
providing’) under the arrangements for specialised services.  These include: 
 
• Cardiothoracic transplantation, for those with end-stage heart failure. 
• Complex electrophysiology, including implantable defibrillators, for the investigation 
and management of patients with complex arrhythmia 
 
Health care organisations’ compliance with NSFs is now monitored by the Healthcare Commission, as 
part of the new assessment framework (see The Healthcare Commission).  Furthermore, the National 
Institute for Clinical excellence has recommended the use of defibrillators in this patient group (NICE 
Appraisal No. 11).  The NICE recommendation carries with it the statutory duty upon Primary Care 
Trusts to ensure funding is available to facilitate provision (see NICE guidance).  However, a recent 
study of the use of implantable defibrillators in England found evidence that uptake was inequitable 
and that an inverse care law84 appeared to be operating, despite recommendations in the NSF, 
supported by monitoring by the Healthcare Commission and reinforced further by NICE guidance 
(Parkes et al., 2005).  Barriers to implementation of guidance reported in the study included 
identification and referral of eligible patients to implanting centres; staff capacity; and funding 
constraints.   
 
A national evaluation NHS Trusts’ or Primary Care Trusts’ compliance with NICE guidance found 
variable implementation.  Looking at rates of prescribing and use of procedures and medical devices, 
the time series analysis found that significantly increased prescribing of some taxanes for cancer and 
orlistat for obesity in line with guidance.  Although prescribing of drugs for Alzheimer's disease and 
removal of wisdom teeth showed trends consistent with NICE guidance, the changes could not be 
reliably attributed to the guidance.  Often, prescribing practice appeared to have little relation to 
detailed guidance.  No change was apparent in the period following NICE guidance regarding the use 
of hearing aids, hip prostheses, implantable defibrillators, laparoscopic hernia repair, and 
laparoscopic colorectal cancer surgery (Sheldon et al., 2004). 
 
The evidence suggests that the English system is heading towards a more formal statement of 
benefits and entitlements.  NICE guidance on new and existing technologies is in effect establishing a 
‘positive list’ of technologies that the NHS should fund; National Service Frameworks describe 
interventions that should be implemented to achieve standards of care.  The Payment by Results 
                                                     
83 http://specialistdentalaccountants.co.uk/new_nhs_dental_contract_delayed.htm, accessed 25/04/05 
84 The inverse care law predicts that access to good quality services in more deprived areas will be less than that in affluent areas 
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system will be rolled out to cover non-elective care and the Healthcare Commission will increasingly 
encourage NICE and NSF implementation, reinforcing standards through its new ‘annual health 
check’ (Healthcare Commission, 2005).  In addition to the new legal contracts for general medical and 
general pharmaceutical services, legal contracts specifying service provision between NHS Trusts 
and PCTs will become more common as NHS Trusts take on Foundation Trust status.  These factors 
together take the NHS forward towards defining a more explicit health basket for England.  
CHE Research Paper 2 
 
   
57
References 
Abraham, A. (2003) NHS funding for long term care: 2nd report: session 2002-2003, The Stationery 
Office, London. http://www.ombudsman.org.uk/hsc/document/care03/index.htm 
Audit Commission (2003) Acute hospital portfolio reviews 2003, London - 1 Vincent Square London 
SW1P 2PN: Audit Commission 2003 
Annual. http://www.audit-commission.gov.uk/itc/acuteportfolio.shtml 
Audit Commission (2004a) Drug misuse 2004: reducing the local impact, The Stationery Office, 
London. http://www.audit-commission.gov.uk/Products/NATIONAL-REPORT/BCD29C60-
2C98-11d9-A85E-0010B5E78136/Drug%20misuse%202004_printfriendly.pdf 
Audit Commission (2004b) Introducing payment by results: getting the balance right for the NHS and 
taxpayers, Audit Commission for Local Authorities and the National Health Service in England 
and Wales, London. http://www.audit-commission.gov.uk/Products/NATIONAL-
REPORT/C353AE7B-25A7-44A5-BF68-
5A17CFD534DA/Payment_NHS_report_accessible.pdf 
Audit Commission (2004c) Older people: building a strategic approach, The Stationery Office, 
London. http://www.audit-commission.gov.uk/Products/NATIONAL-REPORT/E7EB90FE-
1DE9-4D09-B0E6-897A7E0EE46D/OlderPeople2_web_2.pdf 
Audit Commission (2004d) Transforming primary care: the role of primary care trusts in shaping and 
supporting general practice, The Stationery Office, London. http://www.audit-
commission.gov.uk/Products/NATIONAL-REPORT/8AE80592-69BC-48bc-AA1A-
C707CFAD8DE0/TransformingPrimaryCare.pdf 
Calman, K. C. and The Expert Advisory Group On Cancer (1995) A Policy Framework For 
Commissioning Cancer Services: Guidance For Purchasers And Providers Of Cancer 
Services. Department of Health, London. 
http://www.publications.doh.gov.uk/pub/docs/doh/cancerfr.pdf 
Cooke, J., Mason, A. R., Drummond, M. F. and Towse, A. K. (2005) Medication management in 
English National Health Service hospitals. American Journal of Health System Pharmacy, 62, 
2: 189-95. 
Crown, J. (1999) Review of Prescribing, Supply & Administration of Medicines: Final Report (The 
Crown Report), Department of Health, London. 
http://www.dh.gov.uk/assetRoot/04/07/71/53/04077153.pdf 
Davies, H. T. and Shields, A. V. (1999) Public trust and accountability for clinical performance: 
lessons from the national press reportage of the Bristol hearing. Journal of Evaluation in 
Clinical Practice, 5, 3: 335-42. 
Department of Health (1997) The New NHS: Modern, Dependable. HMSO, London. 
http://www.archive.official-documents.co.uk/document/doh/newnhs/newnhs.htm 
Department of Health (1998) A First Class Service: Quality in the new NHS. Department of Health, 
London. 
http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/
PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4006902&chk=j2Tt7C 
Department of Health (1999) National Service Framework for Mental Health: Modern Standards and 
Service Models, Department of Health, London. 
http://www.dh.gov.uk/assetRoot/04/07/72/09/04077209.pdf 
Department of Health (2000a) National Service Framework for Coronary Heart Disease: Modern 
Standards and Service Models, Department of Health, London. 
http://www.dh.gov.uk/assetRoot/04/05/75/26/04057526.pdf 
Department of Health (2000b) The NHS Plan: a plan for investment, a plan for reform, The Stationery 
Office Limited, London. http://www.dh.gov.uk/assetRoot/04/05/57/83/04055783.pdf 
Department of Health (2001a) Guidance on free nursing care in nursing homes, Department of 
Health, London. http://www.dh.gov.uk/assetRoot/04/01/22/04/04012204.pdf 
Department of Health (2001b) National Service Framework for Older People, Department of Health, 
London. http://www.dh.gov.uk/assetRoot/04/07/12/83/04071283.pdf 
Department of Health (2001c) NHS funded nursing care: practice guide and workbook, Department of 
Health, London. http://www.dh.gov.uk/assetRoot/04/07/10/16/04071016.pdf 
Department of Health (2002a) National Service Framework for Diabetes, Department of Health, 
London. http://www.dh.gov.uk/assetRoot/04/05/89/38/04058938.pdf 
Department of Health (2002b) Reforming NHS financial flows: introducing payment by results, 
Department of Health, London. http://www.dh.gov.uk/assetRoot/04/01/87/04/04018704.pdf 
http://www.dh.gov.uk/assetRoot/04/01/87/05/04018705.pdf 
Description of the Benefit Catalogue England 58 
Department of Health (2003a) Chair announced for Independent Healthcare Regulatory Council. 
Press release; 2003/0058. 
Department of Health (2003b) Consultant contract, Department of Health, London. 
http://www.modern.nhs.uk/consultants/14680/Contract.pdf 
Department of Health (2003c) Delivering Investment in General Practice: implementing the new GMS 
contract. 
http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/
PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4070242&chk=tokzna 
Department of Health (2003d) Guidance on NHS funded nursing care, Department of Health, London. 
http://www.dh.gov.uk/assetRoot/04/01/23/03/04012303.pdf 
Department of Health (2004a) 2005 Pharmaceutical Price Regulation Scheme, Department of Health, 
London. http://www.dh.gov.uk/assetRoot/04/09/32/32/04093232.pdf 
Department of Health (2004b) Choosing health: making healthy choices easier, The Stationery Office, 
London. 
http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/
PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4094550&chk=aN5Cor 
Department of Health (2004c) Health secretary welcomes new fertility guideline. Press Release; 
2004/0069. 
Department of Health (2004d) Implementation of new general medical services and personal medical 
services contracts in primary care. http://www.dh.gov.uk/assetRoot/04/09/37/62/04093762.pdf 
Department of Health (2004e) Increased funding for care home residents receiving nursing care. 
Press Release; 2004/0456: 2p. 
Department of Health (2004f) John Reid sets out next steps to improve efficiency and cut bureaucracy 
in NHS. Press Release; 2004/0428. 
Department of Health (2004g) National Service Framework for Children, Young People and Maternity 
Services, Department of Health, London. 
http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/ChildrenServices/Child
renServicesInformation/ChildrenServicesInformationArticle/fs/en?CONTENT_ID=4089111&ch
k=U8Ecln 
Department of Health (2004h) National Service Framework for Renal services, Department of Health, 
London. http://www.dh.gov.uk/assetRoot/04/07/05/25/04070525.pdf 
Department of Health (2004i) National Standards, Local Action: Health and Social Care Standards 
and Planning Framework 2005/06–2007/08. Department of Health, London. 
http://www.dh.gov.uk/assetRoot/04/08/60/58/04086058.pdf 
Department of Health (2004j) New GMS Contract Quality and Outcomes Framework: Determining 
Aspiration Payments for 2004/2005 – Guidance Note for Practices. 
http://www.dh.gov.uk/assetRoot/04/08/47/04/04084704.PDF 
Department of Health (2004k) NHS Dentistry: Delivering Change. Report by the Chief Dental Officer. 
Department of Health, London. http://www.dh.gov.uk/assetRoot/04/08/59/75/04085975.pdf 
Department of Health (2004l) Quality and outcomes framework: Guidance (Updated August 2004). 
Department of Health, London. http://www.dh.gov.uk/assetRoot/04/08/86/93/04088693.pdf 
Department of Health (2004m) Reconfiguring the Department of Health’s Arm’s Length Bodies. 
Department of Health, London. http://www.dh.gov.uk/assetRoot/04/09/81/36/04098136.pdf 
Department of Health (2004n) Reforms with bite: 1000 more NHS dentists by October 2005: Reid 
unveils £368m funding injection for NHS dentistry. Press release; 2004/0265. 
Department of Health (2004o) Reid - Reducing NHS bureaucracy to release resources to the frontline. 
Press Release; 2004/0271. 
Department of Health (2004p) Reid announces new national screening programme to tackle bowel 
cancer. Press Release; 2004/0383. 
Department of Health (2004q) Standards for Better Health. London: DoH 2004, London. 
http://www.dh.gov.uk/assetRoot/04/08/66/66/04086666.pdf 
Department of Health (2004r) Sustaining innovation through new PMS arrangements: revised 18th 
March 2004, Department of Health, Leeds. 
http://www.dh.gov.uk/assetRoot/04/07/80/39/04078039.pdf 
Healthcare Commission (2004) Assessment for improvement: our approach: a consultation document 
on the assessment of the performance of healthcare organisations, Consultation document: 
deadline for response 21/2/2005., London. 
http://www.healthcarecommission.org.uk/assetRoot/04/01/16/22/04011622.pdf 
CHE Research Paper 2 
 
   
59
Healthcare Commission (2005) Assessment for improvement: The annual health check - measuring 
what matters, Healthcare Commission, London. 
http://www.healthcarecommission.org.uk/assetRoot/04/01/68/28/04016828.pdf 
HM Treasury (2004) 2004 Spending review: public service agreements 2005-2008, Stationery Office, 
London. http://www.hm-
treasury.gov.uk/spending_review/spend_sr04/report/spend_sr04_repindex.cfm 
House of Commons Health Committee (2005) NHS Continuing Care. House of Commons Information 
Office, London. http://www.parliament.the-stationery-
office.co.uk/pa/cm200405/cmselect/cmhealth/399/399i.pdf 
House of Commons Information Office (2002) Statutory Instruments: Factsheet L7, House of 
Commons Information Office, London.  
Kaplan, R. S. and Norton, D. P. (1992) The balanced scorecard - measures that drive performance. 
Harvard Business Review, 70, 1: 71-9. 
Kelly, M., McDaid, D., Ludbrook, A. and Powell, J. (2003) Economic Appraisals of Public Health 
Interventions. Paper prepared for the Wanless Team, H.M. Treasury. 
Kennedy, I., Howard, R., Jarman, B. and Maclean, M. (2001) Learning from Bristol: the report of the 
public inquiry into children's heart surgery at the Bristol Royal Infirmary 1984 -1995.  
Command Paper: CM 5207, Bristol Royal Infirmary Inquiry, Bristol. www.bristol-inquiry.org.uk 
Klein, R. (1997) The rationing debate. Defining a package in healthcare services the NHS is 
responsible for. The case against. Bmj, 314, 7079: 506-9. 
Kmietowicz, Z. (2005) NICE proposes to withdraw Alzheimer's drugs from NHS. Bmj, 330, 7490: 5. 
Martin, D. (2005) PCTs must make sexual health a priority, minister warns. Health Service Journal, 16 
February. 
Maynard, A. and Bloor, K. (2004) Reforming the consultant contract again? Bmj, 329, 7472: 929-30. 
Maynard, A., Bloor, K. and Freemantle, N. (2004) Challenges for the National Institute for Clinical 
Excellence. Bmj, 329, 7459: 227-9. 
Montgomery, J. (2003) Health Care Law, Oxford University Press, Oxford.  
National Collaborating Centre for Women’s and Children’s Health (2004) NICE Clinical Guideline No. 
11: Fertility: assessment and treatment for people with fertility problems, Royal College of 
Obstetricians and Gynaecologists, London.  
National Institute for Clinical Excellence (2004) Guide to the Methods of Technology Appraisal. 
http://www.nice.org.uk/pdf/TAP_Methods.pdf 
Newdick, C. (2005a) Evaluating new health technology in the English National Health Service. in Jost, 
T. S. (Ed.) Health Care Coverage Determinations: an international comparative study, Open 
University Press, Maidenhead. 
Newdick, C. (2005b) Who should we treat?  Rights, Rationing and Resources in the NHS, Oxford 
University Press, Oxford.  
Oliver, A. (2002) Reforming public sector dentistry in the UK. British Journal of Health Care 
Management, London, 8, 6: p 212-216. 
Parkes, J., Chase, D. L., Grace, A., Cunningham, D. and Roderick, P. J. (2005) Inequity of use of 
implantable cardioverter defibrillators in England: retrospective analysis. Bmj, 330, 7489: 454-
5. 
Prescription Pricing Authority (2005) Electronic Drug Tariff, Prescription Pricing Authority. 
http://www.ppa.org.uk/edt/April_2005/mindex.htm 
Rogers, R., Williams, S., Jarman, B. and Aylin, P. (2005) HRG drift and payment by results. Bmj, 330, 
7491: 12. 
Secretary of State for Health (1977) National Health Service Act, Chapter 49, HMSO, London.  
Secretary of State for Health (1986) National Health Service (General Ophthalmic Services) 
Regulations 1986 (S.I. 1986/975), HMSO, London. 
http://www.dh.gov.uk/assetRoot/04/10/12/42/04101242.pdf 
Secretary of State for Health (1990) National Health Service and Community Care Act 1990, Chapter 
19, HMSO, London. 
http://www.legislation.hmso.gov.uk/acts/acts1990/Ukpga_19900019_en_1.htm 
Secretary of State for Health (1992a) The National Health Service (General Dental Services) 
Regulations 1992 (S.I. 1992/661), HMSO, London. 
http://www.legislation.hmso.gov.uk/si/si1992/Uksi_19920661_en_1.htm 
Secretary of State for Health (1992b) The National Health Service (Pharmaceutical Services) 
Regulations 1992 (S.I. 1992/662), HMSO, London. 
http://www.legislation.hmso.gov.uk/si/si1992/Uksi_19920662_en_1.htm 
Description of the Benefit Catalogue England 60 
Secretary of State for Health (1998) Human Rights Act 1998, Chapter 42, The Stationery Office 
Limited. http://www.legislation.hmso.gov.uk/acts/acts1998/19980042.htm 
Secretary of State for Health (1999a) Health Act, Chapter 8, The Stationery Office Limited, London. 
http://www.legislation.hmso.gov.uk/acts/acts1999/19990008.htm 
Secretary of State for Health (1999b) The National Institute for Clinical Excellence (Establishment and 
Constitution) Amendment Order 1999 (S.I. 1999/2219), The Stationery Office Limited. 
http://www.legislation.hmso.gov.uk/si/si1999/19992219.htm 
Secretary of State for Health (1999c) The National Institute for Clinical Excellence (Establishment and 
Constitution) Order 1999 (S.I. 1999/220), The Stationery Office Limited. 
http://www.legislation.hmso.gov.uk/si/si1999/19990220.htm 
Secretary of State for Health (2001a) Health and Social Care Act 2001, Chapter 15, The Stationery 
Office, London. http://www.legislation.hmso.gov.uk/acts/acts2001/20010015.htm 
Secretary of State for Health (2001b) National Health Service Act 1977: Directions to Health 
Authorities, Primary Care Trusts and NHS Trusts in England, The Stationery Office Limited, 
London. 
http://www.info.doh.gov.uk/doh/finman.nsf/0/6dbfb0cd58b8139180256b2100615694?OpenDo
cument 
Secretary of State for Health (2002) The National Health Service (Functions of Strategic Health 
Authorities and Primary Care Trusts and Administration Arrangements) (England) Regulations 
2002 (S.I. 2002/2375), The Stationery Office, London. 
http://www.hmso.gov.uk/si/si2002/20022375.htm 
Secretary of State for Health (2003) Health and Social Care (Community Health and Standards) Act 
2003, The Stationery Office Limited, London. 
http://www.legislation.hmso.gov.uk/acts/acts2003/20030043.htm#aofs 
Secretary of State for Health (2004a) The National Health Service (General Medical Services 
Contracts) Regulations 2004 (S.I. 2004/291), The Stationery Office Limited, London. 
http://www.legislation.hmso.gov.uk/si/si2004/20040291.htm 
Secretary of State for Health (2004b) Statement of Dental Remuneration (SDR): Amendment No. 92, 
Department of Health, London. http://www.dh.gov.uk/assetRoot/04/08/11/28/04081128.pdf 
Secretary of State for Health (2005a) The National Health Service (Pharmaceutical Services) 
Amendment Regulations 2005 (S.I. 2005/1015), HMSO, London. 
http://www.legislation.hmso.gov.uk/si/si2005/20051015.htm 
Secretary of State for Health (2005b) The National Health Service (Pharmaceutical Services) 
Regulations 2005 (S.I. 2005/641), HMSO, London. 
http://www.legislation.hmso.gov.uk/si/si2005/20050641.htm 
Secretary of State for Health (2005c) Statement of Dental Remuneration (SDR): Amendment No. 93, 
Department of Health, London. http://www.dh.gov.uk/assetRoot/04/10/69/30/04106930.pdf 
Sheldon, T. A., Cullum, N., Dawson, D., Lankshear, A., Lowson, K., Watt, I., West, P., Wright, D. and 
Wright, J. (2004) What's the evidence that NICE guidance has been implemented? Results 
from a national evaluation using time series analysis, audit of patients' notes, and 
interviews.[see comment]. Bmj, 329, 7473: 30. 
Street, A. and AbdulHussain, S. (2004) Would Roman soldiers fight for the financial flows regime?: 
the re-issue of Diocletian's Edict in the English NHS. Public Money and Management, 24, 5: 
301-308. 
Sutherland, S. S. (1999) Royal Commission on Long Term Care for the Elderly.  With respect to old 
age: long term care - rights and responsibilities, The Stationery Office, London. 
http://www.archive.official-documents.co.uk/document/cm41/4192/4192.htm 
UK National Screening Committee (2004) UK National Screening Committee's Policy Positions and 
estimated timeframe for future consideration. Director’s Annual Report.  Appendix 4. 
Yates, J. (1995) Private eye, heart and hip: surgical consultants, the National Health Service and 
private medicine, Churchill Livingstone, Edinburgh.  
 
CHE Research Paper 2 
 
   
61 
Appendix 
Table 9: International Classification for Health Accounts (ICHA) categories: The National Health Service (England) 
ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
HC.1 Services 
of curative 
care 
HC.1.1 In-patient 
curative care 
 Yes Acts: 1 
NHS plan: 
2 
NSFs: 2 or 
3 
NICE 
guidance: 
2 or 3 
National Health Service Act 
1946 (c. 81) ss. 3(1)(a)-(c), 4 
National Health Service Act 
1977 (c. 49) ss. 3(1)(a)-(c), 4 
R v NW Lancashire Health 
Authority, ex p A, D and G, 
made it illegal for health 
authorities to impose a blanket 
ban on gender reassignment 
surgery or any other ‘low 
priority’ areas86  
The NHS Plan (2000) 
announced guaranteed waiting 
times, refined by the Public 
Service Agreements, 2004 
Some services covered by 
NSFs, e.g. NSF Paediatric 
Intensive Care (1997); NSF 
Mental Health (1999), NSF for 
renal services (2004); 
(transplantation) 
NICE guidance on interventional 
procedures 
NICE clinical guidelines (e.g. 
Head Injury, CG4) 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
Department of 
Health sets 
standards through 
NSFs  
NICE 
NHS Trusts / 
Foundation Trusts 
SHAs 
Physicians 
None 
 HC.1.2 Day cases 
of curative care 
 Yes Implicit See HC1.1 (no explicit 
reference to day care) 
The NHS Plan (2000) 
announced guaranteed waiting 
times, refined by the Public 
Service Agreements, 2004 
Some services covered by 
NSFs, NSF for renal services 
(2004) aims to increase fairness 
of access and improve choice 
and quality in dialysis and 
provides guidance on day 
surgery. 
NICE guidance on interventional 
See HC1.1 (no 
explicit reference 
to day care) 
None 
                                                     
85 In addition, almost all legislation is subject to Parliamentary approval, either explicitly or implicitly. 
86 Unless the clinical evidence of its inefficacy is overwhelming Newdick, C. (2005b) Who should we treat?  Rights, Rationing and Resources in the NHS, Oxford University Press, Oxford. ;(page 107) 
Description of the Benefit Catalogue England 62 
ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
procedures 
NICE appraisal No 48 
recommends that all suitable 
patients be offered the choice 
between home haemodialysis or 
haemodialysis in a 
hospital/satellite unit. 
NICE clinical guidelines (e.g. 
Head Injury, CG4) 
 HC.1.3 Out-patient 
care 
HC.1.3.1 Basic 
medical and 
diagnostic 
services 
Yes Acts: 1 
SIs: 1 to 3 
NHS plan: 
2 
NSFs: 2 or 
3 
NICE 
guidance: 
2 or 3 
National Health Service Act 
1946 (c. 81) ss. 33-34 
National Health Service Act 
1977 (c. 49) ss. 3(1)(c), 15(1) 
National Health Service 
(General Medical Services 
Contracts) Regulations 2004 
(S.I. 2004/291), reg. 
15(3)(5)(6)(8)(essential 
services) 
National Health Service 
(General Medical Services 
Contracts) Regulations 2004 
(S.I. 2004/291), r. 17, 30-32, 
Sch.3, Sch 6(10-13, 70), Sch 7 
(out of hours care) 
The NHS Plan (2000) 
announced guaranteed waiting 
times, refined by the Public 
Service Agreements, 2004 
NSF for Mental Health (1999) 
specifies. 24 hr access to duty 
doctor (section 12 approved) 
and approved social worker 
NICE guidance on interventional 
procedures 
NICE clinical guidelines (e.g. 
Head Injury, CG4) 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
Department of 
Health 
NHS 
Confederation 
British Medical 
Association 
NHS Trusts / 
Foundation Trusts 
General Medical 
Practitioners 
None 
  HC.1.3.2 Out-
patient dental 
care  
Yes Acts: 1 
SIs: 1 to 3 
NHS plan: 
2 
National Health Service Act 
1946 (c. 81) s. 22 (1), 40 
National Health Service Act 
1977 (c. 49) ss. 3(1)(c), 15 (1), 
35-37 
The NHS Plan (2000) 
announced the government‘s 
commitment to ensure universal 
access to NHS dentists for all 
who want it  
NICE clinical guidelines (e.g. 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
Department of 
Some cosmetic 
treatments, such 
as teeth 
whitening87 
implicitly excluded 
                                                     
87 http://www.dentalhealth.org.uk/faqs/leafletdetail.php?LeafletID=30, accessed 17/03/05 
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ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
NICE 
guidance: 
2 or 3 
National Health Service 
(General Dental Services) 
Regulations 1992 (S.I. 
1992/661) 
Statement of Dental 
Remuneration, Amendment 93 
to S.I. 1992/661 
Dental recall, CG19) Health 
Doctors and 
Dentists Review 
Body 
General Dental 
Practitioners 
  HC.1.3.3 All 
other 
specialised 
health care 
Yes Acts: 1 
SIs: 1 to 3 
NHS plan: 
2 
NSFs: 2 or 
3 
NICE 
guidance: 
2 or 3 
National Health Service Act 
1946 (c. 81), s. 3(c) specialist 
services in hospital, outpatient 
clinic and home 
Mental Health Act 1983 (c. 20) 
National Health Service 
(General Medical Services) 
Regulations 1992 (S.I. 
1992/635), s. 32-33 (minor 
surgery) 
National Health Service 
(General Medical Services 
Contracts) Regulations 2004 
(S.I. 2004/291), Sch. 2(8) (minor 
surgery) 
NHS Plan (2000) announced 
‘general practitioners with 
special interests’ (ch 12, §7); 
PCT must ensure that there is 
evidence that the GP has the 
necessary competencies for the 
role, using guidelines from the 
relevant Royal Colleges 
NSFs cover some specialist 
outpatient care, e.g. the NSF for 
Children (Mental Health and 
Psychological Wellbeing) 
outlines specialised services for 
more severe, complex or 
persistent disorders.  
Some relevant topics covered by 
NICE technology appraisals 
(e.g. atypical antipsychotics), 
NICE clinical guidelines (e.g. 
Eating Disorders CG9) 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
Department of 
Health 
NICE 
Royal Colleges 
Physicians 
None 
  HC.1.3.9 All 
other out-patient 
curative care  
Yes Acts: 1 
NSFs: 2 or 
3 
National Health Service Act 
1946 (c. 81), s. 23 (midwives), 
s. 24 (health visitors), s. 25 
(home nurses) 
National Health Service Act 
1977 (c. 49) s. 15 (1), 38-40 
(ophthalmic services) 
Health and Social Care Act 
NSFs cover some paramedical 
services, e.g. the NSF for 
Cancer (2000) recommends that 
physiotherapy, dietetics, speech 
therapy and occupational 
therapy services should be 
easily available. 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
 
None 
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ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
2001 (c. 15), s. 63 (extension of 
prescribing rights to other 
practitioners) 
 HC.1.4 Services of 
curative home care 
 Yes Acts: 1 
SI: 1 
NSFs: 2 or 
3 
National Health Service Act 
1946 (c. 81), s. 23 (midwives), 
s. 24 (health visitors), s. 25 
(home nurses) 
Nurses, Midwives and Health 
Visitors Act 1979 (c. 36) 
Nurses, Midwives and Health 
Visitors Act 1997 (c. 24) 
The Nursing and Midwifery 
Order 2001 (S.I. 2002/253) 
NSFs cover some home-based 
care, e.g. the NSF for Renal 
services (2004) 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
Department of 
Health 
None 
HC.2 Services 
of 
rehabilitative 
care 
HC.2.1 In-patient 
rehabilitative care 
 Yes Acts: 1 
NHS plan: 
2 
NSFs: 2 or 
3 
NICE 
guidance: 
2 or 3 
National Health Service Act 
1977 (c. 49) s. 3(1)(e) 
The NHS Plan (2000) 
announces new intermediate 
care services, reflected in the 
NSF for Older People 
(2001);(standard 3) 
NSF for Mental Health (1999) 
includes requirement that all 
users needing rehabilitation 
have access (standard 5) 
NICE clinical guideline on 
Supportive and Palliative Care 
(CSG) recommends access to 
‘comprehensive rehabilitation 
services’ in all settings 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
Department of 
Health sets 
standards through 
NSFs 
NHS Trusts / 
Foundation Trusts 
None 
 HC.2.2 Day cases 
of rehabilitative 
care 
 Yes Implicit See HC2.1 (no explicit 
reference to day care) 
See HC2.1 See HC2.1  
 HC.2.3 Out-patient 
rehabilitative care 
 Yes Acts: 1 
SIs: 1 to 3 
National Health Service Act 
1946 (c. 81), s. 28 (optional) 
Mental Health Act 1983 (c. 20), 
NSF for Coronary Heart Disease 
(2000) recommends that NHS 
Trusts offer patients cardiac 
rehabilitation programmes 
Secretary of State 
for Health – 
functions 
delegated to 
None 
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ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
NSFs: 2 or 
3 
s. 117 
See also HC2.1 
(standard 12) 
See also HC2.1 
PCTs 
NHS Trusts / 
Foundation Trusts 
 HC.2.4 Services of 
rehabilitative home 
care 
 Yes See 
HC2.3 
See HC2.3 See HC2.1 Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
None 
HC.3 Services 
of long-term 
nursing care 
HC.3.1 In-patient 
long-term nursing 
care 
  Acts: 1 
HSCs: 3 
NSFs: 2 or 
3 
National Health Service Act 
1946 (c. 81) s. 3(1)(a)-(c), 4 
National Health Service Act 
1977, (c. 49) ss. 3(1)(a)-(c), 4  
National Health Service Act 
1977, (c. 49) s. 21 
Community Care (Delayed 
Discharges etc.) Act 2003 (c.5) 
SI 2003/2277 (The Delayed 
Discharges (England) 
Regulations 2003) 
HSC2001/17: LAC(2001)26 
(Direction) Guidance on free 
nursing care in nursing homes 
HSC2003/006 (Direction) 
Guidance on NHS funded 
nursing care 
NSF cancer plan (1995) states 
that palliative care and symptom 
control should be available at all 
stages of a patient's illness and 
that hospitals, primary care, 
social services and the voluntary 
sector should all be involved. 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
Local authorities 
None 
 HC.3.2 Day cases 
of long-term 
nursing care 
  See 
HC3.1 
See HC3.1   None 
 HC.3.3 Long-term 
nursing care: home 
care 
  Acts: 1 
SIs: 1 to 3 
Community Care (Delayed 
Discharges etc.) Act 2003 (c.5) 
SI 2003/2277 (The Delayed 
The NHS Plan (2000) 
announces free nursing home 
care, reflected in the NSF for 
Department of 
Health 
None 
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ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
NHS plan: 
2 
Discharges (England) 
Regulations 2003) 
See also HC3.1 
Older People.   
Eligibility criteria for NHS 
continuing care currently under 
review (April 2005) 
SHAs 
Ombudsman 
HC.4 Ancillary 
services to 
health care 
HC.4.1 Clinical 
laboratory 
 Optional Acts: 1 
SIs: 1 to 3 
NHS Act1946 (s. 17) 
(bacteriological service, 
optional) 
National Health Service Act 
1977 (c. 49), s. 5 (2)(c) 
(microbiological service; 
optional) 
Microbiological Research 
Authority Regulations 1994 (S.I. 
1994/602) 
 Secretary of State 
for Health, 
delegated to 
PCTs 
None 
 HC.4.2 Diagnostic 
imaging 
  Acts: 1 
NICE 
guidance: 
2 or 3 
National Health Service Act 
1977 (c. 49) s. 3(f) 
NICE technology appraisals 
have covered some relevant 
topics (e.g. ultrasound locating 
devices for placing central 
venous catheters) 
Secretary of State 
for Health, 
delegated to 
PCTs 
NHS Trusts / 
Foundation Trusts 
None 
 HC.4.3 Patient 
transport and 
emergency rescue 
 Yes Acts: 1 National Health Service Act 
1946 (c. 81), s. 27  
National Health Service Act 
1977 (c. 49) s. 3(1)(c) 
Health and Social Care 
(Community Health and 
Standards) Act 2003 (c. 43), s. 
167 (payments) 
 Secretary of State 
for Health, 
delegated to 
PCTs 
Ambulance Trusts 
None 
 HC.4.9 All other 
miscellaneous 
services 
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ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
HC.5 Medical 
goods 
dispensed to 
out-patients 
HC.5.1 
Pharmaceuticals 
and other medical 
non-durables 
HC.5.1.1 
Prescribed 
medicines 
Yes Acts: 1 
SIs: 1 to 3 
NHS plan: 
2 
NSFs: 2 or 
3 
NICE 
guidance: 
2 or 3 
National Health Service Act 
1946 (c. 81) ss. 38, 39 
Medicines Act 1968 (c. 67), (ss. 
51, 58, 60) 
National Health Service Act 
1977 (c. 49) ss 15(1), .41 
Health and Medicines Act 1988 
(c. 49) 
Prescription Only Medicines 
(Human Use) Order, 1997 (S.I. 
1997/1830) 
National Health Service 
(General Medical Services 
Contracts) Regulations 2004 
(S.I. 2004/291), §38-52 (note: 
excess prescribing unlawful, 
volume or cost) 
National Health Service 
(Pharmaceutical Services) 
Regulations 2005 (S.I. 
2005/641) 
The NHS Plan (2000) seeks to 
end the postcode lottery for 
cancer drugs 
NICE technology appraisals of 
new and existing treatments 
contain recommendations for 
NHS use. 
NICE clinical guidelines 
NSFs include recommendations 
for the use of some drugs, such 
as the NSF for Mental Health 
(1999), which sets the target 
that all service users should be 
assessed for, and receive where 
indicated, new antipsychotic 
drugs. 
European 
Commission and 
EMEA 
Secretary of State 
for Health (‘black’ 
and ‘grey’ lists) 
MHRA (licensing) 
Medicines 
Commission, 
Committee on 
Safety of 
Medicines 
(advisory) 
PPRS 
PPA 
General medical 
practitioners 
Black and grey 
listed drugs 
explicitly excluded 
(3) 
Drugs and devices 
receiving negative 
appraisal by NICE 
are explicitly 
excluded (3) 
  HC.5.1.2 Over-
the-counter 
medicines  
Yes Acts: 1 Medicines Act 1968 (c. 67), s. 
12 (herbal medicines) 
 MHRA 
Advisory Board 
on the 
Registration of 
Homoeopathic 
Products 
 
 HC.5.2 
Therapeutic 
appliances and 
other medical 
durables 
HC.5.2.1 
Glasses and 
vision products 
Yes Acts: 1 
SIs: 1 to 3 
National Health Service Act 
1946 (c. 81), ss. 41,  
Opticians Act 1958 (c. 44) 
National Health Service Act 
 Primary Care 
Trusts 
NHS Trusts 
Ophthalmic 
NHS glasses and 
vouchers are not 
available to 
working age 
adults, with some 
age- or income-
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ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
1977 (c. 49) ss. 15(1), 38-40 
(ophthalmic services), 77-79 
(charges) 
Health and Medicines Act 1988 
(c. 49), ss. 13-14 
The National Health Service 
(Optical Charges and 
Payments) and (General 
Ophthalmic Services) 
Amendment Regulations 2004 
(S.I. 2004/642) 
opticians related exceptions 
(explicitly 
excluded, 3). 
  HC.5.2.2 
Orthopaedic 
appliances and 
other 
prosthetics 
 NICE 
guidance: 
2 or 3 
 Some relevant NICE technology 
appraisals, e.g. Hip disease - 
replacement prostheses (No. 
2)(2000) 
 None 
  HC.5.2.3 
Hearing aids 
 NICE 
guidance: 
2 or 3 
 NICE guidance No.8 (2000) 
recommended use of the full 
range of analogue hearing aids, 
but did not recommend a 
national introduction of digital 
hearing aids –guidance 
withdrawn three years later 
following widespread adoption of 
digital aids 
 None 
  HC.5.2.4 
Medico-
technical 
devices, incl. 
wheelchairs 
Yes Acts: 1 National Health Service Act 
1977 (c. 49), s. 5 (2)(a) 
(optional) 
 Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
None 
  HC.5.2.9 All 
other 
miscellaneous 
medical 
durables  
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ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
HC.6 
Prevention 
and public 
health 
services 
HC.6.1 Maternal 
and child health; 
family planning and 
counselling 
 Yes Acts: 1 
SIs: 1 to 3 
NHS plan: 
2 
NSFs: 2 or 
3 
Maternal and child health: 
National Health Service Act 
1946 (c. 81), s. 22 
National Health Service Act 
1977 (c. 49), s. 3(d) 
National Health Service 
(General Medical Services 
Contracts) Regulations 2004 
(S.I. 2004/291), Sch. 2(5-7) 
The NHS Plan (2000) 
announces an expansion of 
cancer screening, reflected in 
the NSF for Older People 
NSF for Children, Young People 
and Maternity Services 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
General Medical 
Practitioners 
Some routine 
tests for pregnant 
women, neonates 
and children 
explicitly excluded 
(3) 
Screening children 
for a range of 
diseases explicitly 
excluded (3) 
   Yes Acts: 1 
SIs: 1 to 3 
NICE 
guidance: 
2 or 3 
NSF: 2 or 
3 
Family planning: 
National Health Service Act 
1977 (c. 49), s. 5(1)(b) 
National Health Service 
(General Medical Services 
Contracts) Regulations 2004 
(S.I. 2004/291), Sch.2 (3) 
Some relevant topics covered by 
NICE technology appraisals 
(e.g. routine anti-D prophylaxis), 
NICE clinical guidelines (e.g. 
induction of labour, fertility) and 
NICE guidance in interventional 
procedures (e.g. hysteroscopic 
sterilisation) 
NSF for Children, Young People 
and Maternity Services 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
General Medical 
Practitioners 
 
    Acts: 1 
SIs: 1 to 3 
NSFs: 2 or 
3 
Abortion Act 1967 (c. 87) 
Abortion Regulations 1991 (S.I. 
1991/499) 
Abortion (Amendment) 
(England) Regulations 2002 
(S.I. 2002/887) 
NSF for Children, Young People 
and Maternity Services states 
that young women [should] have 
early and easy access to free 
pregnancy testing, unbiased 
advice and speedy referral for 
NHS funded abortion or ante-
natal care. 
  
 HC.6.2 School 
health services 
 Yes Acts: 1 National Health Service Act 
1977 (c. 49), s. 5 (1)(a) 
Health and Medicines Act 1988 
(c. 49), ss. 10(1) (school dental 
provision no longer mandatory) 
 Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
 
 HC.6.3 Prevention  Yes Acts: 1 National Health Service Act NICE technology appraisals Secretary of State Single vaccines 
Description of the Benefit Catalogue England 70 
ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
of communicable 
diseases SIs: 1 to 3 
NICE 
guidance: 
2 or 3 
NSF: 2 or 
3 
1946 (c. 81), ss. 1(1)(b) 
(general prevention), s. 17 
(bacteriological service, 
optional), 26 (vaccination / 
immunisation), 28 (prevention of 
illness, optional) 
National Health Service Act 
1977 (c. 49), ss. 1(1)(b) 
(general prevention), 5 (2)(c) 
(microbiological service; 
optional), 5(4) (Public Health 
Laboratory Board)  
Public Health (Control of 
Diseases) Act 1984 (c. 22) 
Public Health (Infectious 
Diseases) Regulations 1988 
(S.I. 1988/1564) 
National Health Service 
(General Medical Services) 
Regulations 1992 (S.I. 
1992/635), r.3(2), Sch. 2 
(12)(2)(c) (vaccination / 
immunisation) 
National Health Service 
(General Medical Services 
Contracts) Regulations 2004 
(S.I. 2004/291), Sch 2 (4-5) 
(vaccination / immunisation) 
Health Protection Act 2004 (c. 
17), s. 2(b) 
include preventative 
technologies (e.g. appraisal No. 
67, amantadine and oseltamivir 
for the prevention of influenza). 
NSF for Children, Young People 
and Maternity Services states 
that young people [should be] 
informed of the risks of 
unprotected sexual activity, and 
of sexually transmitted infections 
and the potential consequences 
of teenage pregnancy…with 
rapid access to testing and 
treatment 
for Health – 
functions 
delegated to 
PCTs 
Local authorities 
for measles, 
mumps and 
rubella 
Smallpox 
vaccination 
 HC.6.4 Prevention 
of non-
communicable 
diseases 
 Yes Acts: 1 
SIs: 1 to 3 
NSFs: 2 or 
National Health Service Act 
1977 (c. 49), s. 1(b) 
National Health Service 
(General Medical Services) 
Regulations 1992 (S.I. 
NICE clinical guidelines may 
include screening advice (e.g. 
familial breast cancer, CG14). 
National service frameworks 
may include advice on screening 
Secretary of State 
for Health – 
functions 
delegated to 
PCTs 
Screening for 
some cancers, 
Alzheimer’s and 
depression 
(amongst others) 
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ICHA-HC 
1 digit level 
 
ICHA-HC 
2 digit level 
ICHA-HC 
3 digit level 
Included Implicit/ 
explicit4 
inclusion 
Legislation Regulation Actors (decision 
makers)85 
Implicit / explicit4 
exclusion 
3 
NICE 
guidance: 
2 or 3 
1992/635), r.3(2) Sch. 2 (15)(1) 
(consultations, adults under 75); 
Sch. 2 (16) (consultations, 
adults 75 and over) 
National Health Service 
(General Medical Services 
Contracts) Regulations 2004 
(S.I. 2004/291), Sch.2 
(2)(Cervical screening), Sch 6 
(4-6) (annual health checks) 
National Health Service 
(Pharmaceutical Services) 
Regulations 2005 (S.I. 
2005/641), regs. 15, 17 
for particular disease areas (e.g. 
NSF for coronary heart disease; 
NSF for Mental Health) 
Local authorities 
UK National 
Screening 
Committee 
General 
practitioner  
 HC.6.5 
Occupational 
health care 
  Act: 1 Health and Safety at Work Act 
1974 
 Local authorities  
 HC.6.9 All other 
miscellaneous 
public health 
services 
  Acts: 1 
SIs: 1 to 3 
Ministry of Health Act 1919 (c. 
21) 
Food Safety Act 1990 (c. 16) 
Environmental Protection Act 
1990 (c. 43) 
Human Rights Act 1998 (c. 42) 
Health and Social Care Act 
2001 (c. 15) 
Health Protection Agency Act 
2004 (c. 17) 
Blood Safety and Quality 
Regulations 2005 (S.I. 2005/50) 
 Secretary of State 
for Health – 
functions 
delegated to 
SHAs (water 
fluoridation) 
Local authorities 
 
 
